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Abstract: 
Introduction: The molecular regulation of the lifespan of the human corpus luteum 
remains unelucidated.  Clock genes have been reported to be involved in 
reproduction, as regulators of temporal processes in central and peripheral tissues.  
Recent observations of clock gene expression in mammalian ovarian tissue have led 
us to hypothesise that the human corpus luteum expresses clock genes and that this 
expression is involved in regulation of the luteal lifespan.  We aimed to investigate 
whether clock gene expression was down-regulated during luteolysis. 
Methods: Human corpora lutea (n=18) were obtained at time of benign surgery.  
They were dated, based on the time of LH surge, as Early (n=6), Mid (n=6) and Late 
(n=6) luteal phase.  Expression of the canonical clock genes: Per1, Per2, Cry1, Bmal1 
and Clock was analysed using qRT-PCR and localised using immunohistochemistry. 
Results & Discussion: Several cell types, most notably the steriodogenic cells, within 
the human corpus luteum express all of the canonical clock genes.  This suggests that 
a peripheral clock functions within the luteal cells.  There was no significant change 
in the expression or localisation of any of the clock genes across the luteal phases.  
Therefore, any role for the clock genes in the regulation of luteolytic timing is not 
related to changes in their levels of expression or localisation.  Further work is 
required to investigate whether changes in phase-relationships between the expression 
of these genes is involved.  
 
 
Clock genes and the regulation of reproduction 
Cynthia Chen 
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The involvement of clock genes in the temporal regulation of the function and 
lifespan of the corpus luteum (CL) has not been investigated in detail.  
Immunohistochemistry and real-time quantitative PCR techniques were used to 
examine the expression of the canonical clock genes: period1, period2, period3, 
cryptochrome1, cryptochrome2, clock and bmal1, at protein and mRNA levels 
respectively.  The expression of the clock genes was examined in the human CL, 
cultured luteinised granulosa cells, cultured luteal fibroblast-like cells and the ovine 
CL. 
 
The main findings were that clock genes are expressed in the human and ovine CL; 
that this expression is manifest at mRNA and protein level in all discernible cell types 
within the human and ovine CL, and that the pattern of mRNA expression differs 
between the early luteal phase compared to the late luteal phase.  The circadian 
expression of the clock genes was established in the ovine CL during the late luteal 
phase and could not be determined in the human CL, although indications from 
cultured luteinised granulosa cells and luteal fibroblast-like cells suggest that this may 
also be the case in humans.  With the exception of per2, the circadian pattern of clock 
gene expression emerged in the late luteal phase CL when the early luteal phase CL 
did not demonstrate circadian clock gene expression.  This emergence later in the 
lifespan of the CL was akin to that observed in embryonic development, where the 
clock genes are initially non-rhythmic but then acquire circadian rhythmicity with 
age.  In this case, the clock genes have been proposed to perform a non-classical 
circadian timing role in the timing of embryonic development. 
 
The per2 gene was also found to be special, in its loss rather than gain of rhythmic 
gene expression across the luteal lifespan and in its protein localisation in the 
cytoplasm of some granulosa-lutein cells.  The exceptional behaviour of per2 is 
consistent with a growing body of evidence supporting its role as a unique clock gene 
in many respects, able to maintain circadian protein levels in the absence of circadian 
gene expression, integrating peripheral clock inputs and outputs and acting as a 
tumour suppressor gene.   
 
The CL was also found to be a potential target of melatonin regulation, based on its 
possession of melatonin MT1 receptors and the timing of circadian cry1 gene 
expression in the late luteal phase.  The expression of cry1 is known to be directly 
melatonin-induced in the PT and appeared to be similarly activated, downstream of a 
melatonin signal, in the CL.  This supports the evolving view of a hierarchical 
organisation of the central and peripheral clocks, which are integrated in order to 
establish information feedback loops that maintain circadian homeostasis, and which 






2.1 HISTORY OF CHRONOBIOLOGY 
Chronobiology is defined as the study of periodic or cyclic phenomena in living 
organisms (Vitaterna et al., 2001).  Periodic phenomena in natural history have been 
observed and recorded as early as 10 000 BC in Palaeolithic art and described in writing 
as early as the 4th century BC by Androsthenes, Alexander the Great’s scribe (McClung, 
2006, Sturiale, 1997).  Androsthenes recorded the daily diurnal opening and nocturnal 
closing of tamarind tree leaves in Tylos (modern day Bahrain) (McClung, 2006, Sturiale, 
1997, Chandrashekaran, 1998).  Many centuries later, in 1729, the French astronomer, 
Jean-Jacques d’Ortous de Mairan made a departure from astronomy, to perform 
experiments on heliotrope plants, that exhibited the same periodic phenomena as the 
tamarind trees.  He placed the plants in constant darkness and observed that their leaves 
continued to open during the day and close during the night, despite the absence of 
daylight time cues (McClung, 2006, Sturiale, 1997, Chandrashekaran, 1998). 
 
Around 20 years later, the eminent Swedish botanist, Carolus Linnaeus, famously 
designed his flower clock, which consisted of flowers that, predictably and regularly, 
opened and closed at different times of day (Sturiale, 1997, Chandrashekaran, 1998).  
After almost a century, another botanist, Augustin Pyrame de Candolle, determined that 
the free-running period of the heliotrope plant was 22 to 23 hours.  This was discernibly 
shorter than 24 hours and implied that this circadian rhythm was generated, not simply 
as a response to the day-night environment but rather, as an endogenous rhythm 
(McClung, 2006).  Plant leaf movements continued to be used as the only model of 
circadian biology for the next century (Figure  2.1). 
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Figure  2.1 Opening and closing leaf movements of runner bean plants, Phaseolus coccineus (McClung, 2006). 
 
 
It was not until the 1930s, that these repeated observations began to lead towards more 
sophisticated conclusions that still apply today.  It was around this time that German 
chronobiologist, Erwin Bünning, first established that the endogenous circadian rhythm 
of runner bean leaf movements was heritable (Bunning, 1964).  He also hypothesised 
that these plants, by dint of possessing a circadian rhythm in light sensitivity, were able 
to track the daylength by measuring how far the day ‘encroached’ into the night 
(Bunning and Moser, 1969).  He went on to study the circadian rhythms of Drosophila 
eclosion (the emergence of adult fruit flies from their pupa) (Saunders, 2005).  This 
model became one that was also used by Jürgen Aschoff and Colin Pittendrigh, two 
other pioneers of modern chronobiology (Daan, 1998).  It was also around the 1930s that 
Karl von Frisch and Ingeborg Beling performed their classic experiments with 
honeybees which, they deduced, were able to navigate using the sun’s position in the sky 
because they could intrinsically tell the time of day (Sturiale, 1997).  These experiments 
were corroborated around 1950 by another German ethologist, Gustav Kramer, who 
similarly concluded that European starlings also navigated using the sun’s azimuth, 
again by virtue of possessing internal clocks (Schmidt-Koenig et al., 1991). 
 
In the following two decades, Jürgen Aschoff in Germany and Colin Pittendrigh in the 
United States would go on to play key roles in laying the foundations of the biological 
rhythms field as it now stands.  Aschoff worked predominantly with humans and was 
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able to prove that humans, like many other species, possessed and were subject to 
circadian behaviour and physiology (Aschoff, 1998).  He derived several protocols for 
plotting phase response curves that describe the circadian responses to environmental 
cues, particularly to light and its parametric properties, such as intensity and wave 
frequency (Aschoff, 1999).  He thus demonstrated, along with Pittendrigh, that although 
the internal circadian clocks of many species were endogenous, they were entrainable by 
various environmental time cues that he dubbed zeitgebers (from the German zeit 
meaning ‘time and geber meaning ‘giver’) (Aschoff and Pohl, 1978).  Pittendrigh also 
established that internal clocks were temperature-compensated and went on to delineate 
the phase response curve of circadian entrainment by zeitgebers, particularly by the non-
parametric properties of light (Bruce and Pittendrigh, 1956).  These properties refer to 
parameters such as the timing and duration of light exposure (Pittendrigh and Takamura, 
1987).  Bünning, Aschoff and Pittendrigh together established the fundamental 
principles and the central lines of enquiry of biological rhythms research in an early 
culmination of information and discussion with other scientists, in a seminal symposium, 
convened by Pittendrigh in 1960 and chaired by Bünning, held in Cold Spring Harbor, 
USA (Pittendrigh, 1960, Halberg et al., 2003). 
 
The Proceedings from this symposium are still relevant today, despite pre-dating many 
of the key advances in molecular biology that followed Crick and Watson’s elucidation 
of the structure of DNA in 1953 (Watson and Crick, 1953).  They include a list of 
“Empirical Generalizations” on biological clocks, many of which still hold true 
(Pittendrigh, 1960, Evans, 1961).  Amongst these “Generalizations” was the definition 
of circadian rhythms as rhythms that maintain a period that cycled, independently of 
external time cues, in approximately the same period as the earth’s rotation of 24 hours.  
The term, circadian, is derived from the Latin circa meaning ‘about’ and diel meaning 
‘day’ and was first proposed by Franz Halberg in 1959 (Halberg et al., 2003).  The 
“Generalizations” further stated that these rhythms were endogenous, self-sustained 
oscillations that were innate and ubiquitous in all living systems.  It is now evident that 
this is true in virtually all species and at all levels of biological organisation, from the 
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subcellular to the entire organism.  It was also generally recognised that the period and 
phase of these rhythms could be shifted or entrained in a variety of specific ways 
(Lobban, 1960, Pittendrigh, 1960, Cloudsley-Thompson, 1960). 
 
It was at this landmark symposium that biological rhythms were more clearly defined 
and distinguished from physiological rhythms.  Biological rhythms belong to a specific 
class of principally temporal biology that is distinct from that of physiological rhythms, 
in both evolutionary and physiological origin.  Biological rhythms are highly conserved 
and are thought to have arisen early in evolutionary time as a result of adaptation to 
cyclical environmental phenomena (Paranjpe and Sharma, 2005).  The genotoxic stress 
imposed by the ultraviolet rays of the sun is hypothesised to be a key motivator for the 
circadian adaptation to the day-night cycle.  Some argue that an internal clock was 
actually essential to all life originating on our cyclically driven planet.  In any case, the 
possession of an endogenous clock was also a highly selected trait as it allowed the 
organism to anticipate environmental changes, thus enabling it to better optimise its 
energy uptake and expenditure (Paranjpe and Sharma, 2005).  This anticipation can 
clearly be seen when the periodicities of these biological rhythms are maintained at an 
almost constant frequency in the absence of environmental time cues, as was observed in 
de Mairan’s heliotrope plant experiments (Moore-Ede et al., 1984).    
 
Biological rhythms are thus seen to be specifically clock-driven and are not considered, 
like physiological rhythms, to be the incidental temporal results of physiology or 
metabolic processes.  This is further supported by the lack of variation seen in the 
periodicities of biological rhythms between species and organisms of different size and 
metabolic status.  This is in contrast to physiological rhythms, such as heartbeat, which 
vary in periodicity or frequency according to the species and the organism’s activity 
level and temperature.  Biological rhythms generally follow periodicities that reflect 
well-recognised environmental cycles, principally those of the solar day, lunar day, lunar 
month and seasons.  Physiological rhythms tend to comprise a wide continuum of 
infradian and ultradian periodicities.  Infradian rhythms have periods of over 24 hours; 
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such as the œstrous cycle of most vertebrates and ultradian rhythms have periods of less 
than 24 hours, such as the heartbeat of all animals.  The final criterion that biological 
rhythms fulfil, and physiological ones do not, is that they are directly responsive to 
entrainment by environmental phenomena (Pittendrigh, 1960, Lobban, 1960, Aschoff, 
1960). 
 
The main outcome of this historic symposium was the consolidation of the myriad 
strands of research into a single academic discipline that revolved around, effectively, 
just one basic biological phenomenon: chronobiology.  Two central avenues of 
investigation emerged.  One addressed questions regarding the overall properties of 
circadian clocks, classifying their more corporeal aspects such as anatomical localisation 
and gross responses to altered light-dark schedules.  The other focused on the essential 
mathematic characterisation of the rhythms and elucidation of the underlying clockwork 
machinery that generated them.  It emerged, after the discovery of Drosophila mutants 
with aberrant circadian rhythms in 1971 that this machinery occurs at a fundamental 
molecular level (Konopka and Benzer, 1971).  The study of circadian clocks continued 
apace and gathered momentum with the advent of new experimental techniques such as 
the polymerase chain reaction (PCR), developed by Kary Mullis in 1981 (Stetler et al., 
1982).  Nowadays, these two threads of research, effectively the study of the clocks 
versus that of the clockwork, have become less divergent.  The field has in general 
become more integrated as a discipline, looking now at clock systems at various levels of 
organisation, incorporating other biological disciplines.  These other disciplines in turn 
address the issue of clocks and clockwork within their studies.  The integral role that 
biological clocks play in virtually all physiology and behaviour reflect their ancient and 
highly conserved nature and despite their primitive origins, they are complex and highly 





2.2 BEHAVIOURAL PROPERTIES OF CLOCKS 
Circadian behaviour in both plants and animals continue to be observed and measured in 
present-day experiments.  One such measurement involves the production of actograms 
(Acebo and LeBourgeois, 2006, Brown et al., 1990a, Brown et al., 1990b).  Sensors are 
placed on the subject animal that measure physiological and behavioural parameters like 
body temperature, heart rate and locomotor activity.  These parameters are recorded 
continuously over time.  The data is then analysed using software that correlate the 
various parameters measured and incorporate timing intervals such as light-dark 
schedules.  This information is then often presented in circadian research as an actogram 




Figure  2.2 This is a classic example of an actogram.  It was plotted by Harmar et al. and is of a wild-type mouse 
(Shen et al., 2000).  The shaded regions refer to night time and the unshaded regions refer to daytime.  As the 
actogram travels across the x-axis, it logs any locomotor activity with a black spike.  Lack of activity can be seen as 
an absence of episodes (blocks of activity).  The subject’s activity and inactivity is thus continuously recorded.  Each 
day of recording is then charted down the y-axis.  The x-axis is double-plotted to more clearly display any temporal 




This actogram (Figure  2.2) clearly shows the delineation of circadian locomotor activity, 
gated in this instance, with a nocturnal species, to the night time, as represented by the 
prevalence of episodes falling within the shaded areas.  The change in the position of the 
shaded areas refers to a change in the light-dark schedule, where the timing of light and 
dark have been shifted; in a way not unlike that elicited by a jetlag-inducing 
transmeridian flight.  This shift in the environmental phase results in the subject 
responding by similarly phase shifting its physiology and behaviour, in keeping with the 
new light-dark schedule.  It phase shifts its locomotor activity so that it can continue to 
be active in the subjective night, in order to preserve the selective advantage that this 
confers (Paranjpe and Sharma, 2005).  The subject however can only phase shift overt 
circadian behaviour such as locomotor activity by a finite amount each day and so, it can 
take several days for entrainment and re-synchrony to the light-dark schedule to be fully 
achieved (Yamazaki et al., 2000).  Once achieved though, the maintenance of locomotor 
activity within the night time becomes stably maintained as before. 
 
The animal can phase shift in one of two directions; it can either phase advance or phase 
delay (Illnerova et al., 1989).  In this example, the lighting schedules have been 
manipulated to challenge the animal to phase shift its circadian biology, measured using 
its locomotor activity.  The animal is first entrained to a light-dark schedule where there 
are 12 hours light and 12 hours darkness.  This LD 12:12 division in time is one that is 
maintained throughout all of the experiments.  This maintenance in the phase 
relationship between the light phase and dark phase is one that is reflected by the 
responses of the animal (Shen et al., 2000).  The animal divides its time in the same 
proportions to its active and inactive phases, thus also maintaining a constant phase 
relationship.  The actogram shows that the mouse is a nocturnal animal, most active in 
the early half of the night and most inactive throughout the day.  This strategy could be 
reasoned to have evolved in order to avoid predation and reduce interspecies 
competition for food sources during the daytime (Paranjpe and Sharma, 2005). 
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Once stably entrained to the first lighting schedule, the animal is tested by drastically 
advancing the onset of darkness, so shortening the daytime on that day.  This mimics the 
change in timing of the environmental day-night cycle that is experienced in eastward 
transmeridian flight (Vokac et al., 1984, Gundel and Wegmann, 1989).  The animal is 
then forced to re-entrain to the new cycle by similarly phase advancing its circadian 
rhythms.  The actogram shows this as the animal’s activity gradually shifts from the later 
half of the night time back to the early half.  Once fully re-entrained, the animal is tested 
again.  This time, daytime is extended on one day by delaying the onset of darkness.  
This would be equivalent to the time difference experience with westward transmeridian 
flight.  The animal again re-synchronises its biology to its new environmental time, by 
phase delaying its own circadian clock (Roenneberg and Merrow, 2007, Kennaway, 
2004, Johnson et al., 2003).  This can be seen as it delays starting activity until the onset 
of darkness, though there remains a little residual activity in what used to be the early 
portion of the night.  The residual activity eventually comes to a halt and the entrainment 
to the new time-zone is complete. 
 
Placing the animal in complete darkness (DD) abolishes the phase relationship of the 
environmental cycle as well as removing the most potent entrainment stimulus: light 
(Hastings et al., 1998).  The animal continues to maintain its circadian rhythms and 
phase relationship between different rhythms in the absence of light.  This implies that 
these rhythms are endogenously driven by an autonomous clock rather than by an 
environment-reactive mechanism (Rosbash, 1995).  The autonomous circadian rhythm is 
not orchestrated exactly to 24 hours.  In this rodent, it can be seen to run at a little less 
than 24 hours.  This less-than-24 hour free-running period results in a slight phase 
advance every day.  This phase advance does not have much impact on the animal in 
lighting schedules that are unaltered, where there is no entrainment or no apparent 
requirement for entrainment.  However, return to a lighting schedule corresponding to 
the previous light-dark cycle would mean that the animal would be incrementally more 
out-of-synch with the environmental time with each passing day of free-running 
(Treherne et al., 1977).  Therefore, in order to stay synchronised with the environmental 
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clock, the organism needs to slightly phase delay its own endogenous clock every day.  
This delay is provided by daily entrainment to light (Foster and Helfrich-Forster, 2001, 
Rea, 1998).  The requirement for daily entrainment enables the stabilisation of the clock 
and its rhythms in accordance with the geophysical environment.  The daily calibration 
also permits the detection of any temporal environmental changes and enables the clock 




2.3 ENTRAINMENT PHYSIOLOGY 
The clock functions autonomously as an oscillator.  An oscillator transforms input 
information into a recurring periodic output signal.  The input in the mammalian system 
is the photic information directed from the retina in the entrainment pathway.  The 
oscillator is the master pacemaker, the suprachiasmatic nucleus (SCN).  The output is 
the rhythmic signal that is directed to the rest of the organism.  These three components 
govern the relay of environmental temporal information to the entire organism  
(Ikonomov and Stoynev, 1994).  They are illustrated in Figure  2.3. 
 
 
Figure  2.3 Schematic of the components of a circadian system in an organism. 
 
 
The most potent zeitgeber for the circadian system in mammals is bright light (Gooley et 
al., 2001).  Light is detected by photoreceptors in the inner and outer retinal cell layers 
of the eye.  There are three types of retinal photoreceptor: rods, cones and melanopsin 
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ganglion cells.  Rods are rhodopsin-containing photoreceptors that reside in the outer 
cell layer of the retina.  They detect green (middle wavelength) and blue (short 
wavelength) light only and are therefore more useful for scotopic vision in dim light 
conditions.  Cones are the main photoreceptors used to detect polychromatic bright light 
during the day.  They possess many photopigments or opsins and cover a wide range of 
green, blue and red (long wavelength) light.  They too are located in the outer cell layer.  
Together, the rods and cones detect light for visual processing.  The photic information 
is transduced to the intergeniculate leaflet of the lateral geniculate nuclei (LGN) in the 
thalamus where it is then relayed to the primary visual cortex in the posterior occipital 
lobe of the brain.  Here, the information is collated to form images that represent the 
visible environment with great resolution (Dacey et al., 2005). 
 
The principal photoreceptors of the circadian system are a small subset of ganglion cells 
that reside in the inner cell layer of the retina.  They contain the photopigment, 
melanopsin; an opsin, like rhodopsin, that employs a vitamin A-derived chromophore.  It 
is sensitive to blue light with a maximum absorbance in humans at a wavelength of 480 
nm (Qiu et al., 2005).  These photoreceptors do not detect the various wavelengths of 
light with great acuity; rather they function to detect the general light intensity or 
irradiance.  This information is transmitted via the retinohypothalamic tract (RHT) to the 
hypothalamic SCN, where it is used to entrain the circadian clocks of the master 
circadian pacemaker (Hannibal et al., 2000, Dacey et al., 2005). 
 
Although the rods and cones function principally to detect photic information for image-
formation, they also have some effect on the circadian entrainment system.  Rods 
attenuate and cones enhance the circadian effects of melanopsin receptor activation.  The 
visual system also directs information to the non-visual system from the intergeniculate 
leaflet via the geniculohypothalamic tract (GHT) (Gonzalez and Dyball, 2006).  
Conversely, melanopsin receptors, which function mainly for circadian entrainment, are 
speculated to also provide irradiance information directly to the image-formation 
system.  This slight overlap in function between the photoreceptors, in their otherwise 
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essentially distinct roles, enables the integrated provision of stereoscopic environmental 
information regarding space and time (Foster, 2005, Hattar et al., 2003). 
 
The SCN also integrates neurotransmitter inputs from other brain areas, such as 
serotonin from the midbrain Raphe nuclei and histamine from the tuberomammillary 
nuclei, as well as humoral signals such as melatonin from the pineal gland and œstrogen-
directed signals from the ovary (Gonzalez and Dyball, 2006, De La Iglesia et al., 1999, 
Perreau-Lenz et al., 2004b, Nakamura et al., 2001, Nakamura et al., 2005, Kow and 




2.4 THE SUPRACHIASMATIC NUCLEUS 
The SCN is a bilaterally paired nucleus in the ventral hypothalamus, comprising a 
heterogeneous mix of approximately 20 000 neurones and associated glia (Moga and 
Moore, 1997).    The localisation of the master pacemaker was first isolated, in rats, to 
the hypothalamus by Carl Richter in the United States in the 1960s (Richter, 1978).  He 
ablated the hypothalamus of rats and observed the loss of rhythmicity in their drinking, 
feeding and locomotor behaviour.  Sousa-Pinto and Castro-Correia in Portugal in 1970 
used retrograde staining of degenerating neurones to identify that retinal projections pass 
to the SCN (Sousa-Pinto and Castro-Correia, 1970).  Around two years later, Robert 
Moore and Nicholas Lenn in Chicago used radiolabelled tracers to trace the projections 
of retinal ganglion cells to the LGN and SCN (Moore and Lenn, 1972).  Moore also 
performed SCN-lesion studies that resulted in the loss of rhythmicity in circadian 
adrenal corticosterone secretion in rats (Moore and Eichler, 1972).  He concluded that 
the SCN was a likely participant in the production of rhythmic events such as those 
controlling the hypothalamo-pituitary regulation of adrenal function (Moore and Eichler, 
1972). 
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Further evidence supporting the SCN as the master clock or oscillator can be provided 
by the elucidation of neurotransmitter connections involved in the circadian input 
pathway.  The RHT is composed of the retinal ganglion cell axons, a subset of which is 
involved in mediating photic information to the circadian oscillator (Gooley et al., 
2001).  These cells secrete glutamate and pituitary adenylate cyclase-activating peptide 
(PACAP), and project to the SCN, which possesses glutamate and PACAP receptors 
(Hannibal et al., 2000, Hannibal et al., 2004).  The GHT also projects to the SCN, which 
again possesses the relevant receptors for the neuropeptide Y, encephalin and GABA 
secreted by the GHT neurones (Abrahamson and Moore, 2001, Lall and Biello, 2003). 
 
Functional studies have now proved conclusively that the SCN is the seat of the 
mammalian master pacemaker.  Irving Zucker and Freidrich Stephan in Berkeley 
performed lesion studies that showed the selective loss of circadian drinking behaviour 
in rats with bilateral SCN lesions (Stephan and Zucker, 1972).  Lesions elsewhere in the 
brain did not have any effect on circadian drinking.  Inouye and Kawamura in Tokyo 
isolated the SCN in situ by cutting around it to form a hypothalamic ‘island’ using an L-
shaped Halász knife (Inouye and Kawamura, 1979).  Cells within the island were found 
to retain their multi-unit electrical rhythmicity while those outside of the island were 
found to have lost theirs.  The SCN cells were thus shown to be autonomously rhythmic 
in the absence of neural and humoral input from outside the hypothalamus.   
 
The loss of circadian rhythmicity was found to be reinstated by SCN transplant (Lehman 
et al., 1987).  In 1987, Michael Lehman, Rae Silver and Eric Bittman’s research teams in 
New York and Amherst found that fœtal SCN grafts reinstated free-running locomotor 
activity rhythms in SCN-lesioned arrhythmic adult golden hamsters.  The fœtal grafts 
developed and were observed receiving neural input from the host retina as well as 
output projections to the host brain.  The SCN was also able to reinstate some of the 
circadian rhythms of SCN-lesioned animals apparently using diffusible factors, 
emanating from encapsulated SCN tissue deposited into the third ventricle (Silver et al., 
1996).  Martin Ralph and Michael Menaker further showed in 1988 that the SCN 
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transplant-rescued rhythms of SCN-lesioned hamsters corresponded to the SCN donor 
rather than the host (Ralph and Menaker, 1988).  They were able to do this by 
transplanting a tau mutant SCN into a wild-type hamster.  The tau mutation is a point 
mutation in the semi-dominant autosomal gene for the serine-threonine phosphorylation-
catalysing enzyme, casein kinase 1 epsilon (CK1) gene.  The tau behavioural 
phenotype is a shortened free-running period of the hamster’s circadian rhythms, which 
can be measured using locomotor activity monitoring, of either 20 hours in homozygotes 
or 22 hours in heterozygotes.  The circadian rhythms of the host animal after 
transplantation corresponded to that of the transplanted tau mutant SCN.  It was clear by 
1991 that the SCN contained the dominant pacemaker cells responsible for generating 
overt circadian rhythms in mammals (Ralph and Lehman, 1991). 
 
SCN organotypic slice cultures were found to maintain free-running rhythmicity in 
neuronal firing and secretion (Yamaguchi et al., 2003, Shinohara et al., 1994, Herzog et 
al., 1997).  Dissociated SCN cells also maintained rhythmic output and were found to 
entrain fibroblasts when co-cultured (Welsh et al., 1995, Allen et al., 2001).  Only SCN 
cells have been found to be able to entrain other cells (Pando et al., 2002, Allen et al., 
2001).  However, it is now evident that the SCN is not the only mammalian pacemaker.  
Circadian physiology has so far initially used a relatively restricted range of 
physiological parameters, such as locomotor activity or adrenal corticosterone secretion. 
Developing other ways of measuring circadian physiology, using different circadianly-
driven processes, has lead to the discovery of new clocks or pacemakers; some that can 
free-run sustainably, independent of the SCN and be entrained by zeitgebers other than 
SCN outputs. 
 
One such putative pacemaker is the elusive food-entrainable clock.  There is a growing 
wealth of evidence to support the existence of such a clock in mammals (Saper and 
Fuller, 2007).  Studies in non-mammalian vertebrates, such as birds, reptiles, amphibians 
and fish, have also demonstrated the existence of non-SCN pacemakers (LeSauter et al., 
1996, Guilding and Piggins, 2007).  The pineal gland, for instance, replaces the SCN as 
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the master pacemaker in house sparrows, whereas it works co-operatively with the SCN 
(Zimmerman and Menaker, 1979, Abraham et al., 2003) and the retina as a system of 
pacemakers in the European starling (King and Follett, 1997, Tosini et al., 2008).  As 
such, it is plausible to suppose that there may be a hierarchy of pacemakers, in the brain 
or other organs, which form part of an entire mammalian circadian system and which 
govern other circadian parameters that have yet to be measured and fully described.   
 
Thus far, the SCN remains the only pacemaker that can be defined as a tissue composed 
of cells that are intrinsically and synchronously rhythmic in vivo and in vitro, that are 
absolutely necessary for driving the overt circadian biology of an organism and that are 
able to stably confer rhythmicity, according to its own phase and period, to a new host 




2.5 MAMMALIAN CLOCKWORK MACHINERY 
The SCN contains many thousands of cells, each expressing a circadian rhythm.  This 
rhythm is generated by a small number of highly conserved genes – called clock genes – 
that interact through their proteins to produce a circadian oscillation.  It is the co-
ordination of the rhythmic cells that generates the unique pacemaker properties of the 
SCN.  Cells in most tissues and organs also express clock genes but they are less 
robustly rhythmic than the SCN. 
 
The molecular machinery of the cell-autonomous clock is summarised in Figure  2.4. 
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Figure  2.4 The transcription-translation feedback loops of the canonical clock genes that constitute the circadian 
clock. CLOCK (CLK) and BMAL1 proteins form the positive limb of the feedback loop, driving transcription of period 
(per) and cryptochrome (cry).  PERIOD (PER) and CRYPTOCHROME (CRY) proteins feedback to inhibit the clk and 
bmal1 negative limb of the clock; thus producing a 24-h oscillation. 
 
 
The key mammalian clock genes are clock, bmal1, period and cryptochrome.  The name: 
clock (clk) stands for circadian locomotor output cycles kaput.  The clock gene: bmal1 
stands for Brain and muscle aryl hydrocarbon receptor nuclear translocator-like protein 
1 and is also known as ARNTL, mop3 or tic.  There are three homologs of the period 
(per) gene, period1 (per1), period2 (per2) and period3 (per3).  There are two homologs 
of the cryptochrome (cry) gene, cryptochrome1 (cry1) and cryptochrome2 (cry2).   All 
the clock genes share some sequence homology with each other, possessing E-box and 
E’-box elements in their promoter regions.  Their proteins consequently possess 
common domains, typified by Period-ARNT-Singleminded (PAS) domains that allow 
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clock proteins to bind to each other.  Clock proteins all also possess basic helix-loop-
helix (bHLH) domains that enable them to bind to DNA (Kume et al., 1999, Reppert, 
2000, Reppert and Weaver, 2001, Lee et al., 2001, Jin et al., 1999). 
 
These genes are transcribed and translated, in the daytime, into proteins, CLK and 
BMAL1, which dimerise with each other along their PAS domains in the cytoplasm.  
These CLK:BMAL1 heterodimers translocate to the nucleus and act as transcription 
factors, binding to the promoter E-box elements of the per and cry genes, thus activating 
their transcription.  The genes: per1, per2, per3 are expressed first once the 
CLK:BMAL1 have activated transcription, followed by cry1 and cry2.  PER1, PER2 and 
PER3 proteins are obligate heterodimers with CRY1 and CRY2 proteins (Figure  2.4). 
 
The CRY proteins stabilise the PER proteins, preventing them from being 
ubiquitinylated and degraded by the proteosome.  PER:CRY dimers accumulate in 
discrete foci in the cytoplasm of the cell during the daytime.  After 4-6 hours, the dimers 
abruptly dissociate and the single proteins move rapidly into the nucleus.  Once in the 
nucleus, the PER and CRY proteins inactivate daytime bmal1 transcription.  The CRY 
proteins, in particular, may bind directly to the CLK:BMAL1 dimer to form a complex, 
to alter its phosphorylation status and ability to activate transcription (Dardente et al., 
2007, Ishikawa et al., 2002, Glossop and Hardin, 2002).  The prevention of bmal1 
transcription results in a decrease in BMAL1 that subsequently stops activation of per1, 
per2, per3, cry1 and cry2 transcription.  The nuclear PER and CRY proteins also bind to 
undimerised CLK and BMAL1 respectively, thus again preventing CLK:BMAL1 from 
activating transcription, at night time. 
 
The lack of per and cry transcription results in a decrease in PERs and CRYs, as 
degraded transcripts are not replaced.  Over time, the amount of PER and CRY is no 
longer sufficient to significantly repress activation of the bmal1 promoters.  Thus, clk 
and bmal1 transcription and translation re-initiates the next circadian cycle. Therefore 
clk and bmal1 genes and proteins act as the positive limb of the feedback loop while the 
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per and cry genes and proteins act as the negative limb.  Together, they constitute the 
self-sustained, autoregulated transcriptional-translational feedback loop that is 
effectively the clockwork or machinery of the cellular circadian clock.  
 
The circadian clock incorporates a further feedback loop, involving genes that modulate 
the period of the circadian machinery (Figure  2.5).  This second loop, interlocks with the 
primary circadian feedback loop and imposes post-translation mechanisms of regulation 
on the canonical clock genes.  These mechanisms involve the action of the retinoic acid 
receptor-related orphan receptors (RORs), particularly ROR alpha (ROR or RORA).  
Also involved are receptors from the orphan receptor family: REV-ERBs, particularly 
REV-ERB alpha (REV-ERB).  The action of phosphorylation enzymes is also crucial, 
particularly that of the casein kinases: 1 epsilon (CK1) and 1 delta (CK1).  Both RORs 
and REV-ERBs are circadianly expressed, orphan nuclear receptors that possess E-boxes 
in their gene promoters.  They can thus, be activated by CLK and BMAL1. 
 
Receptor-related orphan receptors alpha (ROR or RORA), beta (ROR or RORB) and 
gamma (ROR or RORC) are transcriptional modulators which are able to bind onto the 
ROR promoter element (RORE) on the bmal1 gene, to up-regulate bmal1 transcription 
(Guillaumond et al., 2005, Emery and Reppert, 2004).  The rev-erb gene is a 
constitutive repressor of gene transcription and when activated by CLK:BMAL1 
binding, represses bmal1 transcription (Preitner et al., 2002).  The RORs and REV-
ERBs are thought to work in competition to modulate the circadian clockwork 
machinery (Guillaumond et al., 2005). 
 
CK1 and CK1 are enzymes that catalyse the phosphorylation, at serine or threonine 
residues, of proteins, such as PER and CRY.  Phosphorylation of undimerised PER 
results in its degradation in the ubiquitin-proteosome proteolysis pathway.   
Phosphorylation of the PER and CRY dimers can inhibit nuclear transport as well as 
promote proteolysis.  PER and CRY are thus prevented from inactivating clock and 
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bmal1 transcription (Vielhaber et al., 2000, Lowrey and Takahashi, 2000, Gallego et al., 




Figure  2.5 The complex, interlocked autoregulatory transcription-translation feedback loops that produce a circadian 
period (Boden and Kennaway, 2006). 
 
 
Further post-translational  mechanisms, along with epigenetic interactions have also 
been implicated in playing a mechanistic role in the circadian oscillator (Stratmann and 
Schibler, 2006, Dardente and Cermakian, 2007). 
 
Circadian rhythms have been observed in histone acetylation (Etchegaray et al., 2003).  
Many of the core clock components have been identified as potential targets of histone 
acetyltranferases and deacetyltransferases (Nakahata et al., 2007).  The per1 and per2 
promoters also show circadian histone H3 acetylation, which along with the associated 
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polymerase activity, peaks concurrently with mRNA levels (Etchegaray et al., 2003).  
CLK itself can act as a histone acetlytransferase, a property that proved essential for the 
rescue of clock gene rhythmicity in clk mutant mice (Doi et al., 2006).  Histone 
deacetyltransferases are also used, for example by mammalian CRY in transcriptional 
repression (Naruse et al., 2004).  It is clear that chromatin remodelling has an important 
part to play in clock gene transcription and so, the timing of clock (Naruse et al., 2004).  
The process of chromatin remodelling often involves other co-activator proteins that are 
recruited and assembled into complexes for transcriptional activity (Etchegaray et al., 
2003).  This implicates that other proteins, apart from the canonical core clock 
components, are subtly involved in the regulation of the circadian clock.   
 
The metabolic status of the cell is also a key influence on the regulation of the circadian 
clock (Rutter et al., 2001, Rutter et al., 2002).  The binding of CLK to E-box elements in 
vitro is strictly regulated by the redox state of the cell.  The redox state is generated by 
the energy metabolism ongoing in the cell and refers specifically to the ratio of reduced 
nicotinamide adenine dinucleotides (NADH or NADPH) to oxidised nicotinamide 
adenine dinucleotides (NAD+ or NADP+).  Glucose uptake by the cell can thus also 
influence the running of the clock (Schibler and Sassone-Corsi, 2002). 
 
It has been proposed that these multiple transcription-translation loops, interwoven with 
post-translational and epigenetic interactions, exist to confer a specific degree of 
flexibility, required by the clock in order for it to adapt to the normal physiological and 
environmental fluctuations encountered daily, without producing overly noisy 
fluctuations in its own system.  The system is thus able to simultaneously co-ordinate 
key properties such as robust entrainment and temperature-compensation (Rand et al., 
2006).  Understanding more about the circadian machinery continues to be a major goal 
of the circadian rhythms field, as new clock components are likely to be discovered 
along with new perspectives offered by structural biology of the clock proteins and 
systems biology applying computational modelling to the feedback loop mechanisms 
(Takahashi, 2004).  This computational approach deals much with the actual mechanics 
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of the clockwork machinery and aims to accurately model the clockwork, such that the 
model can be used to explain and predict phenomena observed in field experiments (De 
Haro and Panda, 2006, Forger et al., 2003, Forger et al., 2007).   
 
Some have argued that this ‘general oscillator’ mechanism is common to all clocks and 
that, despite the high level of conservation of the core molecular components between 
species and cell types, there are a variety of specialisations, that can distinguish the 
properties of clocks such as those in the SCN and the peripheral tissues in mammals 
(Glossop and Hardin, 2002).  Mutations in clock genes have been demonstrated to affect 
central clocks differently to peripheral clocks.  Although the molecular events occurring 
in central and peripheral clocks are fundamentally the same, there are some key 
differences.  Understanding how central and peripheral clocks work, in themselves and 




2.6 CENTRAL AND PERIPHERAL CLOCKS 
The subordinate clocks in cells in peripheral tissues have many of the same properties as 
the cells of the SCN.  They are relatively robust in their rhythmic clock gene expression, 
with the transcriptional activators expressed in antiphase to the transcriptional 
repressors, in interlocked feedback loops that are sustained in the absence of the SCN 
and humoral signals (Balsalobre, 2002).  They are also resistant to biochemical and 
structural changes imposed by the cell division cycle, in fact, interacting with the cell 
cycle.  The circadian clock can gate the entry of dividing cells into the S phase of the 
cell cycle as well as confer an initial entrainment of sorts to the subsequent daughter 
cells.  Peripheral clocks are also able to withstand varying transcription rates (Stratmann 
and Schibler, 2006, Nagoshi et al., 2004). 
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Peripheral clocks however differ from central clocks in some of their properties and 
modes of function, related to specialised function in the periphery.  Peripheral clocks 
still function to provide circadian information that allows the various cells and tissues to 
temporally co-ordinate their biochemical, physiological and behavioural processes.  
Whilst SCN neurones are able to sustain synchronised circadian rhythms in clock gene 
expression and electrical firing for days and even years in culture, peripheral cells, such 
as fibroblasts from cell lines or from adult or embryonic tissues, apparently lose 
rhythmicity. 
 
This dampening of the rhythm can be reversed however, by exposure to serum-shock or 
other chemical or physical treatments.  Closer observation has elucidated that although 
the clock in individual peripheral cells can be persistently self-sustained, it is the 
synchrony between the cell oscillators that is lost over time.  Thus, an overall population 
effect is seen as a dampening of circadian rhythm behaviour.  The serum-shock is 
thought to work as an entrainment signal, resetting the various de-synchronised cell 
clocks back to the same time and phase.  The lack of stringent coupling in peripheral 
clocks is considered more useful as they are required to also respond and incorporate 
temporal information from multiple sources.  Looser coupling enables these clocks to 
adapt more quickly and efficiently than the central clocks. 
 
Peripheral clocks often show a delayed phase compared to the SCN.  The peripheral 
clock gene mRNA and protein peaks and troughs may be four hours behind those of the 
SCN (Balsalobre, 2002). This time lag is likely to be accounted for, in part, by the delay 
that is incurred in the SCN relay and in part, by the intrinsic timing of the peripheral 
organs and tissues.  These differences may occur due to differential responses to SCN 
signalling and/or the effect of other timing information.  The degree of influence exerted 
on peripheral clocks by non-SCN signalling appears to vary between cells and tissues, 
and may explain why peripheral clocks respond differently from the central clocks, to 
circadian perturbations like changes in environmental temperatures or feeding times 
(Brown et al., 2002). 
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Furthermore, the peripheral clocks can be uncoupled from the master clock in vivo by a 
variety of other zeitgebers.  Feeding schedules have dramatic effects on the phase of 
peripheral clocks in the liver, kidney and heart.  The daytime feeding of nocturnal 
animals has been shown to completely invert the phase of the circadian gene expression 
in food-metabolising tissues such as the liver, kidneys and pancreas.  The phase of the 
circadian gene expression the SCN however remains unchanged (Schibler and Sassone-
Corsi, 2002).  The uncoupling of the peripheral clocks from the central clocks seems to 
be inhibited by the glucocorticoid hormones, which have also been implicated in the 
maintenance of circadian S phases in cell division (Schibler and Sassone-Corsi, 2002, 
Pitts et al., 2003).  The VPAC2 receptor (also known as vipr2) knock-out mouse, that 
has a weak SCN system due to poor signalling in the SCN, shows very robust food 
entrainment rhythms, as measured by locomotor activity, corticosterone secretion and 
clock gene expression in the liver (Sheward et al., 2007).  The timing information from 
the feeding regimen is seemingly transduced by a putative food-entrainable oscillator, 
which can function as a pacemaker.  Food-entrained circadian rhythms can even be 
sustained in the absence of feeding time cues in clk-/- mutant mice that are arrhythmic in 
their locomotor activity (Pitts et al., 2003).  Thus, a regular feeding schedule allows the 
organism an alternative way of sampling the geophysical environmental time, apart from 
the light of the sun (Mistlberger, 2006). 
 
Another secondary time cue can be provided by core body temperature of an organism.  
This is cyclical and is influenced by the animal’s sleep-arousal status, locomotor 
activity, food intake and metabolism (Schibler and Sassone-Corsi, 2002).  Although 
central pacemakers like the SCN are temperature-compensated, peripheral clocks can be 
altered by temperature.  Rat cellular clocks in vitro that would have rapidly dampened en 
masse were synchronised by circadian oscillations in temperature that reflected the core 
body temperature of mice.  In vivo, inversion of the circadian environmental temperature 
cycles caused mice to similarly invert the phases of their liver clocks.  Their SCN 
however was able to maintain its original phase (Brown et al., 2002).  
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Evidence is mounting that there is still much to discover about the similarities and 
differences in the functions of central and peripheral clocks.  The signalling from the 
central to the peripheral clocks has been relatively well observed.  The signalling which 
must occur in the opposite direction, from the peripheral to the central clocks, have 
however been less well delineated.  Many peripheral clocks interact with each other in 
order to maintain some synchrony and co-ordinate of their circadian rhythms.  They are 
also likely to provide feedback signalling to the central pacemaker, regarding 
physiological and metabolic status. 
 
It is therefore important to elucidate more about how peripheral clocks impact the 
central clock.  One system that offers avenues of investigation is that regulating the 
reproductive axis.  Reproduction, particularly in females, is governed by temporal 
processes. The female reproductive or menstrual cycle lasts an average of 28 days in 
humans.  The corpus luteum in women has a very precise 14-day lifespan, when 
fertilisation of the ovum does not occur.  The timing of the LH surge which initiates 
ovulation is, certainly in rodents, gated by a circadian clock mechanism (de la Iglesia 
and Schwartz, 2006).  The female reproductive tract is well known to receive and deliver 
signals, both humorally and nervously, from and to the central nervous system (CNS), 
particularly the hypothalamus and pituitary gland (Everett and Sawyer, 1950, de la 
Iglesia and Schwartz, 2006).  The SCN is part of the hypothalamus.  The female 
reproductive axis thus provides a focus for investigating circadian rhythm function, 









2.7 SCN OUTPUTS AND CO-ORDINATION 
Once the environmental time cues have been inputed, the SCN outputs provide time 
cues that allow the peripheral clocks to entrain their timing to match the environment.  
The SCN uses both neuronal and humoral signalling to co-ordinate the peripheral clocks.  
This has been shown using SCN transplantation and parabiosis experiments.  Only some 
of the overt circadian rhythms lost in SCN-lesioned animals have been rescued by 
diffusible signals in specially encapsulated SCN transplants and parabiosis experiments 
(Guo et al., 2005).  This suggests that neuronal connections are also necessary.  The 
main brain cells directly targeted by the SCN are the endocrine neurones in the adjacent 
hypothalamus, the autonomic neurones of the paraventricular nucleus (PVN), as well as 
neurones on other regions of the hypothalamus and rest of the brain (Buijs and Kalsbeek, 
2001).  These targets, in turn, signal environmental time to other cells in the rest of the 
brain and body and co-ordinate processes such as sleep, locomotor activity, food intake 
and hormone secretion.  
 
One key output of the SCN in mammals is a multi-synaptic pathway projecting via the 
PVN to the pineal gland.  The pineal gland produces melatonin during the night and the 
nocturnal increase in melatonin concentrations signals to the rest of the body that it is 
night time.  Melatonin is a sleep-promoting signal, mediating changes such as the drop 
in core body temperature via the sympathetic nervous system (Krauchi et al., 2006).  The 
SCN is known to inhibit melatonin secretion during the daytime via gamma-
aminobutyric acid-releasing neuronal (GABAergic) efferents to the PVN, which inhibit 
melatonin synthesis in the pineal gland (Kalsbeek et al., 1999, Perreau-Lenz et al., 
2004a).  The SCN also plays a role in activating the nocturnal peak in melatonin 
secretion, using glutaminergic innervation of the PVN, which signals to the pineal gland 
(Perreau-Lenz et al., 2004a, Perreau-Lenz et al., 2004b).  Melatonin acts by binding to 
specific melatonin receptors, like type one melatonin receptors (MT1) and type two 
melatonin receptors (MT2).  Melatonin receptors are abundant in the PT of the pituitary 
gland as well as the SCN and other brain areas such as the hippocampus (Williams et al., 
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1995, de Reviers et al., 1991).  They can also be found in other organ systems, including 
the testes and the ovary (Pang et al., 1998). 
 
Other humoral outputs from the SCN include vasopressin (VP), which is released in a 
circadian fashion into the cerebrospinal fluid; and prokineticin 2 and transforming 
growth factor alpha (TGF), which are strong candidates for signalling time from the 




2.8 THE SCN AND THE HYPOTHALAMO-
PITUITARY-GONADAL AXIS 
The hypothalamic-pituitary-gonadal (HPG) axis is involved in the control of 
reproduction via the hypothalamus, pituitary gland and gonads.  The hypothalamus, 
which serves as a relay station, transduces information neurally to the pituitary.  The 
pituitary gland responds to the hypothalamic signals and produces humoral factors, such 
as hormones, which then signal to the gonads: the ovaries or testes.  The gonads then 
effect the key mechanisms of reproduction: ovulation and spermatogenesis. 
 
Circadian timing and clock genes are known to provide time control for the HPG axis 
(de la Iglesia and Schwartz, 2006, Miller et al., 2004).  There are many levels in the 






Figure  2.6Timing in the hypothalamic-pituitary-gonadal axis (de la Iglesia and Schwartz, 2006). 
 
 
At the level of the brain, the SCN affects the reproductive axis through the control of 
gonadotrophin releasing hormone (GnRH).  GnRH is released in a pulsatile fashion from 
nerve terminals in the median eminence of the basal hypothalamus into the 
hypothalamo-pituitary portal blood system to control the synthesis and secretion of the 
gonadotrophins. LH and FSH from the gonadotrophs in the anterior pituitary gland act 
on the gonads to stimulate gamete development and hormone synthesis.  In order to 
regulate the reproductive axis, the GnRH neurones are subject to input directly from the 
SCN as well as indirectly via œstrogen-responsive neurones in the pre-optic area (POA) 
(Mahoney and Smale, 2005, Van der Beek et al., 1997).  In addition, GnRH neurones 
have been seen to express clock genes, which may be involved in the timing of GnRH 
release (de la Iglesia and Schwartz, 2006). 
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In female rodents, the SCN acts to gate the LH surge to the afternoon to control the 
timing of ovulation (Everett and Sawyer, 1950, Kalra, 1993, Palm et al., 2001).  
Nocturnal rodents thus use the circadian clock to synchronise their ovulation with the 
night time, when they are most active and most likely to encounter males.  This 
synchrony optimises the chances of conception.   
 
The circadian control of the pre-ovulatory LH surge was first described in rats and 
published in a seminal paper by Everett and Sawyer in 1950 (Everett and Sawyer, 1950).  
Rats have a four or five day œstrous cycle.  They ovulate on day one, up to 12 hours 
after the pre-ovulatory LH surge on the day of proœstrous.  If the pre-ovulatory LH 
surge is inhibited for a few hours, as with the administration of a short-term barbiturate 
sedative, ovulation does not then occur a few hours later.  Rather it is delayed until the 
afternoon of the following day.  This is because there is a time window in which 
ovulation can occur.  It can only be triggered the following day, when the LH surge falls 
again within the afternoon time window.  If the rat is ovariectomised and permissive 
amounts of oeatradiol administered, the LH surge is seen to occur daily, gated every day 
to the afternoon (Figure  2.7).  This gating of the LH surge and subsequently, of 
ovulation, is dictated by the circadian clock.  The SCN, when ablated by hypothalamic 
knife cuts, is no longer able to communicate neurally.  This results in the loss of œstrous 
cyclicity and disturbance of LH periodicity (Nunez and Stephan, 1977).  Mutation of the 
clock genes have also resulted in perturbed œstrous cycles and abnormal LH surges 
(Miller et al., 2004).  The clock genes and the SCN have therefore been shown to be 
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Figure  2.7 The circadian clock-controlled LH surge occurs in a critical period in rat œstrous cycle.  This occurs in 
intact animals (intact) where the daily or circadian LH peak is masked by overriding hormone physiology, but is 
revealed to be truly circadian when the hormonal signals are removed by ovariectomy of the animal (ovx + E2), which 
is then supplemented with œstradiol, as œstradiol is permissive for the LH surge.  This circadian gating of the LH 
surge and thus, ovulation, is comparable to that of the human menstrual cycle (adapted from Lincoln, G. A.). 
 
 
It is not just in the œstrous cycles of rodents that the circadian clock functions.  It is also 
likely to function to regulate the menstrual cycles of higher primates, including women.  
Shift work and frequent transmeridian flights have been correlated with irregular 
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menstrual cycles and an increased incidence of reproductive cancers in humans (Lauria 
et al., 2006, Megdal et al., 2005, Baker and Driver, 2007). 
 
Many other pituitary hormones involved in reproduction are regulated in a circadian 
manner in the hypothalamus.  VP is expressed in a circadian rhythm in the SCN, PeVN, 
PVN and SON (Moore et al., 2002, Moga and Moore, 1997).  Oxytocin is potentially 
circadianly regulated and has been proposed to gate the circadian timing of birth (Roizen 
et al., 2007, Goldstein, 2004).  Neurophysin has also been observed to be expressed in 
the hypothalamus, particularly in the SCN (Okamura et al., 1995).  GH, ACTH and TSH 
levels have all been found to fluctuate in circadian rhythms and all these hormones are 
involved in reproduction (Szafarczyk et al., 1983, Luboshitzky, 2000, Thorner et al., 
1995, Cano et al., 2008).  As they all are regulated by or closely associated with 
circadian rhythms, one might infer that circadian rhythms, emanating from the 
hypothalamus, regulating pituitary hormones, are in fact (to some degree) regulating 
reproduction (Luboshitzky, 2000). 
 
Furthermore, the clock genes are expressed in both male and female gonads as well as in 
other reproductive tissues.  The gene per is constitutively expressed in the fruit fly 
(Drosophila melanogaster) ovary, as is another fruit fly clock gene, timeless (tim).  
Female flies lacking either per or tim produce almost fifty per cent fewer progeny and 
mature oocytes than wild-type females (Beaver et al., 2003).  The clock genes: clk, 
bmal1, per1, per2, per3, cry1, cry2 and tim were all detected in the unfertilised oocytes, 
uteri and fallopian tubes of pregnant mice (Johnson et al., 2002).  The function of these 
genes in either the fruit fly or mammalian ovary however has yet to be elucidated.  
Expression of clk, bmal1, per1, per2 and cry1 has also been detected in the mouse testes.  
In addition, PER1 and CLK could be localised in the mouse testis (Alvarez et al., 2003, 




Reproductive events in the brain, ovary, fallopian tube and uterus also all occur with 
close temporal synchrony to each other.  Timing of mating in many non-primate species 
corresponds with the timing of the LH surge and subsequently, the timing of ovulation 
(Boden and Kennaway, 2006).  Nocturnal rodent females exhibit behaviour that prompts 
males to copulate at a time which coincides with ovulation during the middle of the 
night.  The synchronisation of the timing of mating to coincide with that of ovulation 
also appears to be much the same in diurnal rodents, like the African grass rat 
(Arvicanthis niloticus), as well as in humans.  African grass rats ovulate in the latter half 
of the dark phase and mate during the early morning.  Humans also tend to ovulate in the 
late night, following an LH surge some time between midnight and 0800 h (Kennaway, 
2005).  There has also been observed a major peak in sexual activity in the late night as 
well as a minor peak in the early morning.  The co-ordination and synchrony of these 
various temporally orchestrated processes must be performed in tandem: both within the 
organism and with its external environment. 
 
Clock gene knockout and mutant animals also frequently display aberrant and subfertile 
reproductive capacity.  Female clk-/- mutant mice have irregular and extended œstrous 
cycles, increased fœtal resorption and a high rate of full-term pregnancy failure (Miller 
et al., 2004).  They also lack the co-ordinated LH surge that is required on the day of 
proœstrous.  This LH surge fails even with œstradiol and GnRH priming of the 
gonadotrophs.  Although most mutant animals did not produce an LH surge, a few 
individuals were able to produce a small increase in LH levels that was sufficient to 
induce ovulation.  This increase was significantly smaller than that of the wild-type.  
Furthermore, male reproductive function was also affected in clock gene mutants.  Clock 
gene mutant fruit flies display a low-fertility phenotype (Beaver et al., 2002).  They 
produce around forty per cent fewer progeny after mating with wild-type females.  
These females lay fewer eggs and of these eggs, there is a greater rate of unfertilised 
eggs.  The per or tim null mutant males, both released significantly less sperm from their 
testes into the seminal vesicles.  Although the actual mechanism remains undefined, it is 
clear that the clock genes are involved in regulating both female and male gonadal 
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function.  All this evidence clearly implies that there is a function for the clock genes in 
the regulation of the reproductive axis and therefore, reproduction.  The clock genes 
appear to affect various hierarchical stages of reproductive regulation.  The reproductive 
axis can therefore be viewed as a mirror of whole body systems with a pacemaker that is 




2.9 SPECIAL FOCUS ON THE HUMAN FEMALE 
REPRODUCTIVE CYCLE 
Female reproductive cycles begin in adults, once sexual maturity is reached.  The 
fundamental reproductive units of these cycles are the gametes or ova, which begin 
developing in utero.  Primordial or precursor germ cells, also known as gonocytes, are 
visible in embryos as early as the third week after conception (Pereda et al., 2006).  
Conception occurs when the ovulated oocyte is fertilised by a spermatazoan, usually in 
the fallopian tubes, also known as the oviduct.  After fertilisation, the resulting zygote 
proceeds through a series of cleavages, producing first two cells, then four cells, then 
eight and so forth, doubling the number of cells each time (Figure  2.8).  The mass of 
cells, around the 128-cell stage, then assume a structure, arranging into a spherical layer 
that surround a fluid-filled cavity called the blastocoel. 
 
These surrounding blastomere cells then differentiate into two cell types, which 
characterise the structure as a blastocyst.  One cell type comprises an outer layer of cells 
called the trophoblast layer or outer cell mass.  The other cell type forms a mass within 
the trophoblast layer, called the inner cell mass or embryoblast.  The trophoblast goes on 
to become the placenta, as the blastocyst cells invade and implant in the endometrial 
lining of the uterus.  Implantation occurs about six to seven days after fertilisation, when 
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the blastocyst exits the fallopian tube and so, enters the uterus (Figure  2.8).  The 
embryoblast differentiates into many cell types as development progresses in utero, 
producing both extra-embryonic and embryonic tissues.  One of these embryonic tissues 
is the embryonic mesoderm, which eventually gives rise to the gonads and germ cells. 
 
Around 14 days after fertilisation, the blastocyst invaginates and cells migrate in the 
process of gastrulation.  The resulting gastrula continues restructuring and differentiating 
into the embryonic disc, with cells forming the primitive streak within a couple of days 
of gastrulation.  By the third week of gestation, the early embryo is recognisable and the 




Figure  2.8The reproductive process from ovulation to implantation (adapted from the Common Gynecological 




In the early embryo, the primodial germ cells of male and female embryos appear alike.  
The determination of sex has however already been made; during fertilisation, based on 
the haploid sex chromosome present in the fertilising spermatozoan.  If the 
spermatozoan contained a Y chromosome; this combined with the X of the oocyte would 
produce an embryo with XY chromosomes: therefore, a male.  If the spermatozoan 
contained an X chromosome; this combined with the X of the oocyte would produce an 
embryo with two X chromosomes: therefore, a female.  The haploid germ cells of males 
are correspondingly able to possess either an X or a Y chromosome, while the haploid 
germ cells of females are able to possess only X chromosomes.  As the embryo 
develops, the germs cells acquire more characteristic sex-specific morphology. 
 
The primordial germ cells, like the cells that form somatic tissues, are diploid, 
possessing 23 paired chromosomes.  These primordial germ cells will eventually 
become haploid germ cells, possessing only half the chromosomal complement: 23 
unpaired chromosomes, by the process of meiosis.  The premeiotic diploid primordial 
germ cells originate from the ventral wall of the hindgut, near the allantois.  They divide 
mitotically and continue proliferating as they migrate through the hindgut and into the 
genital ridge, where somatic mesenchyme cells, also derived from embryonic mesoderm, 
are differentiating to form the matrix of the gonads.  This migration is largely complete 
by about five to seven weeks of gestation. 
 
The primordial germ cells then undergo two further processes: meiosis and atresia, while 
continuing to proliferate.  Meiosis is the division of cells that produces haploid daughter 
cells, known as the gametes.  Meiosis occurs with two rounds of cell division: the initial 
round, meiosis I, occurring much like mitosis except with independent assortment and 
recombination of the chromosomes, giving rise to novel diploid cells, which then 
undergo a second round of cell division, meiosis II, to produce four novel haploid cells.  
Each round of meiosis is divided into four stages: prophase, metaphase, anaphase and 
telophase.  The prophase of the first meiotic division: prophase I can be further 
subdivided into leptotene, zygotene, pachytene, diplotene and diakinesis stages. 
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In females, some of the primordial germ cells at the genital ridge undergo meiosis until 
they are arrested at the diplotene stage of prophase I, thus becoming primary oocytes 
that are dictyate.  Some of the oocytes acquire a layer of squamous pre-granulosa cells 
around them, thus becoming primordial follicles.  The formation of primordial follicles 
begins around the 16th week of gestation.  Simultaneously, some of these follicles as 
well as primary oocytes are lost by a process of apoptotic cell death called atresia.  Thus, 
the opposing effects of continual mitosis and atresia result in a peak number of germ 
cells of approximately six to seven million around 20 weeks of gestation, a number that 
then falls sharply to approximately two million by the time of birth (Macklon and 
Fauser, 1999, Johnson and Everitt, 2000).   
 
At birth, the pool of primordial follicles becomes finite, as mitotic proliferation of the 
germ cells has stopped.  The primordial follicles become quiescent and stop developing 
until puberty i.e. sexual maturity is reached, at which time the follicles can resume 
growing and maturing.  Although a few primordial follicles do sporadically and 
incompletely resume development, becoming primary and even pre-antral secondary 
follicles, prior to puberty, it is not until sexual maturity is reached that follicles are 
regularly recruited into resuming development.  Throughout the time leading up to 
puberty, atresia continues to occur and only approximately 400 000 follicles survive at 
puberty (Johnson and Everitt, 2000, McLaughlin and McIver, 2009). 
 
The onset of puberty in the early teens, is influenced by many factors, including 
nutrition and body fat content (Johnson and Everitt, 2000).  The hypothalamus initiates 
the process by up-regulating the activity of the pulsatile GnRH-secreting neurones, 
which drive the anterior pituitary gland to secrete FSH and LH.  These hormones, in 
turn, cause the gonads to grow to adult size and stimulate both gametogenesis and 
steroidogenesis.  The sex steroids promote the development of secondary sexual 
characteristics such as body and pubic hair growth, widening of the pelvis, increased 
weight and redistribution of fat deposition in women (Johnson and Everitt, 2000). 
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After puberty, the gonadotrophins continue to be secreted, in a cyclical fashion that 
drives the menstrual or ovarian reproductive cycle.  The gonadotrophins play a 
particularly crucial role in the later stages of follicle development.  Around a thousand 
follicles are recruited into a pool of developing follicles in each reproductive cycle.  
These follicles can be primordial or primary follicles.  Primordial follicles resume 
development into primary follicles, characterised by increased follicular size and altered 
squamous pre-granulosa cells, which have become cuboidal and are arranged in a single 
cell layer around the primary oocyte.  The granulosa cells also acquire proliferative 
potential and as the single layer of cells multiply, they become arranged in several cell 
layers around the oocyte, thus denoting the transition of the primary follicle into a 
secondary pre-antral follicle. 
 
Although the oocyte of the secondary pre-antral follicle continues to be arrested in 
meiosis I, it is able to grow and produce ribosomal and messenger RNA, the latter of 
which is used to generate proteins that are stored for later use in oocyte maturation and 
early post-fertilisation oocyte development (Johnson and Everitt, 2000).  The oocyte also 
secretes a glycoprotein-rich matrix, which forms a thick membrane around the oocyte 
called the zona pellucida (Flechon et al., 1984).  Ovarian stromal cells condense around 
the follicle and differentiate into follicular theca cells. The theca cells possess LH 
receptors and upon LH stimulation, they proliferate and facilitate vascularisation, 
secreting steroids such as androgens (Figure  2.11).  They then develop into two layers: a 
theca interna that is glandular and highly vascularised and a theca externa that acts as 















Figure  2.9 Photomicrograph cross-section of a rat antral follicle, stained with heamotoxylin and eosin (adapted from 




The granulosa cells secrete a viscous fluid that combines with serum transudate in-
between the cells to create a fluid-filled cavity in the middle of the follicle called the 
antrum (Figure  2.10).  The antrum denotes the maturation of the pre-antral follicle into 
an antral or secondary or secondary vesicular follicle.  The size of the antrum grows, as 
does that of the follicle.  As the antral cavity increases, the oocyte becomes suspended in 
the fluid.  It is closely surrounded by a dense layer of granulosa cells and is tethered to 
the antrum wall by a thin stalk of cumulus granulosa cells (Figure  2.10).  The cells 
surrounding the oocyte are now referred to as cumulus granulosa cells, while the 
granulosa cells comprising the main granulosa cell layer are referred to as the mural 
granulosa cells.  The cumulus granulosa cells are likely to provide oocyte maintenance, 
while being regulated by the oocyte in turn (Gilchrist et al., 2008, Eppig et al., 2002).  
The mural granulosa cells are involved in steroidogenesis and the regulation of follicular 
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rupture.  The oocytes of antral follicles are also able to now progress through meiosis I 
in vitro and are thus referred to as being meiotically competent, though they continue to 
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Figure  2.10 The ovarian cycle. 
 
 
As the antral follicles continue to grow with increasing cell numbers and antral size, they 
become gonadotrophin-dependent, requiring FSH and LH receptors in order to avoid 
atresia.  Meanwhile, primary, secondary pre-antral follicles and early antral follicles up 
to 2 mm in diameter, while gonadotrophin-responsive, by dint of possessing granulosa 
cell FSH receptors, are not gonadotrophin-dependent (Johnson and Everitt, 2000).  FSH 
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stimulates the growth of follicles and increases in concentration during the follicular 
phase of the menstrual cycle. 
 
The development of the primordial follicle into an antral follicle takes an average of 85 
days, the equivalent of three menstrual cycles.  The recruitment of primordial follicles 
occurs in waves, once every menstrual cycle (McLaughlin and McIver, 2009, Baerwald, 
2009).  By the time the antral stage is reached, only about six to ten follicles remain out 
of the thousand or so recruited in the same wave; the rest having been lost by atresia 
(Johnson and Everitt, 2000).  The surviving antral follicles are now ready to be recruited 
into the reproductive or menstrual cycle where one of them will become the dominant 
follicle of the cycle that will be ovulated.  The timing of the attainment of the antral 
stage must coincide with the ovarian hormonal milieu, which fluctuates with the 
reproductive cycle and must be optimal for successful recruitment and maturation of the 
antral follicles.  If the timing does not coincide, the follicle does not mature any further 
and becomes atretic. 
 
When successfully recruited into the reproductive cycle, the follicles continue to grow 
and the the antral space continues to enlarge.  The follicles begin to produce œstradiol, 
which is largely synthesised from the androgens produced by the theca interna cells.  
The androgens pass from the theca cells, through the basement membrane and into the 
granulosa cells, where the stimulation by FSH enables the activation of aromatase, 
which catalyses the conversion of the androgens into œstrogens, particularly œstradiol.  
The androgens also stimulate aromatase activity in the granulosa cells, resulting in 
increased œstrogen synthesis.  Œstrogens also have an intrafollicular effect, increasing 
granulosa cell proliferation and oestrogen receptor synthesis, thus increasing its own 
production in a positive feedback loop.  The antral follicles therefore grow rapidly as 
does the amount of œstrogen secreted.  These large amounts of œstradiol also feed back 
to the hypothalamus and anterior pituitary gland, where they repress FSH secretion from 
the anterior pituitary (Figure  2.11).  The subsequent drop in FSH levels causes the 
atresia of smaller, competing follicles, leaving a sole survivor: the largest follicle, which 
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is able to survive as it is the most FSH-sensitive.  Thus, the dominant follicle is selected 
for further maturation (Johnson and Everitt, 2000). 
 
It acquires LH receptors on its granulosa cells, under the influence of FSH and 
œstrogens.  It must time this acquisition in order that both the theca and granulosa cells 
can respond to the pre-ovulatory LH surge.  The LH surge occurs as a result of 
increasing œstrogen levels from the antral follicles that signal to the hypothalamus, 
which directs the tonic release of LH from the pituitary gland.  The rising œstradiol now 
reverses the œstradiol repression of FSH secretion, creating a positive feedback loop 
with FSH and LH (Figure  2.11).  The rising LH levels reach a threshold value, after 
which the release of LH surges to a sudden maximum.  It is this pre-ovulatory LH surge, 
gated by the circadian clock to the afternoon, that allows the adequately responsive 
dominant follicle to enter the pre-ovulatory stage of growth and that triggers ovulation 
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Figure  2.11 Hormone levels across the ovarian cycle.  The follicle makes œstrogen that increases exponentially as it 
develops.  High concentrations of œstrogen promote a surge of gonadotrophins.  This causes follicular rupture, 
oocyte release and transformation of the remaining cells into the corpus luteum that secretes large amounts of 
progesterone as well as some œstrogen (adapted from The University of New South Wales (UNSW) Embryology 
program Version 5.7 September 2006: http://embryology.med.unsw.edu.au/wwwhuman/MCycle/images/Mcycle.GIF). 
 
 
After the LH surge, the final follicular growth phase is rapid with changes in the 
follicular cells as well as the oocyte.  The pattern of follicular steroid secretion is altered, 
with a transient rise in œstrogen and androgen levels within 2 hours after the LH surge, 
followed by a decline.  The rise in these steroid levels coincide with changes in the theca 
cell layer, which become hyperaemic.  The outer layer of granulosa cells also change, 
with œstrogen synthesis being halted and progesterone synthesis being initiated.  The 
synthesis of progesterone is further stimulated by LH acting on the recently acquired 
receptors of the granulosa cells.  At the same time, the follicular cells lose or become 
largely unable to bind FSH and œstrogen. 
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The LH surge also drives the oocyte into exiting meiotic arrest and completing its first 
meiotic division (Motlik and Kubelka, 1990).  The two diploid cells thus produced are 
not identical, as virtually all the cytoplasm segregates with one of the daughter cells, 
known as the secondary oocyte, while the other receives very little apart from its diploid 
chromosomes.  The latter cell is referred to as the first polar body, which subsequently 
dies.  The secondary oocyte continues to mature.  The unequal division of the cytoplasm 
between the daughter cells means that the protein stores are conserved in the secondary 
oocyte.  The secondary oocyte undergoes meiosis II but arrests at the second metaphase 
spindle (metaphase II).  By the end of the pre-ovulatory phase, the follicle and follicular 
fluid have rapidly expanded, so that the peripheral layers of thecal and mural granulosa 
cells with the intervening basement membrane have become relatively thin.  The diploid 
secondary oocyte with its cumulus granulosa cells, collectively known as the cumulus-
oocyte mass is now tenuously tethered by a thinning stalk to the peripheral follicular cell 
layers.  The increasing size of the follicle and its position in the ovary causes it to bulge 
out of the ovarian wall.  The bulge becomes thinner due to protease activity and less 
vascularised, and eventually ruptures, releasing the cumulus-oocyte mass into the 
peritoneal cavity (Figure  2.10) (Johnson and Everitt, 2000). 
 
The ovulated cumulus-oocyte complex is captured by the fimbriae of the fallopian tube, 
where cilia beat it towards the uterus.  The oocyte now has a six-hour window in which 
it can be fertilised.  If a spermatozoan does penetrate the zona pellucida that then acts to 
prevent polyspermic fertilisation, the male and female gametes then fuse.  The oocyte-
spermatazoan fusion activates an influx of calcium from oocyte stores, which alters the 
calcium concentration in the oocyte such that it exits meiotic II arrest and proceeds to 
the completion of meiosis II.  The completion of meiotic division results in the 
production of two haploid daughter cells: a daughter cell which is fused with the 
spermatozoan to create a zygote and a second polar body which is expelled.  Gamete 
fusion initiates a developmental programme as the zygote travels along the oviduct and 
into the uterus, where it implants in the endometrium and develops into an embryo, then 
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into a fœtus which is then born.  If the oocyte is not fertilised, it dies and is lost with 
menstrual discharge (Johnson and Everitt, 2000). 
 
Implantation of the blastocyst is dependent on progesterone support, provided by the 
corpus luteum.  The corpus luteum is formed from the follicular cells of the ruptured 
pre-ovulatory follicle that were not expelled from the ovary during ovulation.  The 
luteinised mural granulosa cells enlarge, stop proliferating and differentiate into LH-
responsive, progesterone-secreting granulosa-lutein cells.  The theca cells, now known 
as theca-lutein cells, are maintained and continue to produce the androgen substrate for 
luteal œstradiol synthesis.  The basement membrane between the theca and granulosa 
cells breaks down and the previously avascular granulosa cells develop a marked blood 
supply (Figure  2.10).  These cells are remodelled into a vascular yellow structure that 
gives this glandular tissue its name: the “yellow body” or corpus luteum (CL).   
 
The CL rapidly increases in size and secretes increasing amounts of progesterone, 17-
hydroxyprogesterone, œstradiol and inhibin, under the influence of LH.  Progesterone is 
a necessary requirement of the conceptus, which in turn is able to maintain the CL using 
the secretion of human chorionic gonadotrophin (hCG) that acts through the LH 
receptor.  Luteal steroids and other peptides, such as inhibin, are able to suppress 
gonadotrophin secretion from the anterior pituitary gland.  The CL serves to promote 
implantation and support the survival of the conceptus, which comprises the placenta, its 
membranes and the implanted embryo.  The CL is also able to block further ovulation.  
 
In women, the CL of pregnancy persists until some time between the 9th and 14th week 
of pregnancy, after which time, its luteal function begins to fade, as the conceptus or 
feto-placental unit becomes increasingly able to independently produce sufficient 
quantities of progesterone and other hormones (Johnson and Everitt, 2000).  By 20 
weeks, both luteal function and plasma hCG levels have declined dramatically.  The 
feto-placental unit is now able to sustain itself with its own hormone production. 
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The failure to conceive does not however impact on the formation of the CL in women.  
The lifespan of this CL, now called the CL of the reproductive cycle, is however 
curtailed by the lack of pregnancy.  The CL of pregnancy persists for only about 14 
days, before it regress into a white structure, called the corpus albicans.  During its 
relatively short lifespan, its fully functional status declines steadily until it degenerates 
completely.  The corpus albicans becomes scar tissue, which is eventually resorbed by 
the ovary.  Overt menstruation then occurs with the discharge of the uterine 
endometrium, unfertilised oocyte and blood.  Thus, a new ovarian reproductive cycle 
begins. 
 
The ovarian reproductive cycle lasts approximately 28 days and accounts for the time 
required for antral follicle recruitment and maturation, ovulation, CL formation and 
regression.  The time taken for antral follicle recruitment and maturation lasts 
approximately 14 days and can vary greatly between individual women as well as 
between cycles in the same individual.  This time, from the onset of menstruation to the 
time of ovulation is referred to as the follicular phase or stage of the reproductive cycle 
(Figure  2.11).  Ovulation is virtually instantaneous and occurs on average 36 hours after 
the LH surge.  It is immediately followed by the non-conception luteal phase, which 
lasts a relatively invariate 14 days, during which time the CL is formed, functions briefly 
then regresses.  The timing of the luteal lifespan is relatively fixed and constant between 
individual women and between ovarian cycles in the same individual. If conception and 
successful implantation occurs, the CL persists.  The ovarian cycle is subsequently 
suspended for the duration of pregnancy.  It resumes fully at the end of the lactation 








The relatively precise timing of the luteal lifespan in the absence of conception suggests 
there may be a function for clock genes and circadian clockwork.  Therefore, some 
timing machinery is likely to reside within the corpus luteum.  The corpus luteum 
undergoes many rapid changes as soon as it is formed.  Its whole endocrinology 
becomes vastly different from that of a follicle.  Massive tissue and vascular remodelling 
occurs within a scant few days (Johnson and Everitt, 2000).  These processes are likely 
to require temporal as well as spatial co-ordination and synchronisation. 
 
The luteinisation of the post-ovulatory ‘follicle’ proceeds as the ruptured follicle 
collapses in on itself.  The granulosa cell layer is thrown into folds around the breached 
antrum.  The antrum, made up of elements of blood and follicular fluid contains a core 
of fibrin, a clotting factor, which now undergoes fibrosis.  The basement membrane 
between the theca and granulosa cell layers also breaks down.  The theca interna cells 
are then borne into the incipient CL by the invasion of connective and vascular tissue at 
the folds of the granulosa cell layer (Figure  2.12).  The vascular tissue continues 
invading until the cavity of the collapsed follicle is reached.  The connective tissue also 
continues to invade, in radially orientated strands which can form divisions or septa 
within the CL.  This also allows the penetration of large blood vessels deeper into the 
CL.  Extensive capillary branching completes the angiogenesis of the CL.  The mature 
CL now receives the highest blood supply per unit mass of any organ in the body 
(Johnson and Everitt, 2000, Murphy, 2000). 
 
The theca cells form small lutein cells, referred to as the theca-lutein cells.  They 
produce progesterone and androgens and remain rich in LH receptors.  The follicular 
granulosa cells stop dividing and undergo rapid hypertrophy.  They grow into large 
lutein cells, referred to as granulosa-lutein cells (Figure  2.12).  They are heavily stocked 
with mitochondria, smooth endoplasmic reticula, lipid droplets, Golgi bodies and in 
many species, a carotenoid pigment called lutein.  It is lutein that confers the 
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characteristic pale yellow or orange colouring to corpora lutea.  The granulosa-lutein 





Figure  2.12 Cross-section of a human CL showing the infoldings of the vascular steroidogenic cell layers around a 




The granulosa-lutein cells are the main source of progestogen hormones in the CL.  In 
most species, the principal progestogen is progesterone.  Progesterone, as its name 
implies, is a key requirement for implantation and early pregnancy.  Although the 
granulosa-lutein cells produce the bulk of the progesterone released by the CL, the 
theca-lutein cells are also able to synthesise progesterone.  Progesterone is synthesised 
from cholesterol in a series of chemical reactions, catalysed by enzymes, most notably 
















































Figure  2.13 Two-cell-two-gonadotrophin theory of œstradiol synthesis in the follicle and in the CL. 
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Primate granulosa-lutein cells also secrete significant amounts of 17-
hydroxyprogesterone.  In a few species, like humans, they also secrete notable amounts 
of œstrogens, particularly 17-œstradiol (Murphy, 2000).  The œstradiol is derived from 
an androgen precursor obtained from the theca-lutein cells, just as it occurs in the follicle 
(Figure  2.13).  The theca-lutein cells produce the androgen precursor: androstenedione, 
from cholesterol using a series of enzymes (Figure  2.13).  The androstenedione is then 
converted into œstrogen, via another series of enzyme-catalysed reactions, in the 
granulosa-lutein cells.  The key enzyme involved in this is the cytochrome P450 
aromatase.  Granulosa-lutein cells do not possess the necessary enzyme to produce an 
androgen precursor for œstradiol.  They therefore, most likely, have obtained 
androstenedione from the theca-lutein cells, to produce œstrogen.  This involvement of 
the two cell types in steroidogenesis is referred to as the two-cell-two-gonadotrophin or 
cell co-operative hypothesis (Johnson and Everitt, 2000) (Figure  2.1). 
 
The granulosa-lutein cells also secrete other hormones, including inhibin, oxytocin and 
relaxin.  The role of luteal oxytocin and relaxin in women is not entirely clear.  Inhibin is 
able to suppress FSH synthesis and secretion and is likely to be involved in preventing 
follicular development.  However, FSH inhibition during the luteal phase is largely 
driven by negative feedback from œstradiol in women and sheep (Welt et al., 2003, 




2.11 CORPUS LUTEUM MAINTENANCE 
A luteotrophic complex of chemicals is required to maintain a viable CL.  Human 
chorionic gonadotrophin is considered to be the key ingredient in this complex.  In 
humans, it is produced by the conceptus, in increasing amounts with time.  It functions 
as a maternal-recognition-of-pregnancy signal.  It is able to act on the LH receptors of 
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the luteal steroidogenic cells in order to regulate them.  Other species have markedly 
different mechanisms for maintaining the CL.  For example, rats and hamsters require 
the provision of prolactin in their luteotrophic complex.  In these species, the granulosa-
lutein cells possess prolactin receptors, which are often already present in the pre-
ovulatory follicle.  The prolactin is released from the pituitary gland after ovulation as a 
response to mating stimulus.  It thus functions a signal indicating that mating has 
occurred and provokes the CL into differentiating into a CL of pregnancy.  Once this 
signal has been received, the CL persists until parturition.  There is no requirement in 
this case for a maternal recognition of pregnancy (Johnson and Everitt, 2000, Murphy, 
2000). 
 
The maintenance of the CL can vary considerably between species.  Some species, such 
as the sheep, do not require a trophic signal from the pregnancy or recognition of mating 
stimulus.  Here, the CL is maintained in the absence of a luteolytic signal (Johnson and 
Everitt, 2000).  Normally, two weeks after ovulation, the uterus will produce 
prostaglandin F2 (PGF2) by default.  This is now able to act on the CL which in turn 
feeds forward to further augment PGF2.  PGF2 is luteolytic in nature and causes the 
CL to degenerate.  Pregnancy is able to stop this prostaglandin signalling and so prevent 
luteolysis.  PGF2 is a hormone-like substance that is episodically secreted by uterine 
endometrial cells, to act on dedicated membrane-associated receptors, to induce 
apoptosis of luteal cells (Diaz et al., 2002, Niswender et al., 2007).  This luteolytic signal 
occurs due to P4 signalling from the CL throughout the oestrous cycle.  During the early 
phase, the luteal P4 secretion inhibits uterine PGF2 release.  As time passes, the 
continued secretion of the P4 becomes less and less effective at inhibiting the release of 
PGF2 from the uterus.   By the mid-luteal phase, P4 is no longer able to block PGF2 
release.  The endometrial tissue has begun to lose its sensitivity to P4 and so, PGF2 is 
increasingly secreted.  Thus, by virtue of its initial and continued secretion, P4 is 
considered the key regulator of luteal lifespan in sheep (Schams and Berisha, 2004).  It 
is not just the uterine endometrial cells that secrete PGF2; the CL itself secretes PGF2.  
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The effect of the luteal PGF2 however is unlike that derived from the endometrium.  
The luteal PGF2 is luteotrophic during the early and mid-luteal phases.  P4 is again 
involved in regulating the PGF2 secretion, this time from the CL.  It has been observed 
that the inhibition of P4 has produced opposite effects on PGF2 release, depending on 
the luteal phase.  Antagonism of P4 during the EL phase results in a reduction of luteal 
PGF2 secretion.  Antagonism of P4 during the mid-luteal phase however results in an 
increase in luteal PGF2 secretion (Dupre et al., 2008).  The conceptus uses interferon 
tau (IFNτ) to signal to the uterus to prevent it issuing the luteolytic PGF2 signal.  The 
sheep thus employs an anti-luteolytic strategy as opposed to the human luteotrophic 
strategy. 
 
Other species, such as dogs, do not employ any maternal recognition at all.  They 
produce and maintain corpora lutea, irrespective of their pregnancy status.  Thus, even in 
the absence of pregnancy, they are able to maintain a pseudopregnancy.  Horses, on the 
other hand, use maternal recognition of pregnancy but do so in a slightly different way 
to humans.  Horses produce accessory corpora lutea throughout pregnancy.  There is 
often a primary and a secondary corpus luteum present in the ovary at any one time.  
They use their equine gonadotrophin signal to maintain a steady turnover of these 
corpora lutea (Murphy, 2000, Johnson and Everitt, 2000).  These various ways of 
maintaining corpora lutea extend inevitably into a correspondingly wide array of 





Luteolysis is the functional and structural degradation of the corpus luteum that occurs at 
the end of the luteal phase in the absence of pregnancy.  It is necessary that the CL, in 
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the absence of pregnancy, be eliminated from the body rapidly in order to allow the 
recovery of normal reproductive function as steroids and inhibin from the CL inhibit 
ovulation.  The luteolytic processes involved in the degeneration of the CL of pregnancy 
are less well understood and are probably not identical to those of the degeneration of 
the CL of the reproductive cycle.  It is the luteolysis of the CL of the reproductive cycle 
which will be focussed on here. 
 
Luteolysis progresses firstly, with a loss of function, then with a loss of structural 
integrity, although these processes are intimately linked and run in parallel.  
Progesterone production and secretion decline drastically and eventually cease.  This is 
associated with an initiation of programmed cell death within the CL.   The luteal cells 
die mainly by apoptosis, although necrosis and autophagy have also been implicated 
(Stocco et al., 2007).  Tissue remodelling causes involution of the whole structure with 
the loss of vascularisation (Stocco et al., 2007).  This results in a gland formed 
principally by connective scar tissue.  It is then called the corpus albicans, due to its 
white colour.  The corpus albicans has no known function.  It is resorbed by the ovary 
and replaced by ovarian stroma (Stocco et al., 2007). 
 
The processes that trigger luteal regression remain poorly understood.  Many processes 
have been implicated, involving the action of prostaglandins, prolactin and luteinising 
hormone for example.  Unravelling the roles of these complex processes is further 
complicated by the fact that they seem to vary greatly between species.  In some species, 
luteolysis, like luteal maintenance, can be an active process, whereas in others, it can be 
a passive process.  Active processes involve the triggering of CL destruction by 
luteocidal signals.  Passive processes may involve the withdrawal of luteotrophic signals 
which then, more indirectly initiate the destruction of the CL. 
 
In rats, the trigger for luteolysis is the pre-ovulatory LH surge of the next ovarian cycle.  
In ruminants, like cattle and sheep, the trigger appears to be a luteocidal PGF2 signal.  
In humans, it is the lack of a luteotrophic gonadotrophin signal that appears to trigger 
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luteolysis (Sugino and Okuda, 2007).  All these signals cause the cessation of 
progesterone biosynthesis.  The catabolism of progesterone may also occur and this is 
particularly well described in rodents (Stocco et al., 2007).  Progesterone secretion 
declines when it is catabolised into 20-dihydroprogesterone.  This catabolism is 
catalysed by 20-hydroxysteroid dehydrogenase (20-HSD).  PGF2 has been shown to 
increase 20-HSD levels, which in turn increase the depletion of the protective 
progesterone from the luteal cells.  Prolactin has also been reported to alter 20-HSD 
levels in the CL. 
 
There are many ways in which the loss of progesterone can adversely affect the CL 
(Sugino and Okuda, 2007, Stocco et al., 2007).  The depletion of progesterone can 
relieve the inhibition of apoptotic receptors on the surface of the luteal cells; receptors 
such as Fas.  These Fas receptors are then no longer prevented from binding to Fas-
ligands.  Once this interaction takes place, the Fas and Fas-ligand complexes are able to 
directly activate protease enzymes that orchestrate apoptosis.  These calcium-dependent 
proteases are called caspases.  They catalyse the cleavage of cellular structural proteins, 
such as myosin in the cytoskeleton and lamins in the nuclear scaffold.  They also work 
to cleave other caspases, thus initiating them in a caspase cascade.  Fas and Fas-ligand 
complexes upregulate caspase-8, an initiator caspase.  It, in turn, activates the 
executioner caspase, caspase-3.  Caspase-3 catalyses the cleavage of the endonuclease, 
caspase-activated DNase (CAD) from its inhibitor: inhibitor of CAD (ICAD).  The 
released CAD then enters the nucleus, where it proceeds to fragment the DNA.  DNA 
repair mechanisms are also compromised and the nuclear scaffold impaired.  The 
apoptotic demise of the cell is then inevitable (Sugino and Okuda, 2007, Stocco et al., 
2007).  Other forms of programmed cell death apart from apoptosis are also thought to 
be involved in the luteolytic process. The degree to which apoptosis contributes towards 
the programmed cell death mechanisms involved in luteolysis appears vary over the 
course of the entire luteolytic process and may vary between species (Morales et al., 
2000).   The contribution of the various programmed cell death mechanisms towards the 
demise of the CL is also likely to be observed in the duration of the luteolytic process 
 53 
itself, which has been reported to be shorter in some primates than in species such as the 
sheep (Fraser et al., 1999). 
 
The reduction in progesterone is also associated with an invasion of immune cells.  
Some of these cells are able to produce Fas-ligand.  Some also possess prolactin 
receptors and are therefore, likely to be directed by prolactin, in prolactin-mediated 
luteolytic processes.  Many second messenger systems appear to be involved in the 
transduction of extracellular luteolytic apoptosis signals (Sugino and Okuda, 2007, 
Stocco et al., 2007). 
 
Luteal cells have also been observed undergoing autophagy.  This is another form of 
programmed cell death, where the cell breaks down its own cellular components using 
lysosomal vesicles or vacuoles and effectively digests itself.  This process is often 
initiated by changes in mitochondrial permeability.  These changes would be triggered 
by a luteolytic signal (Stocco et al., 2007). 
 
Necrosis also accounts for some of the luteolytic cell death, in both rodents and 
primates.  The apoptosis of rodent luteal endothelial cells is followed by the necrosis of 
steroidogenic cells.  It has been proposed that the loss of vascular endothelial cells in 
corpora lutea can lead to secondary ischaemia, which in turn leads to necrosis of the 
steroidogenic luteal cells (Stocco et al., 2007). 
 
Luteolysis is a very special example of the body’s routine use of programmed cell death.  
It appears to be triggered by various extrinsic humoral factors, some of which derive 
from the uterine endometrium.  It is mediated by an array of processes, which are 
regulated in complex, intersecting pathways.  Triggering mechanisms and how they 
effect the luteolytic process remain, as yet, not fully characterised.   The various specific 
luteolytic processes themselves are also not yet fully delineated.  Separating the 
processes that are common from those that are not, between species, may also unveil 







 TIMING IN THE CORPUS LUTEUM 
The processes of luteinisation, luteal maintenance and luteolysis are varied and complex.  
Some of these processes may are likely to involve some sort of temporal aspect in its 
regulation.  The human CL, for example, has a uniquely well-timed luteal phase.  In the 
absence of pregnancy, it lasts 14 days before the initiation of luteolysis (Heffner and 
Schust, 2006). 
 
Timing is clearly important in many aspects of reproductive physiology.  It is important 
in the timing of pulsatile release of many hormones, such as GnRH from the brain.  It is 
crucial for the temporal co-ordination of many processes, such as in the timing of mating 
or oestrus with the timing of ovulation.  Timing also appears to be important in the 
regulation of fallopian tube function (Boden and Kennaway, 2006).  It is also likely to be 
important in regulating the lifespan of the CL of the reproductive cycle and hence, also 
of luteal function.  There is a dearth of information regarding the temporal regulation of 
luteal lifespan and function.  Hence, the focus of the current thesis is to provide a better 
understanding of the temporal workings of the corpus luteum, particularly to elucidating 





To summarise, circadian clocks exist in virtually all organisms.  They are found at 
various levels of organisation, from individual cells to whole, multicellular organisms.  
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They are driven by interconnecting, autoregulated transcription-translation negative-
feedback loops.  The principal genes being transcribed and translated in these loops are 
the canonical clock genes: clk, bmal1, per1, per2, per3, cry1 and cry2.  These genes are 
rhythmically expressed and translated with a circadian period. 
 
The various circadian clocks of an organism are organised hierarchically.  Circadian 
clocks can be designated as central or peripheral.  Central clocks are pacemakers.  They 
are directly entrained by the circadian geophysical environment via sunlight.  Only one 
central master clock has been identified in mammals.  It is the SCN that resides in the 
hypothalamus.  It works as a master clock, directing the timing of slave clocks.  These 
slave clocks are peripheral clocks, residing in peripheral tissue outside of the SCN.  
They are entrained principally by the central clock.  They are however, also able to 
integrate other timing information from elsewhere in the tissue or body and from the 
geophysical environment.  The precise way that circadian clocks function in the SCN 
and the periphery is not yet understood.  There are many similarities and many key 
differences. 
 
The hypothalamus (in which the SCN resides) is vital to the regulation of the pituitary 
gland.  It is able to regulate the secretion of pituitary hormones in a timely manner.  The 
pituitary hormones are involved in many numerous physiological processes.  One of 
these processes, in which virtually all the pituitary hormones are involved, is 
reproduction.  Many timing phenomena affect reproductive function.  There appears to 
be significant windows of time during which several key female reproductive processes 
are performed.  Ovulation, mating, luteolysis and parturition all occur predominantly at 
certain times.  Clock genes have been found expressed in brain regions involved in 
reproductive function as well as in the reproductive organs of both sexes.  Moreover, 
clock gene knockouts and mutations often demonstrate impaired reproductive and 
subfertile phenotypes. 
 
The, human and ovine, CL appear to be regulated in a timely fashion.  The human CL of 
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the reproductive cycle undergoes luteolysis after 14 days without luteotrophic support 
from a conceptus.  The ovine CL of the reproductive cycle undergoes luteolysis after 14 
days without inactivation by a conceptus of a default luteotrophic signal issued by the 
uterus.  This apparently specific gating of the timing luteolysis suggests that there is a 
timing mechanism akin to a clock at work in the female reproductive tract.  Whether this 
clock resides in the CL, the ovary, the uterus or elsewhere has yet to be elucidated.  
Whether clock genes and circadian timing are involved in this luteal clock also remains 
a mystery.  How this luteal clock functions is also unknown.  It is proposed that putative 
timing mechanisms be examined in the human and ovine CL.  Special attention should 
also be paid to the hypothalamus and the pituitary gland, as these are also crucial 
regulators of reproductive timing. 
3 CLOCK PROTEIN LOCALISATION IN THE 
HUMAN CORPUS LUTEUM 




3.1.1 HUMAN CORPUS LUTEUM 
The human CL is special in that it possesses a relatively fixed lifespan, that is 
endogenously regulated.  This is unique amongst mammals and contrasts greatly to the 
relatively unfixed duration of the follicular phase of the ovarian cycle (Lenton and 
Woodward, 1988, Atkinson et al., 1975, Neill, 2005, Behrman, 1993).  Once generated, 
the human CL persists for 14 days before spontaneously degenerating and disappearing; 
that is, unless it is maintained by luteotrophic factors signalling from a conceptus. 
 
It is not known what governs the timing of the luteal lifespan or what triggers its 
spontaneous demise in the absence of pregnancy (Duncan, 2000).  Other programmes of 
luteal regression follow a luteolytic process, where a luteocidal signal is automatically 
sent unless it is forestalled by pregnancy (Auletta and Flint, 1988).  This is the case for 
ruminants such as sheep, where, without pregnancy, pulsatile PGF2 is released from the 
uterus and causes luteolysis after 12 days.  This predictable luteal lifespan however, is 
different from that of the human, because it is determined by exogeneous rather than 
endogenous factors (Neill, 2005, Niswender et al., 2007, Niswender et al., 2000).  
Therefore, if the luteal lifespan was governed by a clock, it may lie at the level of the 
uterus and/or the hypothalamus and/or the pituitary gland in ruminants, because the 
hypothalamus and pituitary govern the pulsatile release of oxytocin that closes the 
positive feedback loop of uterine PGF2 secretion (Silvia et al., 1991). 
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The human CL also seems to have a clock of its own.  This has been supported by three 
bodies of evidence.  Firstly, the restoration of ovarian cyclic function, by pulsatile 
GnRH treatment, of hypogonadal infertile women and hypothalamus-lesioned primates, 
does not account for the determination of the luteal lifespan (Loucopoulos and Ferin, 
1984, Johnson and Everitt, 2000, Pohl et al., 1983).  Secondly, manipulation of the 
GnRH or LH pulse frequency or LH concentrations do not alter the lifespan of the CL, 
suggesting that although the pulsatile LH permits the luteal lifespan, it does not time it 
(Neill, 2005).  Thirdly, cultured luteinised granulosa cells (LGCs), that have been 
obtained from pre-ovulatory follicles under an assisted conception protocol, appear to 
possess some inherent timing (Myers et al., 2007a, van den Driesche et al., 2008).  These 
cells are able to persist in culture for approximately 14 days before disappearing, unless 
they are rescued by hCG treatment.  This implies that the timing of the non-conception 
style luteal lifespan is intrinsic to the cells of the CL itself and is not dependent on 
exogenous factors, such as gonadotrophins, which are permissive. 
 
Gonadotrophins do however play an important role in the maintenance of the CL and the 
absence of sufficient LH/hCG activity has been correlated with the demise of the CL.  It 
is known that in vivo, the normal lifespan of the human CL is supported by LH from the 
pituitary gland (Stouffer, 2003).  It is also known that although the manipulation of LH 
does not directly alter the timing of the luteal lifespan, its total removal does however 
cause luteolysis, which can then indirectly shorten the lifespan of that CL (Duncan et al., 
1996, Fraser et al., 1995).  Human chorionic gonadotrophin also augments the human 
CL during pregnancy.  It is secreted by the conceptus and acts to signal maternal 
recognition of pregnancy that facilitates the luteal support of early gestation (Stouffer et 
al., 1989).  It is so potent a luteotrophic factor that hCG treatment of non-pregnant 
women and luteal cells in vitro results in the forestalling of luteolysis and thus, the 
extension of the luteal lifespan (Duncan et al., 1996, Illingworth et al., 1990).  Therefore, 
it could be argued that although the intrinsic timing system that controls the luteal 
lifespan does not necessarily require gonadotrophins, gonadotrophins do however 
interact with that system in order to affect its timing and so, prolong or shorten the 
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lifespan of the CL.  This is further supported by the fact that the longer the CL persists, 
the greater the amount of hCG it needs to maintain its fully functional status, indicating 
that the CL actually ages, but that it also requires exogenous factors to extend its 
lifespan beyond the 14-day norm. 
 
From the studies already described, it is evident that the human CL provides a unique 
opportunity for investigating the temporal regulation of a key reproductive process, 
which is intrinsic to the reproductive tissue.  The whole process of reproduction is 
largely reliant on co-ordinated timing.  As such, the elucidation of how this is provided 
would be an important contribution to existing knowledge, which may also have clinical 
application in procedures such as those conducted in assisted reproduction.  
Furthermore, the mechanism by which hCG affects the luteal lifespan and luteolysis may 
be revealed; a mechanism that has long evaded detailed explanation (Duncan, 2000). 
 
It is therefore proposed, that as the CL has a cell-based clock, regulated by the most 
well-described cellular clock components in biology: the circadian clock genes.  These 
genes have already been observed in areas of the mammalian female reproductive tract, 
in structures such as the fallopian tubes, ovary and uterus.  They have not however been 
investigated in the CL in general and in the human CL in particular (Kennaway et al., 
2003, Boden and Kennaway, 2006).  The putative luteal clock genes are proposed to 
comprise a circadian clock functioning, as it does in other peripheral tissues, 
independently but open to exogenous signalling of temporal information from co-
ordinating pacemaker clocks.  This information may be provided by the ovarian 
hormonal milieu which is regulated by the hypothalamus, the part of the brain that also 
incidentally contains the master pacemaker.  It is proposed that the putative circadian 
clock in the CL works as a timer, accruing time which counts down towards luteolysis, 
thus determining the length of the luteal lifespan.  This timer can be overridden or reset 
by hCG signalling, which facilitates the extension of the luteal lifespan during 
pregnancy.  In order to first address the validity of this hypothesis, it is necessary to 
demonstrate bona fide clock gene expression, by looking at the clock proteins, in the 
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human CL.  This expression must also persist across the luteal lifespan if the clock genes 
were to behave as a timer for the orchestration of the luteal lifespan.  The luteal cell 
types expressing the clock genes may also be important in the provision of temporal 
regulation, as various luteal cell types perform various specific luteal functions, such as 
steroidogenesis, vascularisation, tissue support and modelling. 
 
Therefore this chapter aims: 
 
1. to localise the expression of the canonical clock proteins: CLK, BMAL1, PER1, 
PER2, CRY1 and CRY2 in the human CL using immunohistochemistry; 
 
2. to determine which cell types in the human CL express the clock genes over the 
luteal lifespan in a normal, non-conception, reproductive cycle. 
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3.2 MATERIALS AND METHODS 
3.2.1 ETHICAL APPROVAL 
Ethical approval for the use of human corpora lutea was obtained from the Reproductive 
Medicine Subcommittee of the Lothian Medical Ethics Committee, as well as being re-
approved by the Common Research Ethics Committee (COREC) on two further 
occasions.  Informed consent was then obtained from all the patients and their consultant 
gynaecologists.  The recruitment of patients and the collection of corpora lutea was 
initiated and performed by Dr W. Colin Duncan, under the supervision of Dr Peter J. 




3.2.2 SAMPLING HUMAN CORPORA LUTEA 
Human corpora lutea were enucleated, at the time of surgery, from women undergoing 
hysterectomy for benign reasons as described previously (Duncan et al., 1998a).  All the 
women had regular menstrual cycles and had not received any hormonal treatment for 
three months prior to engaging in the study.   Prior to surgery, the women collected urine 
samples every morning and these were analysed for LH concentrations. The date of the 
urinary LH surge was determined and the stage of the luteal phase was classified 
accordingly. 
 
There were 8 corpora lutea in the early luteal phase, dated to within 1 to 5 days after the 
LH surge; 12 corpora lutea in the mid-luteal phase of 6 to10 days after LH surge and 6 
corpora lutea in the late luteal phase, 10 to 14 days after LH surge.  This dating of the 
corpora lutea was corroborated by endometrial biopsy (Maybin and Duncan, 2004).  The 
timing of the CL collection however could not be standardised but all corpora lutea were 
sampled between 10:00 and 15:00 hours clock time.  At operation, the whole CL was 
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enucleated from the ovary by blunt dissection and the ovary oversewn.  The tissue was 
immediately divided into radial blocks in order to ensure that the whole thickness of the 
gland was represented in any piece.  The tissues were collected over a period of 12 years 
to provide a tissue bank and stored as paraffin wax-embedded blocks in dedicated 




3.2.3 CONVENTIONAL IMMUNOHISTOCHEMISTRY 
The pieces of human luteal tissue were immediately immersion-fixed in 4% 
paraformaldehyde and processed into paraffin wax blocks.    The blocks were sectioned 
at  5 μm thick on a Leica Jung RM 2035 microtome (Leica Microsystems, Milton 
Keynes, UK) and mounted on Menzel-Gläser Superfrost Plus slides (BDH via VWR 
International Ltd, Leicester, UK), then left to dry and adhere at 40oC overnight.  The 
dried sections were then stored at room temperature. 
 
The sections were dewaxed in 100% xylene and rehydrated in a series of graduated 
alcohols then water.  They were then antigen retrieved by pressure cooking in 0.01 M 
citrate buffer (pH 6) for 5 min at full pressure, then left to stand for 20 min and finally 
cooled under running tap water.  Any endogenous peroxidase activity in the tissues was 
blocked by washing the sections in 3% (v/v) hydrogen peroxide (H2O2) in 40% methanol 
for 30 min at room temperature.  The sections were then washed three times for 5 min in 
phosphate-buffered saline (PBS) (0.01 M phosphate, pH 7.4, and 0.85% NaCl).  Any 
nonspecific antibody-binding sites were blocked by incubating sections in blocking 
serum composed of normal goat serum (NGS) (Autogen Bioclear UK Ltd, Wiltshire, 
UK) diluted 1:4 in PBS containing 5% bovine serum albumin (BSA) (Sigma, Dorset, 
UK).    The sections were then incubated in humidity chambers, overnight at 4oC with 
the primary antibody diluted in blocking serum. 
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The primary antibodies against clock proteins (Autogen Bioclear UK Ltd, Wiltshire, 
UK) were used at various dilutions, in blocking solution, determined during pilot studies 
(Table  3.1).  Control sections were incubated with antibody and control peptide in 
blocking serum to confirm the specific action of the primary antibody.  Clock protein 
control peptides (Autogen Bioclear UK Ltd, Wiltshire, UK) were added, ten times in 
excess of the antibody concentration, to the antibody diluted in blocking serum and 
mixed well by brief vortexing and incubating overnight at 4oC before adding to the 
sections.  The luteal steriodogenic cell marker antibody against 3-beta hydroxysteroid 
dehydrogenase (3HSD) (kindly supplied by Prof J. Ian Mason, Department of Clinical 
Biochemistry, The University of Edinburgh, Edinburgh, UK) was used at a 1:1000 









Rabbit anti-human PER1 IgG 1:200 GARB 
Rabbit anti-mouse PER2 IgG 1:100 GARB 
Rabbit anti-mouse CRY1 IgG 1:20 GARB 
Rabbit anti-mouse CRY2 IgG 1:100 GARB 
Rabbit anti-drosophila BMAL1 IgG 1:80 GARB 
Rabbit anti-human CLOCK IgG 1:80 GARB 
Rabbit anti-porcine 3HSD 1:1000 GARB 
Table  3.1 Primary antibodies used in this study, indicating the species that the antibody was raised in and against, the 
dilution used and the appropriate secondary antibody.  
 
 
Excess primary antibody was washed off in three 10-min PBS washes.  The sections 
were then incubated with goat anti-rabbit biotinylated (GARB) (Vector Labs, California, 
USA), diluted 1:500 in blocking serum, for 1 h at room temperature.  Unbound antibody 
was washed off in three 10-min PBS washes.  Avidin-biotin conjugated with horseradish 
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peroxidase (ABC-HRP) (Dako, Cambridge, UK), diluted in 0.05 M Tris-HCl (pH 7.4) 
according to the manufacturer’s instructions, was added to the sections.  They were 
incubated at room temperature for 30 min then the excess ABC-HRP was washed off in 
three 5-min PBS washes.  The ABC-HRP was then detected using the peroxidase 
substrate, 3,3'-diaminobenzidine tetrahydrochloride (DAB) (Dako, Cambridge, UK).  
When the DAB staining was optimal (neither too weak nor too strong), as detected under 
a Zeiss ICS KF2 light microscope (Carl Zeiss Ltd, Welwyn Garden City, Hertfordshire, 
UK), the peroxide reaction was stopped, by immersing the sections in distilled water.  
The DAB stain was effectively that of the immunoreactive-protein. 
 
The sections were then counterstained with a nuclear stain: Harris’ haematoxylin (BDH 
via VWR International Ltd, Leicester, UK) and dehydrated in graduated alcohols and 
xylene.  They were then mounted (Cover Glass; VWR International Ltd, Leicester, UK) 
with Pertex mounting medium (Cell Path, Hertfordshire, UK).  The cellular localisation 
of the immunoreactive protein was examined and any staining photographed, using a 
Provis AX70 microscope (Olympus Optical, London, UK) fitted with a Canon DS6031 
digital camera (Canon Europe, Amsterdam, The Netherlands). 
 
One of the clock protein primary antibodies however failed to work using conventional 
IHC.  The polyclonal anti-CLK IgG failed to work in any of the human, ovine and 
murine tissues tested.  The tissues used were ovine and murine brain and testes, and 
human CL.  The antibody was supposed to work in human and murine tissues (Alpha 
Diagnostic International Clock Antibody Catalogue Number: CLO12-P Product 
Specification Sheet).  Various fixatives and fixation methods were tested, combined with 
a variety of antigen-retrieval methods, including no antigen retrieval at all.  A range of 
concentrations and incubation and wash times were also employed for both the primary 
and the secondary antibodies.  The signal was also amplified using Tyramide.  
Alternative IHC methods using frozen tissue were also employed.  Thin (5 μm) 
cryosectioned murine and ovine brain sections were mounted onto slides, fixed in a 
variety of fixatives for various durations and then processed as per the conventional 
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IHC.  Thick (50 μm) sections of cryoprotected and non-cryoprotected murine and ovine 
brain tissues were also used, in a free-floating system, for IHC with anti-CLK.  Finally, 
dot blots and Western blots of ovine proteins were performed using anti-CLK.  The 
proteins were obtained from various ovine brain and somatic tissues, including the 
mediobasal hypothalamus that contains the SCN, the pituitary gland, the liver, the testis 
and 16 other tissues.  Despite all these attempts to successfully use the anti-CLK 
antibody to detect CLK, it was not possible to evince any meaningful localisation of the 
CLK protein in any of the tissues used, in any of the methods employed.  It was finally 
decided that the successful localisation of BMAL1 would suffice for the initial 





3.2.4 IMMUNOFLUORESCENT HISTOCHEMISTRY 
The localised expression of clock proteins was further investigated by 
immunofluorescent histochemistry.  Immunofluorescent histochemistry was used to co-
localise clock proteins with cell type markers to luteal cell populations.  The cell type 
markers used were: 1) cytochrome P450 aromatase, which localises to the granulosa-
lutein cells, 2) cluster of differentiation molecule 31 (CD31), which localises to vascular 
endothelial cells, and 3) cluster of differentiation molecule 68 (CD68), which localises 
to macrophages.  The usual theca-lutein cell marker is a 17-hydroxylase antibody; this 
could not however be obtained for use in co-localisation.  The cells were confirmed 
however, using 3HSD antibodies in conventional IHC in serial sections, as they would 
be 3HSD-positive and aromatase-negative, while granulosa-lutein cells would be both 
3HSD-positive and aromatase-positive.  Alternatively, theca-lutein cells can be 
identified using their characteristic morphology and location in the layered structure of 
the human CL.  They are considerably smaller than granulosa-lutein cells and lie 
between the stroma and granulosa-cell layers, invaginating into the granulosa-cell layer. 
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The pieces of human luteal tissue sampled were immediately immersion-fixed in 4% 
paraformaldehyde and processed into paraffin wax blocks.  The blocks were sectioned at 
5 μm thick on a Leica Jung RM 2035 microtome (Leica Microsystems, Milton Keynes, 
UK) and mounted on Menzel-Gläser Superfrost Plus slides (BDH via VWR 
International Ltd, Leicester, UK), then left to dry and adhere at 40oC overnight.  The 
dried sections were then stored at room temperature. 
 
The sections were dewaxed in 100% xylene and rehydrated in a series of graduated 
alcohols then water.  They were then antigen retrieved by pressure cooking in 0.01 M 
citrate buffer (pH 6) for 5 min at full pressure, then left to stand for 20 min and finally 
cooled under running tap water.  Any endogenous peroxidase activity in the tissues was 
blocked by washing the sections in 3% (v/v) H2O2 in 40% methanol for 30 min
 at room 
temperature.  The sections were then washed twice for 5 min in PBS.  The blocking of 
endogenous peroxidise blocking is generally not required for immunofluorescent 
histochemistry (fluorescent IHC) as HRP-conjugated antibodies is generally not used.  
This was not the case here, when a Perkin Elmer Tyramide Signal Amplification™ 
(TSA) System (Perkin-Elmer Life Sciences, Boston, MA) was used, which employed an 
HRP-conjugated secondary antibody. 
 
Any endogenous biotin or biotin-binding proteins, lectins, or nonspecific binding 
substances were blocked by applying, as per manufacturer’s instructions, avidin (Vector 
Laboratories, Peterborough, UK) for 15 min followed by two washes with PBS for 5 
min each.  Biotin (Vector Laboratories, Peterborough, UK) was then added to block any 
remaining biotin-binding sites on the avidin.  It was added, as per manufacturer’s 
instructions, for 15 min followed by two 5-min PBS washes. 
Any nonspecific antibody-binding sites were blocked by incubating sections in blocking 
serum composed of NGS (Autogen Bioclear UK Ltd, Wiltshire, UK) diluted 1:4 in PBS 
containing 5% BSA (Sigma, Dorset, UK).    The sections were then incubated overnight 
in humidity chambers at 4oC with the primary antibody diluted in blocking serum (Table 
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 3.2).  Two types of negative control were included: one with control peptide pre-
absorption and the other with the omission of the primary antibody. 
 
Excess primary antibody that had not bound to the sections overnight was washed off 
using two 5-min PBS washes.  The sections were incubated for 30 min at room 
temperature with GARB secondary antibody, diluted 1:500 in blocking serum.  Unbound 
antibody was removed by two 5-min PBS washes.  The chromagens could now be 
added.  These chromagens are composed of fluorescently labelled avidin or streptavidin, 
which can bind onto the biotin that is conjugated to the secondary antibody.  The 
chromagens used were either AlexaFlour® 488 (Invitrogen, Paisley, UK) or AlexaFlour® 
546 (Invitrogen, Paisley, UK), which were conjugated to streptavidin (Table  3.2).  The 
Streptavidin-AlexaFlour was diluted 1:200 in the PBS.  The sections were incubated 
with the chromagens for 1 h at room temperature.  The slides were incubated in the dark 
to prevent bleaching of the light-sensitive chromagens.  Unbound chromagen was 
removed by washing twice for 5 min with PBS. 
 
The sections were blocked a second time with blocking serum for 30 min at room 
temperature.  The second primary antibody was added, at various dilutions, diluted in 
blocking serum (Table  3.2).  The slides were incubated in humidity chambers, overnight 
at 4oC.  Unbound primary antibody was removed with a 5-min wash in PBS with 0.05% 
Tween-20 detergent (PBST) followed by a second 5-min wash in PBS.  The HRP-
conjugated secondary antibody was added.  The sections were incubated with the 
secondary antibody, diluted 1:200 in blocking serum, for 30 min at room temperature.  
Unbound secondary antibody was the removed by washing for 5 min, firstly in PBST 
then secondly, in PBS. 
 
The secondary antibody signal was enhanced using either a Perkin Elmer TSA™ Plus 
Flourescein (TSA Flr) System (Perkin-Elmer Life Sciences, Boston, MA) or a Perkin 
Elmer TSA™ Plus Cyanine 3 (TSA Cy3) System (Perkin-Elmer Life Sciences, Boston, 
MA) (Table  3.1).  The Tyramide is the amplification agent.  It is activated by HRP in 
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order to bind to protein residues in the tissues.  In this way, it only binds to areas of the 
section that are attached to the HRP-conjugated secondary antibody.  The Cyanine 
fluorescent dye is attached to the Tyramide and so, allows the visualisation of the 
Tyramide.  The Flourescein Amplification Reagent or Cyanine 3 Amplification Reagent 
was diluted 1:50 in the 1x Plus Amplification Diluent provided.  This was added to the 
sections and incubated in the dark for 10 min at room temperature.  Unbound chromagen 
















CD31 1:20 GAMB 
Streptavidin 
Alexa 546 
BMAL1 1:120 GARP TSA 
Flr 
CD68 1:20 GAMB Streptavidin 
Alexa 546 
BMAL1 1:120 GARP TSA 
Flr 







PER1 1:16 GAMB Streptavidin 
Alexa 488 CD31 1:80 GAMP 
TSA 
Cy3 
PER1 1:16 GAMB Streptavidin 
Alexa 488 CD68 1:50 GAMP 
TSA 
Cy3 
CD31 1:20 GAMB Streptavidin 
Alexa 546 PER2 1:200 GARP 
TSA 
Flr 
CD68 1:20 GAMB Streptavidin 
Alexa 546 PER2 1:200 GARP 
TSA 
Flr 
CD31 1:20 GAMB Streptavidin 
Alexa 546 CRY2 1:150 GARP 
TSA 
Flr 
CD68 1:20 GAMB Streptavidin 
Alexa 546 CRY2 1:150 GARP 
TSA 
Flr 
Table  3.2 Co-localised primary antibodies used in this study, indicating the dilution used and the appropriate 
secondary antibody and chromagen. 
 
The sections were then counterstained with the nuclear stain: 4'-6-diamidino-2-
phenylindole (DAPI), diluted 1:1000 in PBS, by incubating for 10 min at room 
temperature.  They were washed twice for 5 min with PBS.  The sections were mounted 
(Cover Glass; VWR International Ltd, Leicester, UK) using Shandon Permaflour™ 
aqueous-based mounting medium (Fisher Scientific UK Ltd, Loughborough, Leicester, 
UK).  The cellular localisation of the immunofluorescent-protein was examined and 
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photographed, using a Zeiss LSM 510 Meta Confocal microscope (Carl Zeiss Ltd, 
Welwyn Garden City, Hertfordshire, UK). 
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3.3 RESULTS 
3.3.1 CLOCK PROTEIN IN THE HUMAN CORPUS LUTEUM 
The human CL was successfully visualised using IHC.  The gross appearance of the 
human CL can be observed in photomicrographs, taken with relatively low power 
magnification (Figure  3.1).  The human CL is organised into layers of cells.  The 
granulosa-lutein cell layer is the largest of the cell layers.  The theca-lutein cells are 
generally distributed at the edge of the granulosa-lutein cell layer.  The granulosa-lutein 
cell layer is invaginated by theca-lutein cells and stromal fibroblasts.  The fibroblasts 
mostly surround the steroidogenic cell layers.  They are contained mostly in the 
peripheral stromal cell layer, though there are also some located between the central clot 
and the steroidogenic cells.  They invaginate into the steroidogenic cell layers from both 
these areas.  Blood vessels can also be distinguished, in the stroma and in the 
steroidogenic cell layers.  The central clot, that once comprised the follicular antral 
cavity, lies at the centre of the CL structure. 
 
The principle canonical clock proteins: PER1, PER2, CRY1, CRY2 and BMAL1 were 
localised to the human CL using immunohistochemistry (IHC) (Figure  3.1).  CLK could 
not be visualised in these or any other tissue sections using the antibodies available.  The 
anti-CRY1 antibodies were also difficult to use as the positive staining that they 
provided of the putative CRY1 protein was not removed by pre-incubation with excess 
control peptide (Figure  3.1 Panel C inset).  Although the failure of this negative control 
does effectively invalidate the CRY1 localised using IHC, the images of these 
potentially false-positive staining has been included as the staining patterns appeared to 
be specific with some cells clearly not immunoreactive adjacent to clearly positively 
stained cells (Figure  3.1).  The general staining pattern was much more similar to that of 
CRY2 than that of PER1 and PER2, as would be expected as the cry genes are homologs 
of each other and are known to have closely related circadian roles.  Furthermore, the 
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negative controls omitting the primary antibody was clear of any staining (Figure  3.1 
Panel F). 
 
The staining patterns of each of the clock proteins were, at first glance, generally very 
similar to each other in all of the CL sections stained.  There were however, overall 
differences in the degree of staining observed between the clock proteins, which are 
illustrated in one example of a single CL, which was stained for the clock proteins in 
serial sections (Figure  3.1).  Overall, the clock proteins were found in all the major cell 
types in the human CL.  These cell types were discerned using their morphology, 
relative size, location in the layered human CL structure and detection with co-
localisation markers (Maybin and Duncan, 2004).  With these criteria, the cells 
identified were luteal fibroblasts, granulosa-lutein cells, theca-lutein cells, vascular 
endothelial cells and macrophages.  Specific nuclear and cytoplasmic localisation of all 
the clock genes that were examined was detected in all these cell types.  The clock 
proteins were present in various amounts between cells of the same cell type as well as 
between cell types.  The presence and absence of the clock proteins, and the degree to 
which they were present differed between cells of the same cell type in single fields of 
view.  This heterogeneity in clock protein localisation did not conform to any detectable 
pattern between cell types or between CL samples, or indeed between the specific clock 
proteins.  It may be that the degree of heterogeneity observed would differ between 
luteal phases, perhaps pertaining to the timing of the luteal lifespan and luteolysis.  In 
order to assess whether this was the case, it was necessary that the localisation of the 
clock proteins, and the heterogeneity so far inherent in the human CL, be examined in 
human corpora lutea from throughout the luteal cycle. 
 
Where there was a marked difference between the cytoplasmic staining and nuclear 
staining, the nucleus being much more darkly stained than the cytoplasm, indicating a 
higher concentration of protein located in the nucleus, the difference was referred to as 
the ratio between the nuclear and the cytoplasmic degree of staining.  When there was a 
large difference, this ratio was said to be relatively high, and when there was less 
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obvious difference between the nuclear versus cytoplasmic compartmentalisation of the 




Figure  3.1 Photomicrographs of immunohistochemistry of the clock proteins in serial sections of a mid-luteal phase 
human CL.  Each photomicrograph is labelled as follows: A: PER1, B: PER2, C: CRY1, D: CRY2, E: BMAL1 and F: 
negative control lacking primary antibody with scale bar for 100 m.  The insets are of control peptide pre-absorption 
negative controls.  Luteal cell layers are labelled as follows: SC: stromal cell layer, TC: theca-lutein cell layer, GC: 




Although all of the clock proteins successfully examined were found to be located in 
every discernible luteal cell type, not every cell within each cell type displayed these 
proteins.  Some cells were not immunoreactive and no overall pattern could be clearly 
elucidated for these cells.  Closer examination of the CL sections was conducted using 
higher microscope magnification (Figure  3.2).  Generally, the PER1 and PER2 staining 
was more distinct than that of CRY1, CRY2.  The staining of Per1, PER2 and CRY2 





Figure  3.2 Higher magnification photomicrographs of immunohistochemistry of the clock proteins in mid-luteal human 
CL at 20x magnification.  Each photomicrograph is labelled as follows: A: PER1, B: PER2, C: CRY1, D: CRY2, E: 
BMAL1 and F: negative control lacking primary antibody with scale bar for 100 m. Various luteal cell types are 
indicated by colour-coded arrowheads, with the colours corresponding to individual cell types, as follows:- blue: 
stromal cells, green: theca-lutein cells, orange: granulosa-lutein cells and red: vascular endothelial cells.   
 
 
PER1 can be seen to be clearly and strongly nucleic in its localisation with some 
cytoplasmic staining, in all cell types (Figure  3.1 Panel A and Figure  3.2 Panel A).  The 
most pronounced cytoplasmic staining was in the steroidogenic cells: particularly in the 
theca-lutein cells.  There was however a handful of not immunoreactive theca-lutein 
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cells embedded deep into the granulosa-lutein cell layer.  The fibroblasts in general were 
more likely to be negative for PER1 than the steroidogenic cells, which were mostly 
PER1-positive.  The weakest nuclear:cytoplasmic signal was also that of the fibroblasts.  
The fibroblasts located more internally within the CL, close to the central clot and 
invaginating deeply into the steroidogenic layers appeared to have a higher incidence of 
PER1-negative staining than those located in the peripheral stroma.  The heterogeneity 
in the degree of staining and in the cellular compartmentalisation of the protein between 
cells of the same cell type was particularly evident in the granulosa-lutein cells, two of 
which have been marked out by arrows in Figure  3.1 Panel A.   One of these cells has a 
distinct and strong nuclear staining with some cytoplasmic staining in a relatively high 
nuclear:cytoplasmic ratio of staining strength.  The other cell has mostly cytoplasmic 
staining, which is much stronger than in the first cell described.  It also has no or barely 
discernible nuclear staining, thus again presenting a relatively high nuclear:cytoplasmic 
staining strength ratio, although this ratio is lower than that for the first cell.  The 
staining of the first cell described is more characteristic of the majority of the granulosa-
lutein cells in this field of view, in this section.  The overall degree of nuclear staining 
and the nuclear:cytoplasmic ratio of staining in the theca-lutein cells also varies, though 
not as much as in the granulosa-lutein cells.  Some of the theca-lutein cells, along with 
fibroblasts, which were deeply embedded in the granulosa-lutein layer, were not 
immunoreactive.  Many of the theca-lutein cells located closer to the outskirts of the 
granulosa cell layer had a lower nuclear:cytoplasmic ratio of staining strength compared 
to the adjacent granulosa-lutein cells.  The fibroblasts were generally the most 
heterogeneous in their staining, with as many cells being not immunoreactive as there 
were positively stained, and with a highly variable degree of positive between cells.  
Examples of strong and faintly stained fibroblasts are depicted with arrows in the Figure 
 3.7 Panel A, alongside a non-immunoreactive fibroblast.  PER1 was also observed in 
some but not all of the vascular endothelial cells (Figure  3.7 Panel A). 
 
The staining pattern of PER2 was similar to that of PER1 (Figure  3.1 Panel B and Figure 
 3.2 Panel B).  Again, all the cell types were PER2-positive, with a pronounced nuclear 
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signal and less pronounced cytoplasmic signal.  There appeared to be more PER2 in the 
cytoplasm of the theca-lutein cells than in any other cell type, with a 
nuclear:cytoplasmic ratio in the strength of the staining that was very similar to that of 
PER1.  This ratio however differs between these two proteins when the granulosa-lutein 
cells are inspected.  Whereas a general difference could be discerned between the theca-
lutein and granulosa-lutein cells in terms of nuclear:cytoplasmic ratios of staining 
strength with PER1, this was less evident when staining for PER2 (Figure  3.2 Panel B). 
Like the localisation of PER1, PER2 in the fibroblasts is clearly nuclear with much 
fainter cytoplasmic staining, and there appears to be more non-stained fibroblasts 
located closer to the central clot than the stromal fibroblasts closer to the outer boundary 
of the CL.  Fibroblasts and theca cells observed in the midst of the steroidogenic cells 
appeared to also often be PER2-negative.   
 
The staining pattern of PER2 was also unique in the granulosa-lutein cells (Figure  3.2 
Panel B).  Many cells demonstrated staining of cytoplasmic PER2, collected in foci 
radiating around the nucleus of some cells, and closely apposed to what appears to be 
the basement membrane of the cells.  Not all cells however demonstrated the presence of 
the PER2 foci and indeed, their presence differed from CL sample to CL sample.  There 
was also heterogeneity within samples, with some fields of view presenting no such 
staining and with other fields of view from the same sample, presenting many instances 
of foci staining.  Indeed, in a single field of view, some granulosa-lutein cells can be 
seen to have no foci, while others do.  Those that do can also differ in terms of degree of 
cytoplasmic staining, suggesting that the amount of PER2 detected in the cytoplasm 
varied from cell to cell.  The nuclear staining in these cells could also vary.  In Figure 
 3.2 Panel B, three examples of heterogeneous granulosa-cell staining have been picked 
out: 1) with nuclear and cytoplasmic staining, with the nuclear staining predominating 
and without any foci staining, 2) with nuclear and cytoplasmic staining, with the nuclear 
staining predominating but not as much as in the cell in example 1, and with cytoplasmic 
foci staining as strongly as the nucleus and 3) with cytoplasmic staining to a degree that 
is akin to that in example 1 but with foci staining as in example 2 and with very faint or 
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virtually no nuclear staining.  Fibroblasts were found to stain equally heterogeneously, 
with examples of a strongly PER2-positive, a less strongly PER2-positive and a PER2-
negative fibroblast indicated in Figure  3.2 Panel B.  The theca-lutein cells were largely 
PER2-positive with most cells demonstrating stronger nuclear staining than cytoplasmic 
staining.  The vascular endothelial cells were also mostly PER2-positive with generally 
much less heterogeneity observed in their staining between cells within individual fields 
of view.  Some cells closely apposed to the positively-stained vascular endothelial cells 
and which may be pericytes, appear to be PER2-negative. 
 
The staining of CRY1 was very diffuse in the steroidogenic cells, with a relatively low 
nuclear:cytoplasmic ratio in the degree of staining observed between these cell 
compartments in these cell types (Figure  3.1 Panel C and Figure  3.2 Panel C).  The 
theca-lutein cells were again more homogeneously stained than the granulosa-lutein 
cells, both in terms of positive versus negative staining as well as in terms of degree of 
staining in the cytoplasm and nucleus.  Most theca-luteal cells were CRY1-positive with 
a discernible nuclear:cytoplasmic ratio in the degree of staining, with the nucleus more 
strongly stained.  Only a few theca-lutein like cells found in the midst of the granulosa-
lutein layer could be seen to be either CRY1-negative or to have very little nuclear 
staining although cytoplasmic staining was present.  The granulosa-lutein cells were also 
mostly CRY1-positive although there were some CRY1-negative cells.  The non-
immunoreactive cells appeared to account for a larger proportion of the granulosa-lutein 
cell population than the non-immunoreactive theca-lutein cells accounted for in the 
theca-lutein cell population.  The staining of the CRY1-positive granulosa-lutein cells 
was much more mixed in terms of their nuclear:cytoplasmic staining strength ratio.  To 
illustrate this, three granulosa-lutein cells have been pointed out in Figure  3.2 Panel C: 
1) a strongly nuclear and almost-as-strongly cytoplasmic CRY1-positive cell, 2) a 
strongly nuclear but much fainter CRY1-positive cell and 3) a cytoplasmic CRY1-
positive cell with very little if any nuclear CRY1.  The fibroblasts were mostly CRY1-
positive, both those associated with the peripheral stroma as well as those associated 
with the central clot and infiltrating into the steroidogenic cell layers, although there 
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were more CRY1-negative evident closer to the central clot.  Although higher than that 
of the granulosa-lutein and theca-lutein cells, the nuclear:cytoplasmic ratio of staining 
strength in the fibroblasts was lower than that seen with PER1 and PER2.  The nuclear 
staining of the stromal fibroblasts was very pronounced, but so was the cytoplasmic 
staining compared to that of PER1 and PER2 in the fibroblasts.  The vascular endothelial 
cells appeared to be mostly CRY1-positive.  It is notable that the primary antibody-
omitting negative control in Figure  3.2 Panel F was clear, although the control peptide 
pre-absorption negative control for CRY1 was not (Figure  3.1 Panel C inset). 
 
CRY2 was expressed in all the luteal cell types with staining that was much less diffuse 
than that of CRY1, and more closely resembled that of BMAL1 than that of CRY1 
(Figure  3.1 Panel D and Figure  3.2 Panel D).  Although its staining pattern in general 
had a lower nuclear:cytoplasmic signal strength ratio than that of PER1 and PER2, it 
was not as low as that of CRY1.  The cytoplasmic compartmentalisation of CRY2 was 
much less than the nuclear compartmentalisation of BMAL1 in all the cell types.  Once 
again, the theca-lutein cells were the most strongly stained for nuclear clock protein.  
There was also strong nuclear staining in the granulosa-lutein cells and the fibroblasts, 
with virtually all the granulosa-lutein cells being CRY2-positive.  The 
nuclear:cytoplasmic signal strength ratio was no less variable in the stroma-associated 
theca-lutein cells than the granulosa-lutein cells.  The theca-lutein cells found amidst the 
granulosa-lutein cell layer were much more likely to be CRY2-negative then the stroma-
associated theca-lutein cells.  There appeared to be a greater proportion of CRY2-
negative theca-lutein cells in the granulosa-lutein cell layer than CRY1-negative cells in 
the same location.  The staining of the granulosa-lutein cells did however still provide 
instances of cells that were 1) strongly positive in both nuclear and cytoplasmic 
compartments, with nuclear staining predominating, 2) strongly nuclear and faint 
cytoplasmic staining and 3) cytoplasmic staining with little or no nuclear staining 
(Figure  3.2 Panel D).  The nuclei of positively stained steroidogenic cells were, for the 
most part, more densely stained than the cytoplasm.  The nuclear:cytoplasmic ratio of 
the staining strength in the fibroblasts was very similar to that of CRY1.  It was also 
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heterogeneous, with strongly CRY2-positive, faintly CRY2-positive and CRY2-negative 
cells pointed out in Figure  3.2 Panel D.  The fibroblasts near the central clot, and 
particularly those invaginating into the steroidogenic layers from the central clot, were 
largely CRY2-negative.  This was also the case for fibroblasts that were deeply 
embedded in the steroidogenic layers, even those in tracts originating from the 
peripheral stroma.  The theca-lutein cells that were found in invaginating tracts deeply 
embedded in granulosa-lutein cell layer also tended to be CRY2-negative.  The vascular 
endothelial cells were generally CRY2-positive.   
 
The BMAL1 staining, like the CRY1 and CRY2 staining, was more diffuse than the 
PER1 and PER2 staining (Figure  3.1 Panel E and Figure  3.2 Panel E).  The 
nuclear:cytoplasmic ratio in the strength of staining in the steroidogenic cells was 
relatively low and was slightly greater than that of CRY1 but slightly less than that of 
CRY2.  The theca-lutein cells were again distinctly stained, with nuclear staining being 
greater than cytoplasmic staining, providing a higher nuclear:cytoplasmic signal strength 
ratio than the granulosa-lutein cells.  The theca-lutein cells in the midst of the granulosa-
lutein cell layer were however more variable in their positive versus negative BMAL1 
staining, with a larger proportion of these cells being BMAL1-negative than the stroma-
associated theca-lutein cells and granulosa-lutein cells.  The granulosa-lutein cells were 
also virtually all positively-stained.  There were small number of granulosa-lutein cells 
being BMAL1-negative, accounting for a larger proportion of the granulosa-lutein cell 
population than those not stained for of PER1, PER2 and CRY1.  The degree of 
cytoplasmic staining in the steroidogenic cells was however quite varied, with the cells 
closest to the folds in the invaginating steroidogenic cell layers being more strongly 
stained than the cells in the midst of the steroidogenic layers (Figure  3.1 Panel E).  The 
fibroblasts were mostly BMAL1-positive, albeit with some heterogeneity in the degree 
of staining, although most had stronger nuclear staining than cytoplasmic staining.  The 
ratio between the strengths of these stains was relatively similar to that observed with 
CRY2.  The few fibroblasts that were BMAL1-negative were mostly those invaginating 
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from the central clot into the steroidogenic cell layers as well as those deeply embedded 
in these layers.  The vascular endothelial cells were mostly BMAl1-positive. 
 
Figure  3.2 Panel F shows the negative control that lacked incubation with the primary 
antibody.  The negative control is devoid of any DAB staining, demonstrating the 
specificity of the clock protein antibodies in the CL tissue with the protocol used.  All 
the CL sections depicted in Figure  3.1 and Figure  3.2, alongside sections from other 
corpora lutea, were also processed with negative controls that were incubated with the 
primary antibody, pre-absorbed with control peptide.  These negative controls were also 




3.3.2 SPECIFIC CELL TYPES IN THE CORPUS LUTEUM  
It was clear rhat the clock proteins were present in multiple cell types.  Some cells can 
be identified by morphology more easily than others.  Therefore, to ascertain which cell 
types the clock proteins were present in, it was necessary to identify as many cell types 
as possible, using IHC with antibodies raised against cell type marker proteins.  The CL 
consists of different cell types in addition to the steroidogenic cells derived directly from 
the follicular granulosa cells and the steriodogenic cells derived directly from the 
follicular theca cells, such as fibroblasts, endothelial cells, pericytes and immune cells, 
including macrophages (Duncan et al., 1998a).  The cell types which could not be 
identified using visualisation of marker peptides were identified by virtue of their 
characteristic morphology and location in the layered structure of the human CL.  The 
cell types thus identified were fibroblasts and where appropriate, granulosa-lutein cells, 
theca-lutein cells, vascular endothelial cells and erythrocytes (Maybin and Duncan, 
2004).  The cell types that could be identified using marker peptides were the granulosa-
lutein cells, theca-lutein cells, vascular endothelial cells and macrophages. 
 
 81 
The granulosa-lutein cells were identified using antibodies raised against P450 
aromatase.  This enzyme catalyses the aromatisation of androgens into œstrogens, that 
occurs only in the granulosa-lutein cell type in the CL.  This reaction occurs in the 
cytoplasm and so the peptide is only observed in the cytoplasmic compartment of the 
cell.  A commercially available anti-P450 aromatase antibody was successfully used in 






Figure  3.3 Photomicrographs of different cell types in the human CL at 20x and 60x magnification.  A: Confocal image 
of red-staining P450 aromatase-positive granulosa-lutein cells with blue DAPI nuclear counterstain.  B: brown-staining 
3HSD-positive steroidogenic cells revealed using a standard DAB detection system, with an inset image of a 
negative control lacking primary antibody, counterstained with haemotoxylin (blue).  C: Confocal image of red-staining 
CD31-positive vascular endothelial cells with blue DAPI nuclear counterstain.  D: Confocal image of red-staining 
CD68-positive macrophages with blue DAPI nuclear counterstain.  E: a standard haematoxylin and eosin (H&E) stain 
showing all the luteal cells: granulosa-lutein cells (orange arrowhead), theca-lutein cells (green arrowhead) and 
fibroblasts (blue arrowheads).  F: Confocal image of a double negative control lacking primary antibody with blue 




The theca-lutein cells, being steroidogenic, can be identified along with the granulosa-
lutein cells using IHC with antibodies against the 3βHSD enzyme.  This was employed 
as it proved difficult to source a specific theca-lutein cell marker, such as a 17-
hydroxylase antibody, and it was decided that in order to identify these cells, sections 
stained for aromatase would be ‘subtracted’ from serial sections stained for 3βHSD, 
which localises to both types of steroidogenic cell.  The enzyme, like aromatase, also 
localised to the cytoplasmic compartment.  The comparison of serial sections was further 
made necessary, because the 3βHSD antibody could not be successfully used in an 
immunofluorescent protocol, and only worked in a conventional IHC protocol.  The 
inset photomicrograph in Figure  3.3 Panel B is the negative control, which omitted a 
primary antibody.  It successfully demonstrated the specificity of the primary antibody, 
as it was clearly not stained by DAB, and showed only the haematoxylin nuclear 
counterstain. 
 
The CL contains a large number of blood vessels, which are lined by vascular 
endothelial cells.  These cells have a characteristic morphology.  They are very flat, 
elongated cells with long intercellular junctions and distinct nuclei.  They occur in a 
single layer around the blood vessel.  They were identified in the human CL using the 
cytoplasmic marker: CD31.  The CD in its name refers this marker being a cluster of 
differentiation molecule.  These molecules are located on cell surfaces and are often cell 
surface receptors or ligands.  CD31, also known as platelet/endothelial cell adhesion 
molecule-1 (PECAM-1), is an endothelial cell adhesion molecule.  The surface of the 
luteal vascular endothelial cells was successfully visualised using an antibody raised 
against CD31, using single immunofluorescent IHC (Figure  3.3 Panel C). 
 
The CL also contains various immune cells, including macrophages.  Macrophages 
phagocytose (engulf then digest) pathogens and cellular debris as well as stimulate other 
immune cells to mount a defence against pathogenic infection.  Macrophages also have a 
characteristic morphology.  They are round, mononuclear cells with one or two 
elongated tail-like extensions.  In humans, they are approximately 21 μm in diameter.  
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Macrophages in the human CL were identified using another CD marker: CD68.  CD68 
is a glycoprotein that binds low-density lipoproteins, and is only expressed on 
macrophages.  The outline of these cells can be clearly seen using single 
immunofluorescent IHC (Figure  3.3 Panel D). 
 
The general architecture of the human CL is revealed in a section stained with 
haematoxylin and eosin (Figure  3.3 Panel E).  Eosin is a dye that stains cytoplasm, 
collagen and muscle while haematoxylin stains basophilic molecules such as nucleic 
acids, which are found in cell nuclei.  The photomicrograph in Figure  3.3 Panel E shows 
the invagination of the granulosa-lutein cell layer by vein-like tracts of theca-lutein cells 
and fibroblasts.  The fibroblasts have a characteristic flat and elongated morphology, 
which was used to identify them. 
 
Figure  3.3 Panel F shows a negative control, lacking primary antibody, photographed at 
the same settings as those in Figure  3.3 Panel C and D.  It shows minimal red 





3.3.3 CLOCK PROTEINS IN SPECIFIC LUTEAL CELL TYPES 
In order to definitively identify the cell types in which the various clock genes could be 
seen, co-localisation of the clock genes and cell marker peptides was performed using 
dual immunofluorescent histochemistry.  This required the use of higher antibody 
concentrations, which precluded some of the clock protein antibodies.  Some of the 
clock protein antibodies were also unsuitable as they were raised in the same animal 
species as that of the marker peptide antibody, making it impossible to distinguish the 
two antibodies using a secondary antibody that simply recognises proteins from the 
antibody donor-animal species.  The use of late luteal phase human luteal tissue was also 
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preferred as this better enabled the identification of the various cell types based on their 
morphology, relative size and relative location.  The clock proteins that were 
successfully co-localised with some of the marker peptides were: PER1, PER2, CRY2 
and BMAL1. 
 
PER1 co-localised with aromatase in the granulosa-lutein cells in the late luteal phase 
human CL (Figure  3.4 Panel A).  In this section, most of the granulosa-lutein cells 
contained strong nuclear PER1 fluorescence.  A few cells however were much less 
fluorescent, showing nuclei with more predominant nuclear DAPI fluorescence than that 
of PER1, although there did appear to be some nuclear PER1 present.  Interestingly, the 
nucleoli of the nuclear PER1-positive granulosa-lutein cells were often negative for 
PER1.  The theca-lutein cells were identified using their morphology, location and size, 
relative to the other cells, particularly the granulosa-lutein cells.  The nuclei of the theca-
lutein cells were also heterogeneously fluorescent for nuclear PER1, demonstrating 
strong staining, faint staining and no staining in various cells in the same field of view 
(Figure  3.4 Panel B).  In the field of view in Figure  3.4 Panel B, there were as many 
nuclear PER1-positive theca-lutein cells as nuclear PER1-negative theca-lutein cells.  
The fibroblasts were similarly heterogeneously fluorescent, with some staining 
predominantly with DAPI and others predominantly with PER1.  PER1 was also co-
localised with CD31 in some of the vascular endothelial cells (Figure  3.4 Panel D), 
while other CD31-positive cells were PER1-negative (Figure  3.4 Panel C).  PER1 did 
not co-localise with CD68 in the macrophages in this field of view (Figure  3.4 Panel E).  
A negative control omitting primary antibody showed relatively very low background 
red fluorescence and no green fluorescence, and no specific fluorescence of any 
particular cell or cell type, thus demonstrating the specificity of the antibodies in this 




Figure  3.4 Confocal photomicrographs of immunohistochemistry of PER1 (green) co-localising with A and B: P450 
aromatase (red), C and D: CD31 (red) in vascular endothelial cells and E: CD68 (red) in macrophages.  F is the 
negative control lacking primary antibody.  A DAPI nuclear counterstain (blue) was used in all sections.  The 
arrowheads indicate granulosa-lutein cells, the arrowheads with asterisks indicate theca-lutein cells, the arrows 
indicate vascular endothelial cells, the arrows with asterisks indicate macrophages and the triangles indicate 
fibroblasts.  The scale bar represents 100 m. 
 
 
PER2 also co-localised to luteal cell markers in the late phase human CL.  It was found 
in many, but not all, the vascular endothelial cells, which were identified by CD31 
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fluorescence (Figure  3.5 Panel C).  The inset image shows a higher magnification of the 
CD31-positive vascular endothelial cells containing PER2. 
 
PER2 could not be co-localised with aromatase, as it would require too high a 
concentration than that which was available, in order to definitively characterise the 
presence of PER2 in the granulosa-lutein cells.  Figure  3.5 Panel A however, although 
showing the co-localisation of PER2 and CD31, could be used for the purpose of 
illustrating the PER2 fluorescence in the granulosa-lutein cells.  These cells were 
identified by their characteristically large size and cuboidal shape, as well as their 
layered location in relation to the other surrounding cells of different cell type.  The 
aggregates of PER2 in foci, radiating around the nucleus and closely apposed to the 
outer boundary of the cell, which were previously described (Figure  3.2 Panel B) were 
again observed in some, but not all, of the granulosa-lutein cells, using dual 
immunofluorescent histochemistry.  Some of the foci-laden cells were strongly PER2-
positive in the nuclear compartment as well as in the cytoplasmic compartment.  Other 
foci-laden cells appeared to have virtually no nuclear PER2 while others still appeared to 
have only a faint fluorescence of PER2, indicating that there was only relatively small 
amounts of PER2 in their nuclei (Figure  3.5 Panel B).  The staining of the foci also 
varied, with some cells demonstrating thick rings of highly fluorescent PER2 in the 
cytoplasm, while other cells demonstrated only a light peppering of fluorescent foci, 
arranged in a very thin ring, close to the edge of the cells.  In general, the foci-laden cells 
were arranged in close proximity to each other, occurring in small clusters.  Granulosa-
lutein cells that did not contain foci were also loosely arranged together in small clusters. 
This unusual pattern of staining appears to be unique to this protein in these cells, as 
they have not been previously reported. 
 
Theca-lutein cells were also visible in confocal photomicrographs of PER2 co-localised 
with CD31 (Figure  3.5 Panel D).  The theca-lutein cells were identified by their 
morphology, size and location, relative to the other cells in the CL.  PER2 could be seen 
in the nuclei of some, but not all, of these cells.  It could also been seen in some, but not 
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all, of the fibroblasts, which were also identified by their characteristic morphology, size 
and relative location in the CL. 
 
PER2 was also successfully co-localised to CD68, indicating its expression in 
macrophages.  It was both nuclear and cytoplasmic, appearing green in the nucleus and 
orange when co-localised with the red fluorescent cytoplasmic CD68 (Figure  3.5 Panel 
E).  The inset image is a confocal photomicrograph taken at a higher power, depicting a 
PER2-positive macrophage.  Figure  3.5 Panel F is a confocal photomicrograph, which 
better shows the cytoplasmic CD68 fluorescence demarcating the characteristic flame-
like shape of the macrophages with DAPI nuclear counterstain and without the 





Figure  3.5 Confocal photomicrographs of immunohistochemistry of PER2 (green) co-localising with various peptides 
(red) and nuclear counterstained with DAPI (blue).  A: PER2 co-localised with CD31 (red) in macrophages (arrows 
with asterisks), with an inset image of a magnified macrophage.  B: CD31 (red) staining with DAPI and without PER2 
staining.  C: PER2 co-localised with CD31 (red) in vascular endothelial cells (arrows), with an inset image of a 
magnified vascular endothelial cells.  D: PER2 co-localised with CD31 (red) in granulosa-lutein cells (arrowheads) and 
fibroblasts (triangular arrowheads).  E: PER2 co-localised with CD68 (red) macrophages (arrows with asterisks), with 
an inset image of a magnified macrophage.  F: CD68 (red) localising to macrophages (arrows with asterisks).  No 
clear theca-lutein cells could be identified.  The scale bars represents 100 m. 
 
 
CRY2 was also successfully co-localised to the CD31 and CD68 markers.  The co-
localisation of CRY2 with CD31 appears as orange in the vascular endothelial cells seen 
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in Figure  3.6 Panel A.  The nuclei of some of these cells were predominantly CRY2-
negative, while others were clearly CRY2-positive in both nuclear and cytoplasmic 
compartments.  This is particularly obvious when the field of view is expanded using a 
lower power magnification, as demonstrated in Figure  3.6 Panel B.  This also enables 
the observation of CRY2 in many of the granulosa-lutein cells, as well as, in the theca-
lutein cells.  The theca-lutein cells appeared to have a much fainter CRY2 signal with a 
more cytoplasmic distribution.  The fibroblasts also demonstrated heterogeneous CRY2 
localisation, with some fibroblasts being CRY2-positive and others being CRY2-
negative. 
 
CRY2 co-localised with CD68 in some of the macrophages.  The degree of CRY2 
staining in these macrophages was heterogeneous with fainter CRY2 fluorescence 
observed in some cells (Figure  3.6 Panel C) than in other cells (Figure  3.6 Panel D).  
The CRY2 protein was both nuclear and cytoplasmic, with a varied nuclear:cytoplasmic 
signal strength ratio.  The nuclear compartment was more strongly fluorescent in some 
macrophages (Figure  3.6 Panels C and D) while in others, the cytoplasmic compartment 





Figure  3.6 Confocal photomicrographs of immunohistochemistry of CRY2 (green) co-localising with various peptides 
(red) and nuclear counterstained with DAPI (blue).  A and B: CRY2 co-localised with CD31 (red) in macrophages 
(arrows with asterisks), with an inset image of a magnified macrophage.  C and D: CRY2 co-localised with CD31 (red) 
in vascular endothelial cells (arrows).  The granulosa-lutein cells (arrowheads) also appear to be CRY2-positive while 
the theca-lutein cells (arrowheads with asterisks) were less easily identified as CRY2-positive.  The scale bars 
represents 100 m. 
 
 
BMAL1 also successfully co-localised with the vascular endothelial cell marker peptide, 
CD31 and the macrophage marker peptide, CD68 (Figure  3.7).  BMAL1 was mostly 
nuclear in the vascular endothelial cells (Figure  3.7 Panel A), which were virtually all 
BMAL1-positive in this field of view.  BMAL1 was also present in the luteal 
macrophages, in both nuclear and cytoplasmic compartments: fluorescing green in the 
nucleus and orange (a combination of the red fluorescence of the CD68 and green 
fluorescence of the BMAL1) in the cytoplasm (Figure  3.7 Panel B).  The steroidogenic 
cells could also be identified by their size and location (Figure  3.7 Panel A).  They were 
found to be mostly BMAL1-positive, although there were also a few putative theca-
lutein cells that were BMAL1-negative.  The fibroblasts were also identified by their 
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classic morphology; some of which were BMAL1-negative and some of which were 




Figure  3.7 Confocal photomicrographs of immunohistochemistry of BMAL1 (green) co-localising with A: CD31 (red) in 
vascular endothelial cells (arrows) and B: CD68 (red) in macrophages (arrows with asterisks) with DAPI nuclear 
counterstain (blue).  BMAL1 could also been seen in some steroidogenic cells, some of which were granulosa-lutein 




3.3.4 CLOCK PROTEINS THROUGHOUT THE LUTEAL PHASE 
Sections from early, mid- and late luteal phase human corpora lutea were examined 
using conventional IHC of the clock proteins.  This revealed that the clock proteins were 
present in the human CL at each of the phases of the luteal cycle.  The heterogeneity in 
the localisation of the clock genes that was observed in the late luteal phase corpora 
lutea was also evident in the early and mid-luteal phase corpora lutea.  No gross 
differences could be found between the corpora lutea of different phases that could not 
also be found between corpora lutea of the same phase.  Therefore, the degree of 
heterogeneity observed in the clock protein localisation was not noticeably different 




3.3.5 PERIOD1 IMMUNOSTAINING 
In all the luteal phases, PER1 was found located predominantly in the nucleus though 
also, more faintly staining, in the cytoplasmic compartment of theca-lutein, granulosa-
lutein and vascular endothelial cells.  Virtually all the granulosa-lutein cells contained 
PER1, as did most theca-lutein cells.  There were a few, isolated PER1-negative theca-
lutein cells (Figure  3.8).  The vascular endothelial and perivascular cells were more 
variable in their staining, with the cells of some blood vessels staining positive while 
cells of other blood vessels were less strongly stained and others still, were negative 
(Figure  3.8 Panels A and E).  There was also the occasional blood vessel lined with an 
admixture of PER1-positive and PER1-negative cells (Figure  3.8 Panel C).  Staining in 
the fibroblasts was mostly only nuclear with a few exceptions displaying both nuclear 
and cytoplasmic staining.  The fibroblasts were stained in all samples but the proportion 
of fibroblasts positive for PER1 varied from sample to sample (Figure  3.8 Panels A and 
E).  This variation was also evident between different areas of the same section in some 
samples (Figure  3.8 Panel D).  PER1 was also found in some macrophages but was 
generally infrequent.  The strength of staining in both the nucleus and cytoplasm varied 
greatly between individual cells of each cell type, within and between samples.  The 
degree of heterogeneity in such staining was also variable within and between samples.  
No evident trends emerged over the luteal lifespan. The negative controls, which used 






Figure  3.8 Photomicrographs of immunohistochemistry 
of PER1 in human CL throughout the luteal cycle: A: 
early, B and C: mid-,D: late and E: very late luteal 
phases. F is the control peptide pre-absorption negative 
control of the late luteal phase human CL.  Various luteal 
cell types are indicated by colour-coded arrowheads, 
with the colours corresponding to individual cell types, 
as follows:- blue: stromal cells, green: theca-lutein cells, 
orange: granulosa-lutein cells and red: vascular 
endothelial cells.  The scale bar represents 100 m. 
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3.3.6 PERIOD2 IMMUNOSTAINING 
PER2 was found throughout the luteal phases, in all cell types; in most granulosa-lutein 
cells and theca-lutein cells.  The amount of positively staining cells amongst the 
fibroblasts, vascular endothelial, perivascular cells and macrophages, was more 
heterogeneous than with PER1 (Figure  3.9).  There may have been a slight trend towards 
more PER2-negative fibroblasts, vascular endothelial, perivascular cells and 
macrophages cells in the late luteal than the mid-luteal phase samples.  The mid-luteal 
samples also appeared to have more PER2-negative cells than the early luteal samples.  
The degree of heterogeneity in the nuclear:cytoplasmic signal strength ratio was 
therefore also increased over time.  This trend however was based on a purely subjective 
observation.  The degree of staining of the cells of each cell type was also very variable.  
It varied greatly among the individual steroidogenic cells in a single population, with 
different groups of steroidogenic cells displaying various ratios of nuclear:cytoplasmic 
staining strength.  The fibroblasts associated with blood vessels appeared to cluster 
loosely into local groups of solely positive or negative cells within each cell type.  The 
vascular endothelial cells around single blood vessels were also largely composed of 
solely PER2-positive or PER2-negative cells. 
 
The PER2 staining in the granulosa-lutein cells, again demonstrated the unusual staining 
pattern of cytoplasmic foci, radiating around the nuclei of cells.  These foci were again 
in some, but not all, of the cells and in some, but not all, of the CL samples.  The nuclei 
of the foci-laden cells were often also PER2-positive, though sometimes, the foci 
appeared without nuclear staining (Figure  3.9 Panel F).  The cells containing foci often 
clustered loosely in local groups of adjoining foci-laden granulosa-lutein cells.  These 
foci-laden cells were however heterogeneously distributed with sometimes, large 
clusters of foci-laden granulosa-lutein cells, and other times, lone foci-laden cells 
occurring sporadically amongst granulosa-lutein cells that contained no foci.  There 
were also clusters of granulosa-lutein cells that all contained no foci.  This heterogeneity 
in PER2 localisation in the granulosa-lutein cells was observed in individual samples as 
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well as between samples, with some samples containing no foci-laden cells at all (Figure 
 3.9 Panel D).  These foci were however found in samples of all the luteal phases 
examined.  The strength of the staining of the foci and of the granulosa-lutein cell nuclei 
was also very variable, even in the groups of adjoining cells.  This heterogeneity in the 
nuclear:cytoplasmic signal strength ratio was observed in many samples but to various 
degrees, with no overt patterns emerging over time.  This was also true of the other cells 
types that were examined.  The strength of the staining of the cell nuclei in all of the cell 
types tended to vary, within individual fields of view, to varying degrees between 
different fields of view and different CL samples.  There were again no trends or 
patterns in the staining of PER2 that could be detected within or between the cell types, 
which changed between samples or with time.   
 
The sample from the CL that was from a very late phase in the luteal cycle clearly 
showed cells dying, presumably by apoptosis (Figure  3.9 Panel G).  The 
photomicrograph shows what appear to be healthy PER2-positive cells and apoptotic 
PER2-negative cells. The control peptide pre-absorption negative control was entirely 
negative of any specific DAB staining, which indicates that the PER2 staining observed 







Figure  3.9 Photomicrographs of immunohistochemistry of PER2 in human CL throughout the luteal cycle: A and B: 
early, C: mid-, D, E and F: late and G: luteolytic luteal phases.  H is the control peptide pre-absorption negative 
control.  Various luteal cell types are indicated by colour-coded arrowheads, with the colours corresponding to 
individual cell types, as follows:- blue: stromal cells, green: theca-lutein cells, orange: granulosa-lutein cells and red: 
vascular endothelial cells.  The scale bar represents 100 m. 
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3.3.7 CRY1 IMMUNOSTAINING 
There were no trends evident with luteal phase (Figure  3.10).  The nuclear:cytoplasmic 
ratio in the staining of the cells did not appear to vary between the luteal phases.  
Nuclear staining was often stronger than cytoplasmic staining in all of the cell types in 
all of the phases.  The vascular endothelial cells tended to be CRY1-positive (Figure 
 3.10 Panels A, B, C and D), although this was not the case in the VL CL (Figure  3.10 
Panel E).  The very late luteal phase CL was slightly different to the other corpora lutea, 
in that there appeared to be apoptotic cells.  These cells were generally CRY1-negative, 
while apparently healthy cells were CRY1-positive (Figure  3.10 Panel E).  The 
fibroblasts did not aggregate into like-staining groups, rather they were more 
heterogeneously intermingled with each other, across the luteal phases (Figure  3.10 
Panels C and D).  Not all cells were positively stained within each cell type, and the 
proportion of unstained cells did not appear to vary particularly with luteal phase.  The 
cell types that tended to have the largest proportion of positively stained cells did not 
differ between the luteal phases.  The specificity of the CRY1 staining was confirmed by 
the negative control that lacked primary antibodies was entirely devoid of staining, but 
not by the negative control that employed pre-absorption with the control peptide, which 
was not devoid of staining, although the staining that was present was much more 








Figure  3.10 Photomicrographs of immunohistochemistry 
of CRY1 in human CL throughout the luteal cycle: A: 
early, B and C: mid-, D: late and E: luteolytic luteal 
phases.  F is the pre-absorption negative control and G 
is the negative control omitting primary antibody.  
Various luteal cell types are indicated by colour-coded 
arrowheads, with the colours corresponding to individual 
cell types, as follows:- blue: stromal cells, green: theca-
lutein cells, orange: granulosa-lutein cells and red: 
vascular endothelial cells.  The scale bar represents 100 
m. 
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3.3.8 CRY2 IMMUNOSTAINING 
CRY2 in most of the sections, throughout the luteal phases, was found in all the cell 
types at all luteal stages, in both nuclear and cytoplasmic compartments (Figure  3.11).  
The distribution of the staining was very much the same as with CRY1 (Figure  3.10).  
CRY2 was more diffusely staining in cytoplasmic and nuclear compartments, with 
mostly stronger nuclear signals than cytoplasmic signals.  This was clearly evident with 
the granulosa-lutein cells.  The fibroblasts near the outer stroma tended to show more 
clearly nuclear staining.  Virtually all the cells were CRY2-positive with a few 
exceptions.  The steroidogenic cells contained the occasional, single isolated, non-
staining cell while the fibroblasts near the stroma layer and vascular endothelial cells 
were less infrequently negative (Figure  3.11 Panel D).  The non-staining fibroblasts 
tended not to be isolated and were often observed with other non-staining fibroblasts 
integrated with positively staining fibroblasts, in a mixed population (Figure  3.11 Panel 
C).  The fibroblasts did not aggregate into like-staining groups, but rather were more 
heterogeneously intermingled with each other (Figure  3.11 Panels B and D). 
 
The degree of staining in each cell type was less heterogeneous than with BMAL1, 
PER1 and PER2.  The very late luteal phase sample showed apparently healthy cells 
containing CRY2 and the apoptotic cells lacking CRY2.  There were no trends evident 
with luteal phase.  The negative control, which used the control peptide to occupy the 







Figure  3.11 Photomicrographs of immunohistochemistry 
of CRY2 in human CL throughout the luteal cycle: A: 
early, B: mid-, C and D: late and E: luteolytic luteal 
phases.  F is the control peptide pre-absorption negative 
control.  Various luteal cell types are indicated by colour-
coded arrowheads, with the colours corresponding to 
individual cell types, as follows:- blue: stromal cells, 
green: theca-lutein cells, orange: granulosa-lutein cells 
and red: vascular endothelial cells.  The scale bar 
represents 100 m. 
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3.3.9 BMAL1 IMMUNOSTAINING 
BMAL1 was found in all cell types, across the early, mid and late luteal phases.  
Granulosa-lutein cells were mostly positive with the odd, isolated negative cells.  These 
cells stained positive most consistently across the luteal lifespan.  Theca-lutein cells 
were also predominantly positive for BMAL1.  When they could be distinguished from 
granulosa cells, in the mid and late luteal phases, it was clear that the theca-lutein cells 
were less consistent in their staining, both within samples and between samples.  There 
were areas where small groups of theca-lutein cells were negative, often when close to 
stromal cell layer.  Theca-lutein cells could be seen as mostly negative then becoming 
mostly positive as they were positioned further from the stroma (Figure  3.12 Panel D). 
This pattern was not dependent on the stage of the luteal phase.  
 
Vascular endothelial cells were also heterogeneously stained between sections, being 
completely negative around some blood vessels (Figure  3.12 Panel C) while completely 
positive around other blood vessels (Figure  3.12 Panel D).  This was confirmed using 
co-localisation with CD31 markers.  The perivascular cells were also heterogeneously 
stained, often negative around negative vascular endothelial cells and positive around 
positive vascular endothelial cells.  It was also not uncommon that these perivascular 
cells were negative around positive vascular endothelial cells.  This was also the case in 
all the luteal phases examined.   
 
The stromally stained were also in some samples mostly not immunoreactive and in 
other samples, mostly positive, with no clear correlation to luteal phase.  The stromal 
cells could also change the ratio of positive to negative cells, similarly to the theca-lutein 
cells, as they became increasingly embedded in the steroidogenic cell layers.  The 
number of cells staining also differed between fibroblasts occurring close to the central 
clot and those occurring close to the outer stroma in some samples. 
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There was no overt trend in any of the BMAL1 staining over the luteal lifespan.  The 
protein was located both in cytoplasmic and nuclear compartments, though it was 
predominantly nuclear in the fibroblasts.  In one sample, the late-luteal phase CL 
appeared to be undergoing luteolysis.  In this sample, it looked like the apoptotic cells 
were mostly BMAL1-negative whilst the cells that appeared healthy were BMAL1-
positive (Figure  3.12 Panel E).  The negative control, which used the control peptide to 
occupy the primary antibodies, was entirely negative, thus indicating the specificity of 








Figure  3.12 Photomicrographs of BMAL1 expression in 
human CL throughout the luteal cycle: A: early, B: mid-, 
C: late, D: late and E: very late (Day 14) luteal phases.  
F is a control peptide pre-absorption negative control of 
BMAL1 in a human corpus luteum at late luteal phase.  
Various luteal cell types are indicated by colour-coded 
arrowheads, with the colours corresponding to individual 
cell types, as follows:- blue: stromal cells, green: theca-
lutein cells, orange: granulosa-lutein cells and red: 




The clock proteins: PER1, PER2, CRY2 and BMAL1 were all evident in the human CL.  
They were localised to each of the luteal cell types that could be discerned and were 
detected throughout the luteal phases.  The cell types identified were: theca-lutein cells, 
granulosa-lutein cells, fibroblasts, vascular endothelial cells and macrophages.  A full 
complement of clock genes and proteins have now also been detected in the CL of 
rodents, with PER1, PER2 and ARNTL (BMAL1) localising to the steroidogenic cells 
(Karman and Tischkau, 2006, Boden and Kennaway, 2006, He et al., 2007a, Fahrenkrug 
et al., 2006). 
 
CRY1 also appeared to be localise to all the discernible cell types in the human CL, 
throughout the luteal cycle.  The detection of CRY1 using IHC was however difficult to 
validate as the staining of the protein was not removed by pre-absorption with control 
peptide.  This could be because the binding of the antibody was not specific to the CRY1 
protein.  The pre-absorption was conducted with ten times more control peptide than 
antibody, which would be more than sufficient to occupy all the antigen-recognition 
sites of the antibodies so that they would be unable to bind to any CRY1 protein in the 
tissue.  Pre-absorption with fifty times more control peptide than antibody would more 
likely produce a successful negative result.  However, at such high control peptide 
concentrations, it would highly possible that any failure of antibody binding to CRY1 in 
the tissue was due to stearic hindrance rather than any specific interaction between the 
control peptide and the antibody.  It is not known whether the individual batches of these 
polyclonal anti-CRY1 antibodies, reported to work reliably in murine and human tissues, 
were tested with control peptide pre-absorption before being sold.  If not, it may be that 
the polyclonal IgG population of this particular batch resulted in non-specific binding of 
the human luteal tissue.  In order to test this, it is possible to use an isotype of the IgG to 
see whether a similar distribution of non-specific binding was observed to that with 
CRY1.  Another explanation, given that these antibodies are polyclonal, is that one or 
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more of the clonal population bound with greater affinity to the native CRY1 in the 
luteal tissue than to the control peptide. 
 
Despite these difficulties, the distribution pattern observed with the anti-CRY1 antibody 
in the human CL, using conventional IHC was very similar to that observed with the 
anti-CRY2 antibodies.  This would be consistent with the idea that these two proteins, 
derived from genetic homologs, are similar in their structure and function, and also in 
their localisation in the human CL.  The staining was also clearly a direct result of the 
action of the primary antibody as its omission resulted in the absence of staining.  It was 
therefore possible that the staining observed with the anti-CRY1 antibodies was specific 
to luteal CRY1 and as such, the use of anti-CRY1 antibodies was included in the runs 
with conventional IHC.  Another antibody that proved difficult to use was the polyclonal 
anti-CLK IgG.  This antibody failed to work in any of the human, ovine and murine 
tissues tested.   
 
Although the lack of success achieved in visualizing the CLK and CRY1 localisation in 
the human CL precluded the detection of the full complement of six canonical clock 
proteins, four of these proteins were successfully and robustly detected.  PER1, PER2, 
CRY2 and BMAL1 were all detected in the human CL, evident in both nuclear and 
cytoplasmic compartments of all the luteal cell types that could be identified.  The 
distribution of the clock proteins did not show any trends in terms of cellular 
compartmentalisation, between cells of the same cell type or between CL samples.  
Neither were there any patterns apparent between the clock proteins of the nuclear 
versus cytoplasmic compartmentalisation of the proteins.  It would have been expected 
that while the clock proteins belonging to the negative limb of the circadian clock 
mechanism were nuclear, the clock proteins belonging to the positive limb of the 
circadian clock mechanism would be cytoplasmic; or vice versa.  This did not appear to 
be the case, though direct co-localisation experiments could not be carried out because 
the species that the antibodies were raised in were the same.  The cellular 
compartmentalisation of each of the clock genes was not uniform in any cell type with 
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any single CL section or indeed any single field of view.  This lack of uniformity made 
it difficult for any conclusions to be drawn regarding the cellular compartmentalisation 
of PER1, PER2 and CRY2 versus that of BMAL1, which should be largely opposite to 
each other.  This has not however yet been demonstrated using IHC in existing 
literature.  The presence of the clock proteins in both compartments of the cell however, 
is consistent with the idea that these proteins function as transcription factors - activating 
and repressing gene expression in the nucleus, while also being timed to do so in a 
specifically circadian fashion, by their sequestration in dimerised forms in the 
cytoplasm.  It is therefore very possible that these cells, which are clock protein-positive, 
possess circadian clocks. 
 
The robust detection of the clock proteins: PER1, PER2, CRY2 and BMAL1, 
demonstrate that the distribution of the clock proteins was very heterogeneous.  It could 
be argued that the heterogeneity is a result of the method used; that the staining is in fact 
an artifact of the IHC and that the heterogeneity is an indication of this.  This argument 
can be convincingly rebutted by the very clear absence of staining in the negative 
controls, particularly where the specificity of the polyclonal IgG antibodies was tested, 
using pre-absorption with control peptides.  The observed heterogeneity could also be 
argued to support the bona fide detection of the clock genes, as they are likely to be 
distributed in a similar manner and to largely the same degree; functioning, as they do, 
as components of the circadian clock mechanism that resides and functions 
autonomously in individual cells. 
 
It seems likely that the individual luteal cells possess circadian clocks.  These clocks 
time the biochemical processes of the cell and can run independently and autonomously 
from the clocks in the other luteal cells.  This would account for the observed 
heterogeneity, where some cells possess higher nuclear:cytoplasmic ratios in clock 
protein abundance than other, possibly adjacent, cells.  The advantage of running so 
many separately timed clocks within the same tissue could be the sustained and constant 
provision of a cellular product, such as progesterone, which is required continuously but 
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which may be produced in a circadian manner.  The expression of the steroidogenic 
acute regulatory protein (StAR) for example, a rate-limiting enzyme involved in 
progesterone synthesis, is now known to occur in a circadian rhythm in poultry (Nakao 
et al., 2007, Ratajczak et al., 2008, Devoto et al., 2001, Devoto et al., 2002).  Thus, 
although the output of each cell is liable to increase and decrease over time, the output of 
the entire tissue is constant.  The continuous provision of progesterone by the CL is vital 
for the conceptus as the drop in progesterone levels is what initiates parturition at the 
end of gestation. 
This loose or non-existent coupling of the putative luteal cellular clocks is consistent 
with reports of other peripheral clocks.  Tissues outside of the brain, and the SCN in 
particular, have been observed to possess significantly weaker coupling between cells 
than in that of the SCN cells, which has been argued to provide greater flexibility in 
incorporating temporal information from diverse sources, such as the SCN and the food-
entrainable oscillator (Balsalobre, 2002, Nagoshi et al., 2004, Stephan, 2002).  The 
flexibility, conferred by loosely coupled clocks within a tissue, is likely to be important 
in the CL for its function within reproduction, a process that is composed of many parts 
that are temporally regulated and subject to temporal perturbation by other physiological 
processes.  Stress is well-known to affect the duration of the reproductive cycle as well 
as the hormonal milieu of the ovary (Kaplan, 2008, Smith et al., 2003, Karsch et al., 
2002).  As such, the CL needs to be able to function accordingly to any hormonal 
changes in the ovary and temporal changes in the reproductive cycle.  It could be argued 
that the loosely coupled cellular clocks help enable the luteal tissue to do this, and that 
the flexibility and responsiveness of the CL to its temporal environment is crucial for its 
efficient functioning and for its timing, particularly with regard to its lifespan. 
 
No differences in clock protein distribution in the corpora lutea between the early, mid- 
and late luteal phases were detected.  This could indicate that no such differences exist 
in the human CL; despite the changes that occur in the luteal cells, which differentiate 
and regress, with time.  Alternatively, the changes in clock protein distribution over the 
lifespan of the human CL were not detected in these studies.  This may be because the 
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windows during which these changes occur are of relatively short duration.  This could 
be supported by the observation that many cells in parts of the section, from the very late 
stage CL which appeared to be undergoing luteolysis, were clock protein-negative.  It 
stands to reason that the human CL, being a strictly regulated tissue in terms of its 
lifespan, would form and regress relatively rapidly, ensuring that the majority of its 
lifespan is spent in a fully functional state.  This would be a very efficient use of time; 
with the processes of luteogenesis and luteolysis occurring in short time windows that 
are regulated by a luteal clock, which may already exist to regulate the duration of the 
luteal lifespan. 
 
The human corpora lutea were collected for practical reasons between 10:00 am and 
3:00 pm.  The circadian changes of these clock proteins could not therefore be assessed, 
nor could whether the circadian time of sampling be implicated in the heterogeneity 
observed between the samples.  The heterogeneity inherent within the samples however 
suggests that the time of day may only impact on the degree of inherent heterogeneity 
rather than on any synchronisation of the cellular clocks with each other within and 
between the tissues.  This impact may however be significant in the regulation of luteal 
function and reproductive timing. 
 
The local staining pattern of PER2 in some of the granulosa-lutein cells has not been 
previously reported.  No evidence could be found of a similar staining pattern with any 
other clock protein, or indeed with any other protein in general.  The per2 gene has often 
been reported to be special amongst the other canonical clock genes in its myriad roles, 
for example, it is able to function as a tumour suppressor gene and it may play a role in 
regulating cell division (Albrecht et al., 2007).  It may be that the PER2 aggregates 
observed in some of the granulosa-lutein cells, throughout the luteal lifespan, are related 
to the mitotic index of these cells, which is known to be particularly high in the 
granulosa cells of a maturing follicle.  However, their persistence throughout the luteal 
phases in the absence of ongoing proliferations argues against this.  PER2 may also 
function in the granulosa-lutein cells in an extra-circadian clock role, which may 
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requires it to aggregate in cytoplasmic foci.  This aggregation of the PER2 could be the 
encapsulation of the protein in vesicles, emanating from the Golgi apparatus, where 
proteins are post-translationally modified and packaged.  The vesicles are however 
unlikely to be excretory as no PER2 was detected outside of the luteal cells.  PER2 is 
thus an unlikely candidate for signalling between cells, unless the PER2 secreted exists 
in a truncated form or in a tertiary conformation that rendered it undetectable by the anti-
PER2 antibody in IHC. 
Ultimately, these studies have revealed conclusively so far, is that the clock proteins: 
PER1, PER2, CRY2, BMAL1 and possibly CRY1 are present in the human CL, and that 
they are present in all the discernible luteal cell types, throughout the lifespan of the CL. 
 
In summary, this chapter demonstrated for the first time that: 
 
1. the canonical clock proteins: PER1, PER2, CRY2, BMAL1 and possibly CRY1 
were expressed in the human corpus luteum; 
 
2. this expression was localised to multiple luteal cell types including the 
steroidogenic cells, fibroblasts, vascular endothelial cells and macrophages; with 
the most consistent and strongest staining in the theca-lutein and granulosa-lutein 
cells; 
 
3. the clock proteins are expressed throughout the human luteal lifespan; 
 
4. the localisation of the clock proteins was heterogeneous, both spatially and 
temporally, in the human CL. 
 
The presence of the clock proteins from both limbs of the circadian clock mechanism 
indicate that a circadian clock may potentially exist in the cells of the human CL.  Using 
IHC methods, it was not possible to address the question of whether the overall clock 
protein levels changed across the luteal cycle in the human CL.  In order to do this, clock 
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gene mRNA expression would be measured quantitatively in the human CL samples 
used in this study. 
4 CLOCK GENE mRNA EXPRESSION IN 
THE HUMAN CORPUS LUTEUM 




The clock proteins: PER1, PER2, CRY2 and BMAL1 have been observed in the 
human CL.  These proteins belong to both the positive and the negative limbs of the 
circadian clock mechanism, and localise to the same cell types; suggesting that a 
functional cell-based circadian clock exists in these cells.  If this were the case, these 
cell-based circadian clocks are likely to be involved in temporally regulating the 
functional processes of the CL, including its relatively fixed 14-day lifespan.  In order 
to elucidate more information in support of this hypothesis, quantitative measurement 
of the clock gene mRNA in human corpora lutea, sampled from across the luteal cycle 
was performed.  These are the same corpora lutea that were used in the previous 
chapter that are therefore known to express the clock genes, at a protein level.  The 
quantitative molecular method will be tested to ensure that it is sensitive enough to 
detect any changes in clock gene expression by applying it to analyse the clock gene 
expression in cultured luteal fibroblast-like cells, derived from pre-ovulatory follicles 
under an assisted reproduction protocol, which is likely to be circadianly rhythmic.  If 
no rhythm is detected, other cells well-known to express clock genes in a robustly 
circadian manner will be used. 
 
Overt changes were not observed in the expression of the clock proteins throughout 
the luteal lifespan.  This does not however indicate that there would be a 
corresponding lack of change in the expression of the clock genes, when measured 
using the messenger RNA (mRNA) concentration.  It has been widely reported that 
many post-transcriptional and post-translational mechanisms exist, which can alter the 
temporal pattern of protein expression in cells from that of their cognate mRNA 
expression (Okamura, 2003, Zwiebel et al., 1991).  Furthermore, there has been report 
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of clock protein expression differing from that of the clock gene in cells across 24 
hours (Jilg et al., 2005).  Therefore, it is possible that, changes exist that may be 
detected in the mRNA levels of the human CL across the luteal cycle.  It could even 
be said to be very likely, as there is clearly a requirement for temporal regulation of 
the CL as a whole tissue, in order to time its lifespan and regression; a regulation that 
does not appear to be provided by change in the clock proteins and therefore may well 
be provided by change at the level of the actual gene transcription.  It is also likely 
that any changes that exist that direct the timing of the luteal lifespan will be more 
easily evident when examining the CL as a whole, rather than by examining it, cell by 
cell or cell type by cell type.  Thus, there is an emergent property related to co-
ordination of luteal timing and luteal regression, which may arise from the mass of 
luteal cells assembled in an intact tissue. 
 
It is therefore proposed that the level of global clock gene expression of the human 
CL changes across the luteal cycle, whereby the advent of luteolysis is triggered by 
the gradual and global loss or gain in clock gene expression as the CL ages. 
 
Therefore, this chapter aims: 
 
1. to establish a positive control by measuring the mRNA expression of per1, 
per2, per3, cry1, cry2, bmal1and clk in luteal fibroblast-like cells;  
 
2. to determine whether global mRNA expression of per1, per2, per3, cry1, cry2, 
bmal1and clk changed over the luteal phase. 
 119 
4.2 MATERIALS AND METHODS 
4.2.1 ETHICAL APPROVAL FOR CORPORA LUTEA 
COLLECTION 
Ethical approval was obtained as described in the previous chapter from the 
Reproductive Medicine Subcommittee of the Lothian Medical Ethics Committee and 
the COREC on two further occasions.  The collection of CL from patients with 





4.2.2 ETHICAL APPROVAL FOR FOLLICULAR CELL 
COLLECTION  
The collection of ovarian and follicular cells from patients undergoing assisted 
conception at the Edinburgh Fertility and Reproductive Endocrine Centre (EFREC) 
was separately approved by the Reproductive Medicine Subcommittee followed by 
further approval by COREC.  Informed consent was obtained from all patients and 




4.2.3 SAMPLING HUMAN CORPORA LUTEA 
Human CL tissues were collected as previously described, with 8 early luteal phase 
corpora lutea obtained 1 – 5 days after the LH surge, 12 mid-luteal phase corpora 
lutea obtained to 6 – 10 days after the LH surge and 6 late luteal phase corpora lutea 
obtained from 10 – 14 days after the LH surge.  Some of the tissue pieces were used 




4.2.4 SAMPLING HUMAN FOLLICULAR FIBROBLASTS 
With patient consent, follicular fluid was collected from women undergoing 
transvaginal oocyte retrieval for in vitro fertilisation after ovarian stimulation using a 
standard procedure.  Briefly, a long-protocol stimulated cycle was followed, using 
intranasal naferelin (Pharmacia Biotech, Milton Keynes, UK), a gonadotrophin-
releasing hormone analogue for down-regulation and daily purified gonadotrophins 
(Menopur, Ferring Pharmaceuticals, Langley, UK) for ovarian stimulation. When at 
least three follicles reached 18 mm diameter, 10 000 IU hCG was administered in 
order to mimic the pre-ovulatory LH surge.  The follicular cells were thus luteinised.  
Transvaginal oocyte collection was performed under sonographic guidance 35 hours 
later (Duncan et al., 2005b, Stamouli et al., 1996).  The aspirate will contain non-





4.2.5 CELL CULTURE OF LUTEAL FIBROBLAST-LIKE 
CELLS 
The cells were derived as described previously (Duncan et al., 2005b, Myers et al., 
2007a, Dickinson et al., 2008).  Briefly luteal fibroblasts were obtained from follicular 
aspirates after the removal of oocytes.  Individual follicles were not distinguished, and 
all follicular fluid from the same individual was pooled and centrifuged at 1500 rpm 
for 10 min.  The cells were resuspended and washed three times with PBS.  The cells 
were then resuspended in culture medium (Dulbecco’s Minimum Essential 
Medium/Ham’s F-12 mixture, Invitrogen Life Technologies, Inc., Gaithersburg, MD), 
supplemented with 2 mmol l-1 glutamine (Sigma, Dorset, UK), 6.25 mg l-1 insulin, 
6.25 mg l-1 transferrin, 6.25 µg l-1 selenious acid (Roche, Welwyn Garden City, UK), 
2.5 mg l-1 amphotericin, 50 mg l-1 penicillin, 60 mg l-1  streptomycin and 10% fœtal 
bovine serum (Sigma, Dorset, UK), then transferred to a culture flask and incubated 
overnight at 37oC in 5% CO2 in air.  The media was changed the next day, after which 
it was only changed weekly.  The cells were passaged every two weeks thus removing 
granulosa cell and other debris and allowing the population to be split into separate 
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flasks.  The cells are allowed to grow to confluence over 5-6 weeks, during which 
time, the luteinised granulosa cells would have disappeared. 
 
The fibroblast-like cells were used as a cellular control as they reliably modelled 
luteal fibroblasts.  This was previously demonstrated when these fibroblast-like cells 
were shown to immunostain uniformly.  They were 3HSD-negative, CD31-negative, 
alpha-smooth muscle actin (-SMA)-positive, and leucocyte common antigen (LCA)-
negative.  Heterogeneous staining had been seen in the luteinised granulosa cell 
cultures.  After 6-8 days of culture, 10.1% (range, 5.4–12.3%) of the cells were 
3HSD negative, 6.9% of cells (4.3–11.1%) were  -SMA positive, 5.7% of cells 
(3.4–8.3%) were CD-31 positive and 5.95% of cells (2.7–9.3%) were LCA positive.  
This confirmed that there was only very low levels of contamination by luteinised 
granulosa cells in the fibroblast-like cell cultures, once other cell types had been 
separated (Duncan et al., 2005b).  Fibroblasts were used as luteal steroidogenic cells 




4.2.6 TOTAL RNA EXTRACTION II 
Total RNA was purified from homogenised tissues using TRI Reagent™ RNA 
Isolation Reagent (Sigma-Aldrich, Poole, Dorset, UK) according to the standard 
method published by Chomczynski and Sacchi (Chomczynski and Sacchi, 1987).  
Briefly, 50-100 mg of each corpora lutea was homogenised with a pestle in sterile 2 
ml microfuge tubes with 500 µl TRI Reagent.  The remaining 500 µl of TRI Reagent 
was added to the tissue homogenate.  These were then left to incubate on ice for 5 
min, in order to allow the complete dissociation of nucleoprotein complexes.   
 
Total RNA was purified from the fibroblasts using TRI Reagent™ RNA Isolation 
Reagent (Sigma-Aldrich, Poole, Dorset, UK) according to the standard method 
published by Chomczynski and Sacchi (Chomczynski and Sacchi, 1987).  The cells 
were rinsed with phosphate-buffered saline and 1 ml of TRI® Reagent added.  The 
cells were quickly scraped off the plates and transferred with the TRI® Reagent into 
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sterile microfuge tubes.  They were stored at -70oC until batch extraction of the RNA, 
when they were thawed. 
 
Phase separation was then achieved by the addition of 0.2 ml chloroform (Fisher 
Scientific, UK), mixing the samples well by inverting the tubes and then leaving the 
samples to stand for 1 hour on ice.  The samples were then centrifuged at 12 000 x g 
for 15 min at 4oC.  This separates the mixture into 3 phases: an organic phase 
containing the proteins, an interphase containing DNA, and an aqueous phase 
containing RNA.  The RNA was carefully pipetted off, without any DNA 
contamination, and transferred to a 2 ml microfuge tube.  The RNA was precipitated 
by the addition of 0.5 ml propan-2-ol (isopropanol) which was mixed well, then left to 
stand for 5 min at room temperature.  The RNA was pelleted by centrifuging at 12 
000 x g for 10 min at 4oC.  The supernatant was discarded and the RNA pellet washed 
twice with 1 ml of 75% ethanol (dissolved in DEPC-treated water), vortexed then 
centrifuged at 7 500 x g for 5 min at 4oC.  The supernatant was discarded and any 
remaining ethanol allowed to evaporate completely.  The pellet was then resuspended 
by pipetting in 50 µl of DEPC-treated water. 
 
As the RNA was intended for use in quantitative real-time PCR, it was important to 
remove any contaminating DNA.  This was achieved by treating the RNA with 1 U 
deoxyribonuclease I (Ambion, Inc., Applied Biosystems, Warrington, UK) per 1 µg 
RNA for 30 min at 37oC.  The deoxyribonuclease (DNase) cleaves the DNA at 
phosphodiester bonds in its backbone, rendering it useless as a template for PCR.  The 
DNase reaction was terminated by the addition of DNase Stop Solution containing 
50mM EDTA, 1.5M NaOAc (pH 5.2) and 1% SDS.  The DNase was inactivated by 
denaturing at 70oC for 10 min.  The DNase would then be unable to cleave newly-
formed DNA in the RT-PCR reaction.   
 
The total RNA yield was then quantified using a small aliquot of each sample.  The 
optical density or absorbance of the RNA was measured using ultraviolet 
spectrophotometry on a GeneQuant™ pro RNA/DNA Calculator (Amersham 
Pharmacia Biotech, Little Chalfont, UK).  The absorbance at 260 nm was used to 
automatically calculate the RNA concentration in the following equation: 
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RNA concentration = Absorbance260 x Dilution factor x 40 µg/ml 
 
because 40 µg/ml of RNA has an absorbance at 260 nm of 1.  The ratio of absorbance 
between the 260 nm and 280 nm wavelengths provided an indication of RNA purity.  




4.2.7 MESSENGER RNA PURIFICATION 
Some of the total RNA was purified further.  QuickPrep™ mRNA Purification Kit 
(Amersham Pharmacia Biotech, Little Chalfont, UK), which employed 
oligodeoxythymidylate (oligo(dT))-cellulose spin columns, were used to isolate 
messenger RNA (mRNA) from ribosomal and other ubiquitous small RNA.  
Messenger RNA generally contains long tracts of polyadenylate (poly(A+)) at its 3’ 
end.  This allows the purification of these poly A+ RNA away from other nucleic 
acids by hybridisation of the poly(A+) ‘tails’ to oligo(dT) in oligo(dT)-cellulose spin 
columns. 
 
Total RNA (1.25 mg) from each sample was purified for poly(A+) RNA.  The 
oligo(dT)-cellulose spin columns were prepared by inverting several times to 
resuspend the resin in the columns.  The top and bottom closures of the spin columns 
were removed and the columns placed upright in sterile 15 ml centrifuge tubes.  They 
were then centrifuged at 350 x g for 2 min at room temperature.  The columns were 
removed from the centrifuge tubes and the tubes and eluted liquid discarded.  The 
bottom closure was replaced onto the drained columns.  The columns were placed into 
sterile 15 ml tubes containing open sterile 1.5 ml screw-top microfuge tubes, so that 
the tip at the bottom of the column is in the opening of the microfuge tube.  The tubes 
were then placed upright in a rack.   
 
Elution buffer containing 10 mM Tris-HCl (pH 7.4) and 1 mM EDTA was added to 
the total RNA samples so that each sample constituted 1 ml.  The samples were 
incubated at 65oC for 5 min then chilled on ice for 5 min.  Sample Buffer containing 
10 mM Tris-HCl (pH 7.5), 1 mM EDTA and 3 mM NaCl (0.2 ml) were added to the 
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samples and mixed gently before placing on ice.  The samples were then added to the 
top of the column bed and allowed to enter the resin under gravity.  The bottom 
closure of the column was removed and the columns centrifuged at 350 x g for 2 min 
at room temperature. 
 
The poly(A+) RNA on the columns were washed with high and low salt washes.  High 
Salt Buffer (0.25 ml) containing 10 mM Tris-HCl (pH 7.4), 1 mM EDTA and 0.5 M 
NaCl was added to each column.  The columns were centrifuged at 350 x g for 2 min 
at room temperature.  The high salt wash was then repeated with a second 0.25 ml of 
High Salt Buffer.  The same was then repeated twice with the Low Salt Buffer, which 
contained 10 mM Tris-HCl (pH 7.4), 1 mM EDTA and 0.1 M NaCl. 
 
The 1.5 ml microfuge tubes containing eluted wash buffer were discarded and 
replaced with new sterile 1.5 ml microfuge tubes.  The poly(A+) RNA bound to the 
column is eluted by the addition of 0.25 ml Elution Buffer, pre-warmed to 65oC, 
followed by centrifugation at 350 x g for 2 min at room temperature.  Subsequently, 
0.75 ml of eluate should be obtained from the elution and this was repeated twice.  A 
total of 2.25 ml of eluant containing poly(A+) RNA was extracted from each sample 
of total RNA.  The RNA was then centrifuged at maximum speed in a bench 
microcentrifuge for 1 min to remove any residual cellulose.  The supernatant 
containing the poly(A+) RNA was transferred into sterile 1.5 ml microfuge tubes, 





4.2.8 PREPARATION OF COMPLEMENTARY DNA BY 
REVERSE-TRANSCRIPTION 
The RNA was batch reverse transcribed using GeneAmp® RNA PCR Kit (Applied 
Biosystems, Warrington, UK) with random hexamers.  Total RNA (200 ng) was 
added to a reaction mix containing 5.5 mM MgCl2, 2.5 µM random hexamers, 500 µM 
of each deoxy-NTP, 0.4 U µl-1 RNase inhibitor, and 1.25 U µl-1 Multiscribe reverse 
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transcriptase (Applied Biosystems, Warrington, UK).  The samples were incubated at 
room temperature for 10 min.  They were then heated to 42oC for 60 min in order to 
provide the optimum temperature for enzymatic action.  The reaction was then 
stopped and the enzyme denatured by incubating at 95oC for 10 min.  Two types of 
negative control were used.  One involved reactions performed on 3-5 randomly 
selected test samples with RT mix that was extracted prior to the addition of the 
reverse transcriptase.  The other involved reactions with RT mix that omitted the 
template RNA, which was replaced by the same volume of RNase-free water.  The 





4.2.9 PRIMER DESIGN 
Gene sequences were obtained from the National Center for Biotechnology 
Information (NCBI) GenBank nucleotide database, available online 
http://www.ncbi.nlm.nih.gov/.  This database lists sequences by ascribing them 
Accession Numbers.  Primers were designed as standard using primer design 
software.  The software used was Primer3, available online at www-
genome.wi.mit.edu/cgibin/primer/primer3_www.cgi.  Primers were checked for 
specific binding by using the NCBI Basic Local Alignment Search Tool (BLAST), 
available online at http://blast.ncbi.nlm.nih.gov/Blast.cgi.  This tool enables the 
identification of regions that are the same or similar between nucleotide sequences.  It 
does this by mining genome and other nucleotide databases which are published 
online, using a search-term sequence.  To minimise amplification of genomic DNA, 
the forward and reverse primers for each gene were chosen from different exons 
where possible. The sizes of the polymerase chain reaction (PCR) products were 
designed to be less than 250 bp to optimise the real-time quantification of the 
amplified DNA during reverse-transcribed polymerase chain reaction (RT-PCR).  The 
RT-PCR technique quantifies the PCR products in real-time, using fluorescent SYBR 
Green I dye, that fluoresces when it is incorporated into newly-made DNA.  The 
amplicon sizes must therefore be designed to be approximately the same, between the 
gene of interest and the gene standard, in order that kinetics within each amplification 
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reaction is relatively the same; so that the quantification of the PCR products are 
comparable between the various reactions.  
 
As many of the clock genes have different RNA transcripts, the primer sequences 
were compared to these transcript sequences.  This ensured that the PCR products 
would be of consistent size and that, as much as possible, the total transcript 
expression of each gene would be measured.  The primers were also checked to see if 
they were intron-spanning.  This would be a further way of ensuring the amplification 
of only the template DNA derived from RNA.  Fully annotated transcript sequence 
data was obtained as standard from the Ensembl database using the Ensembl Genome 
Browser, available online at http://www.ensembl.org/index.html. 
The per1 primers did not span an intron but the PCR product did, according to the 
Ensembl Gene Report for ENSG00000179094.  Sections of both per1 transcripts 
(Ensembl Gene Report for ENST00000354903 and ENST00000317276) would be 
amplified, producing products that were 133 base pairs (bp) in size.  The per2 reverse 
primer and PCR product were both intron-spanning, according to the Ensembl Gene 
Report for ENSG00000179094.  Sections of all three per2 transcripts (Ensembl Gene 
Report for ENST00000254657, ENST00000254658 and ENST00000355768) would 
be amplified, producing products that were 154 bp in size. 
 
Neither the per3 primers nor the PCR product were intron-spanning, according to the 
Ensembl Gene Report for ENSG00000049246.  Sections of four per3 transcripts 
(Ensembl Gene Report for ENST00000168666, ENST00000361923, 
ENST00000377527 and ENST00000377532) would be amplified, producing products 
that were 150 bp in size.  A fifth, short-sequence transcript however was not 
amplified, according to ENST00000377541.  It took two attempts to design and 
optimise primer pairs for this gene. 
 
The cry1 primers did not span any introns but the PCR product did, according to the 
Ensembl Gene Report for ENSG00000008405.  Sections of, only one of the two, cry1 
transcripts (Ensembl Gene Report for ENST00000008527) would be amplified, 
producing 128 bp products.  The other transcript (ENST00000319645) was not 
amplified.  It took two attempts to design and optimise primer pairs for this gene.  The 
cry2 primers did not span an intron but the PCR product did, according to the 
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Ensembl Gene Report for ENSG00000121671.  Sections of the only known cry2 
transcript (Ensembl Gene Report for ENST00000263762) would be amplified, 
producing 142 bp products. 
 
The bmal1 (also known as the aryl hydrocarbon receptor nuclear translocator-like 
protein 1 (arntl) gene) forward primer was intron-spanning, according to the Ensembl 
Gene Report for ENSG00000133794.  Sections of all three bmal1 transcripts 
(Ensembl Gene Report for ENST00000256172, ENST00000339640 and 
ENST00000361003) would be amplified, producing 175 bp products.  Neither the clk 
primers nor product were intron-spanning, according to the Ensembl Gene Report for 
ENSG00000134852.  Sections of all three clk transcripts (Ensembl Gene Report for 
ENST00000309964, ENST00000381322 and ENST00000381325) would be 
amplified, producing 147 bp products.  It took three attempts to design and optimise 
primer pairs for this gene. 
 
In order to perform real-time quantitative PCR, a standard endogeneous control was 
required.  This would be a gene which is constantly expressed at constant levels in the 
tissue or cells of interest.  The quantification of this gene expression provides a 
baseline for comparing the quantification of the genes of interest, which were 
expected to fluctuate.  The gene chosen was the, constitutively expressed, 
housekeeping gene: glucose 6-phosphate dehydrogenase (g6pdh).  Its PCR products 
but not primers were intron-spanning, according to the Ensembl Gene Report for 
ENSG00000160211.  Sections of three of the four g6pdh transcripts (Ensembl Gene 
Report for ENST00000291567, ENST00000343440 and ENST00000369624) would 
be amplified, producing 215 bp products.  One of the four transcripts would not be 
amplified (Ensembl Gene Report for ENST00000369620). 
 









FORWARD PRIMER 5’-3’ REVERSE PRIMER 5’-3’ 
per1 NM_002616 cagcagttccattgcctaca gagctctcgaagtgctgtca 
per2 AB002345 gccaagtttgtggagttcct cactgacacggcaaaagaaa 
per3 AB047686 gatttcccaccttccagtga actcaaaagggcaacagcac 
cry1 NM_004075 ttggaaaggcatttggaaag cgacatgacaaacaaccaaa 
cry2 AB014558 tcctgccgcctcttctacta ggtcaaacctggggttgtt 
bmal1 AF070917 ctccaggaggcaagaagattt ctactt*gatccttggtcgttg 
clk AB002332 ccagaaggggaacattcaga tggctcctttgggtctattg 
g6pdh NM_000402 cggaaacggtcgtacacttc ccgactgatggaaggcatc 
* t was added to the sequence listed with the accession number to correspond with human bmal1 (also known as arntl) 
Table  4.1 The gene sequence accession numbers and PCR primer sequences for the clock genes. 
 
 
The primers were synthesised by MWG-AG Biotech (Milton Keynes, UK).  All the 
PCR products were sequenced using ABI PRISM Big Dye Terminator Sequencing 
Kits (Applied Biosystems) to confirm that the sequence of the PCR-amplified 




4.2.10 CONVENTIONAL POLYMERASE CHAIN 
REACTION 
Before real-time quantitative gene expression analysis was performed, the primers 
were tested using conventional PCR.  Briefly, 1 μl of cDNA was added to a PCR mix 
containing 0.25 U µl-1 of thermostable Thermus aquaticus DNA polymerase (Taq) 
(Promega, Southampton, Hampshire, UK), 0.5 µM each of forward and reverse 
primer, 0.2 mM deoxynucleotide triphosphates (dNTPs), 0.1% Triton X-100 
detergent, 50 mM potassium chloride (KCl), 10 mM Tris-HCl, 2.5 mM MgCl2 and 
nuclease-free water to achieve a final reaction volume of 10 μl.  Complementary 
DNA template from cultured luteal fibroblast-like cells was used as an exogenous 
positive control, known to express clock genes.  Negative controls employed the same 
PCR mix but substitute nuclease-free water for the template cDNA.  The tubes 
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containing test samples mixed with PCR mix were briefly vortexed then collected by 
brief centrifugation in a bench microcentrifuge.  Mineral oil was then laid over the 
mixes in each tube to minimise the dispersion of the reaction mix by evaporation and 
condensation during the PCR.  The samples were then placed in a DNA Engine 
Peltier Thermal Cycler PTC-200 (MJ Research, Inc., Watertown, MA) and incubated 
at 95oC for 5 min to activate the polymerase.  The PCR then consisted 35 cycles of 
denaturation at 95oC for 30 s, annealing at the optimal primer pair temperature for 90 
s and elongation at 72oC for 90 s, followed by a final denaturation step at 72oC for 10 
min.  The optimal PCR annealing temperatures are listed below alongside 








per1 64 133 
per2 64 154 
per3 62 150 
cry1 60 128 
cry2 61 142 
bmal1 56 175 
clk 62 147 
g6pdh 62 215 
Table  4.2 Conventional PCR primer-pair annealing temperatures and product sizes. 
 
 
The PCR products were visualised using electrophoresis to separate the DNA 
fragments on a 1% agarose gel submerged in a 1x Tris-acetate-EDTA (TAE) buffer 
with 100 volts (V) for 75 min.  The agarose gel contained 0.002% ethidium bromide, 
which intercalates into the DNA and can be observed and photographed fluorescing 
under ultraviolet (UV) transillumination.  Products were verified using a 100-bp DNA 






4.2.11 REAL-TIME QUANTITATIVE REVERSE 
TRANSCRIBED POLYMERASE CHAIN REACTION 
USING THE ROCHE LIGHTCYCLER SYSTEM  
Real-time quantitative reverse-transcribed polymerase chain reaction (qRT-PCR) was 
performed using, using a two-step RT-PCR protocol, in the Roche LightCycler 
system, which was comprised of the carousel-based LightCycler 2.0 instrument with 
reagents from the LightCycler FastStart Kit.  This system follows the standard 
principles behind real-time qRT-PCR, using the incorporation of the fluorescent 
SYBR Green I binding dye into double-stranded DNA during the PCR transcription 
process to monitor the amount of template amplification.  The procedure involved 
adding the LightCycler FastStart polymerase enzyme to the LightCycler FastStart 
Reaction Mix SYBR Green I solution.  This mixture was then referred to as the 
LightCycler FastStart Reaction Mix SYBR Green I and contained ‘hot-start’ FastStart 
Taq DNA polymerase buffer, DNA double-strand specific SYBR Green dye and 1 
mM magnesium chloride (MgCl2).  Additional MgCl2 was added to achieve the 














per1 64 3 84 133 
per2 64 4 83 154 
per3 62 3 76 150 
cry1 60 5 77 128 
cry2 61 3 82 142 
bmal1 56 4 80 175 
clk 62 3 76 147 
g6pdh 62 3 76 215 
Table  4.3 Real-time qRT-PCR primer-pair annealing temperatures, Mg2+ concentrations, measurement 
temperatures and product sizes. 
 
 
The annealing temperature and Mg2+ concentrations for each primer pair were 
optimised using either human placental cDNA or previously extracted and 
characterised human luteal cDNA (Table  4.3).  These optimisation PCRs were 
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performed using Thermo-Start™ Taq DNA polymerase (ABgene Ltd, Epsom, UK) in 
a DNA Engine Peltier Thermal Cycler PTC-200 (MJ Research, Inc., Watertown, 
MA).  Eight PCRs of each primer pair, using the gradient annealing temperature 
facility of the cycler, were performed to observe the PCR efficiency of annealing 
temperatures between 52oC and 68oC.  PCR products were examined using gel 
electrophoresis with UV transillumination of ethidium bromide in the DNA.  The 
brightest, most well-defined single band of PCR product corresponding to the 
expected size was an indication of the optimal PCR conditions.  The presence of 
single bands of the expected size along with low amounts of primer-dimer further 
confirmed the specificity of the primers. 
 
Magnesium concentrations of 3-5 mM were used to identify the optimal Mg2+ 
concentrations for the most efficient PCR reaction using the LightCycler 2.0 
instrument (LightCycler).  The DNA amplification step enabled the identification of 
the optimal temperature required for quantifying the level of gene expression.  This 
meant that the artefact caused by background fluorescence from non-specifically 
amplified DNA was minimised.  A DNA melting curve analysis could then be 
performed at the optimal quantification temperature.  A single DNA melting curve 
peak indicated a single real-time qRT-PCR amplified product.  This was used to 
confirm the specificity of the primers. 
 
A standard curve was required for quantification of the gene expression from the test 
samples.  It was generated using serial dilutions of standardised cDNA, derived from 
human placental RNA, in real-time qRT-PCR in the LightCycler.  The cDNA was 
derived from RNA of known concentration.  A dedicated LightCycler program 
(version 3.3) using the second derivative maximum method (Kubista et al., 2006). 
 
Briefly, 1 μl cDNA was added to a PCR mix consisting of 1 μl each of the forward 
and reverse primers, 1 μl LightCycler FastStart Reaction Mix SYBR Green I solution 
containing SYBR Green, 3 mM Mg2+ and  LightCycler FastStart polymerase, 5 μl 
nuclease-free water and any extra Mg2+ that was required.  The final reaction volume 
was 10 μl.  The reaction mixes and test samples were carefully transferred into 
LightCycler capillary tubes, which were then closed.  The tubes were briefly 
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centrifuged then loaded into the LightCycler.  The PCR was then implemented using 
the standard LightCycler protocol. 
The PCR product concentrations were automatically calculated for each sample using 
the dedicated LightCycler software.  It compared the sample threshold cycle (CT) 
number to those of the standard curve.  As the standard curve was produced using 
cDNA derived from RNA of known quantity, the test sample RNA levels could thus 
be extrapolated by comparison with the standard curve.  In all cases the level of gene 
expression within the samples fell within the boundaries of the corresponding standard 
curve.  All the samples were analysed in duplicate and assay variation was typically 
within the accepted standard 10%.  The expression levels of the genes of interest were 
normalised to the expression level of g6pdh for each sample.  Each sample was 
amplified in duplicate.  The PCR products were then extracted from the LightCycler 
capillary tubes and run on 2% agarose gels using electrophoresis, in order to confirm 





The assumption of homogeneity of variance was confirmed for all the data.  This 
meant that the variance within each of the data sets (n) was equal.  The statistical 
computer program: SPSS was used test the homogeneity of variances of these data 
sets.  This program employed Levene’s test of homogeneity of variance.  The 
variances within these data sets were homogeneous.  This data could then be tested 
using analysis of variance (ANOVA).  ANOVA assumes that the data sets are 
normally distributed and that the samples are independent. 
 
ANOVA is a collection of statistical models and procedures which use variances to 
test the equality of multiple mean values.  The null hypothesis predicts that all the 
means will be equal.  This will be disproved if at least one mean is different from the 
others.  A difference is detected if a mean value is sufficiently higher or lower than its 
value predicted using variance and normal distribution.  If this difference is detected 
in a sufficient number of data sets, statistical significance of this difference can be 
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calculated.  A statistically significant difference is one that is unlikely to have 
occurred by chance. 
 
The real-time qRT-PCR data was analysed using one-way ANOVA that provides an F 
statistic from which probability was calculated.  Statistical difference was set at a 
probability (P) value of 0.05.  Where significant differences were detected, pairwise 
comparisons were conducted using the Bonferroni post hoc test.  This test compares 
all possible pairs of means to find differences, while taking into account the fact that 
more than two samples were taken.  The standard error of the mean was also 
calculated.  The data was assumed to be normally distributed and was not 
transformed.   
 134 
RESULTS 
The expression of the clock genes, clk, bmal1, per1, per2, per3, cry1 and cry2 was 
successfully detected in the human CL, indicated here by images obtained from the 
electrophoresis of PCR products from conventional RT-PCR (Figure  4.1).  The 
electrophoresis of the PCR products from real-time qRT-PCR, using the LightCycler 
system provided the same result.  The amplicons were of the expected size and the 
PCR products were sequenced to confirm their identity.  Template from the luteal 
fibroblast-like cells, obtained from extended cultures of cells from luteinised pre-
ovulatory follicles, was used to provide an exogeneous positive control for clock gene 
expression.  The housekeeping gene, g6pdh, was used as an endogenous positive 
control for the real-time quantitative PCR and the expression of the clock genes was 
normalised to the g6pdh expression (Myers et al., 2007a).  By using the band intensity 
of the amplicons from the luteal fibroblast-like cells as a baseline, it was noted that 
the level of clock gene expression varied between the early, mid- and late luteal 




Figure  4.1 Agarose gel electrophoresis of clock gene PCR products.  The expression of clk, bmal1, per1, per2, 
per3, cry1 and cry2 and, positive control standard gene, g6pdh was evident in the PCR-amplified cDNA obtained 
from human intact CL tissue, at early (EL), mid- (ML) and late (LL) luteal phases and from human luteal fibroblast-
like cells (F), which were used as a positive control DNA template. All the amplicons localised to the correct size 
on the gel when lined up with a 100 bp DNA ladder (L) and were further identified by sequencing.  
 
The use of ethidium bromide in agarose gels is however not robustly quantitative and 
better measures can be obtained using real-time qRT-PCR.  The amount of clock gene 
expression in the intact human CL was therefore quantified at three stages across the 
luteal lifespan, using real-time qRT-PCR with the Roche LightCycler 2.0 system. 
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The overall level of clk and bmal1 gene expression did not alter significantly 
throughout the three stages of the luteal phase.  There was a trend for the clk 
expression to increase over time, from the early luteal phase to the late luteal phase, 
but this was not significant due to the relatively large errors of the mean, which can be 



























Figure  4.2 Histogram of clk and bmal1 gene expression in the human intact CL, normalised to g6pdh gene 
expression.  The gene expression levels were quantified using cDNA concentration extrapolated from a standard 
curve using real-time qRT-PCR; and statistically analysed with ANOVA with Bonferroni pairwise comparisons.  
Neither clock nor bmal1 gene expression was significantly different between any of the three luteal phases: early, 
mid- and late (P>0.05).  The error bars refer to the standard error of the mean. 
 
 
The level of gene expression of all the per genes changed over the luteal lifespan.  
The per1 gene was significantly increased between the mid-luteal phase and the late 
luteal phase (P=0.035), per2 between the early and late luteal phase (P=0.026), and 
per3 between the early and late luteal phase (P=0.043) (Figure  4.3).  There was 
overall an increase in the per1 mRNA expression with time.  The level of clock gene 
expression relative to that of the housekeeper control gene was greater for per3 than 



























Figure  4.3 Histogram of per1, per2 and per3 gene expression in the human intact CL, normalised to g6pdh gene 
expression.  The gene expression levels were quantified using cDNA concentration extrapolated from a standard 
curve using real-time qRT-PCR; and statistically analysed with ANOVA with Bonferroni pairwise comparisons.   
The late luteal per1 gene expression was significantly greater than that of the mid-luteal phase (P = 0.035).  The 
late luteal per2 gene expression was significantly greater than that of the early luteal phase (P = 0.026).  The late 
luteal per3 gene expression was significantly greater than that of the early luteal phase (P = 0.043).  The error 
bars refer to the standard error of the mean. 
 
 
Likewise, both the cry1 and cry2 genes were expressed at higher levels during the 
late-luteal phase when compared to the early luteal phase.  Expression of cry1 was 
significantly higher (P=0.045) whereas cry2 showed a more marked change in gene 
expression levels between the early and late luteal phases (P=0.006) (Figure  4.4).  The 
































Figure  4.4 Histogram of cryptochrome1 and cryptochrome2 gene expression in the human intact CL, normalised to 
g6pdh gene expression.  The gene expression levels were quantified using cDNA concentration extrapolated from 
a standard curve using real-time qRT-PCR; and statistically analysed with ANOVA with Bonferroni pairwise 
comparisons.   The late luteal cryptochrome1 gene expression was significantly greater than that of the early luteal 
phase (P = 0.045).  The late luteal cryptochrome2 gene expression was significantly greater than that of the early 
luteal phase (P = 0.006).  The error bars refer to the standard error of the mean. 
 139 
4.3 DISCUSSION 
The mRNA expression of all the clock genes investigated: per1, per2, per3, cry1, 
cry2, bmal1 and clk, was successfully detected and quantified in the human CL, 
across the luteal cycle. 
 
In the absence of any corroborating independent evidence found in literature to date, 
the question of the reliability of the results presented in this chapter must be 
addressed.  Firstly, the primers were specific and successfully amplified the cDNA 
into amplicons of the correct size and sequence identity.  The PCR reactions were 
designed to be approximately the same between the reactions of the clock gene 
amplification and the standard gene amplification.  This was important for reliable 
normalisation with the endogenous control gene standard curve.  The running of these 
two amplification reactions in separate tubes was not ideal, but the reactions were 
performed in parallel and in duplicate to ensure any errors that may have been 
introduced were minimised.  The melting curve analysis that was performed after 
each real-time qRT-PCR run further validated the accuracy of the nucleic acid 
quantification.  The successful amplification of all seven genes investigated, in the 
luteal fibroblast-like cells, derived from pre-ovulatory follicles under an assisted 
reproduction protocol, successfully established an exogenous positive control that 
added confidence to the results obtained with the human CL.  The luteal fibroblast-
like cells were found to robustly express all of the clock genes, and the successful 
detection of these genes further validated the primers and PCR protocols using them.  
The use of the same standard endogenous control in every run also enabled the 
comparison and validation of the separate PCR runs against each other, so that they 
could be combined into a single data set.  The negative controls were also 
successfully devoid of any PCR reaction.  Thus, the data generated is a real 
representation of the global clock gene expression of the intact human CL. 
 
These demonstrate the global expression of clock genes in the intact human CL, 
throughout the early, mid- and late luteal phases.  Significant changes were observed 
in the level of mRNA expression in the genes belonging to the negative limb of the 
circadian clock mechanism: per1, per2, per3, cry1and cry2, between the early luteal 
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phase and the late luteal phase.  All these negative limb clock genes were generally 
found to increase their level of mRNA expression as the CL aged, from the early 
luteal phase through the mid-luteal phase and into the late luteal phase.  The pattern 
was marginally less clear for per1 since the difference between the early luteal phase 
and late luteal phase gene expression levels was not significant, although the level of 
expression in the late luteal phase was greater than that of both the other two luteal 
phases. 
 
There was no significant change observed in the level of mRNA expression in the 
genes belonging to the positive limb of the circadian clock mechanism: bmal1and clk 
between any of the luteal phases.  The mRNA level of clk though, did demonstrate an 
upward trend with time, which was similar to those observed in with the negative 
limb clock genes (Figure  4.2 clk). 
 
The general difference in the increasing levels of mRNA expression between the 
genes of the negative limb of the circadian clock mechanism and the genes of the 
positive limb is notable.  This is similar to the events occurring in a cell-based 
circadian clock, where it has been shown that only one set of genes: the negative limb 
genes need to oscillate in a circadian rhythm, while the other set of genes: those of the 
positive limb of the circadian clock mechanism are constitutively expressed, in order 
to generate a circadian clock (Sumova et al., 2003, King and Takahashi, 2000, Oishi 
et al., 1998, Sato et al., 2006, Ueda et al., 2005, Ko and Takahashi, 2006).  The 
significant change in expression of only the negative limb genes may be the related to 
the function of producing clockwork that is able to regulate the longer term timing of 
the luteal lifespan.  The increased levels of clock gene expression observed may be an 
artefact of the changing cellular composition of the CL as it ages.  It could be argued 
that the clock gene expression detected in this study is the result of an increasing 
proportion of a particular cell type, for example, macrophages which are known to be 
more prevalent as the CL ages (Duncan et al., 1998b).  However, the IHC studies in 
the previous chapter do not demonstrate any particular cell type predominantly 
contributing to the clock gene expression in the corpora lutea, as they aged. 
 
The working hypothesis is that the level of global clock gene mRNA expression 
changes across the luteal lifespan.  This is so far supported by the clock gene 
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expression levels increasing with time rather than decreasing.  There was no evidence 
for any loss of clock gene expression as the CL aged, and approached the time of 
luteolysis.  This is similar to other reports on clock gene expression in the rodent 
ovary in vitro (He et al., 2007b, He et al., 2007a, Karman and Tischkau, 2006).  The 
clock genes: per1, per2, cry1, arntl (bmal1) and clk, were all expressed in the intact 
rodent CL (Karman and Tischkau, 2006).  The corpora lutea employed in these 
studies though were not staged, nor the animals assessed for œstrous cycle staging.  
What was observed however, may relate to the timing of the CL and its lifespan was 
the discovery of circadian variation in the level of bmal1 expression in large antral 
follicles but not in corpora lutea.  This suggests that the next logical step, in 
elucidating more about the temporal regulation of the human CL and its lifespan, 





In summary, this chapter has demonstrated for the first time that: 
 
1. the clock genes: per1, per2, per3, cry1, cry2, bmal1and clk are expressed in 
the human CL and luteal fibroblast-like cells; 
 
2. these genes are expressed throughout the luteal cycle, in the early, mid- and 
late luteal phases; 
 
3. the level of global of per1, per2, per3, cry1 and cry2 gene expression 
increased significantly across the luteal cycle; 
 
4. the expression of clk and bmal1 did not change significantly across the luteal 
cycle; 
 
5. there was no decrease or loss of global clock gene expression across the luteal 
cycle. 
 
Although the level of global gene expression has now been elucidated, and some of 
that clock gene expression has been found to change significantly across the human 
luteal cycle, it has still not been established whether these genes are circadianly 
expressed in the human CL.  The investigation of 24-hour clock gene expression in 
human luteal cells will be the focus of the next chapter. 
5 CLOCK GENE EXPRESSION ACROSS    
24-H IN HUMAN LUTEINISED 




The previous two chapters established that clock genes are expressed in the human 
CL and that the expression changes across the luteal lifespan.  There is robust 
expression of the clock proteins in the steroidogenic cells of the human CL, including 
the granulosa-lutein cells.  This is relevant because, in order to assess the clock gene 
expression in the human CL across 24 hours, an in vitro model is needed, as it is not 
possible to sample corpora lutea from women at different times of the day due to 
logistical and ethical considerations.  It is still crucial however, that the 24-hour 
expression of the clock genes is investigated in the human CL, as this is the main 
function of these genes in virtually all the cells of the body.  It is also likely that the 
gene expression profiles that emerge for these genes will pertain to the temporal 
regulation of luteal function and lifespan. 
 
The in vitro model proposed for establishing the 24-hour mRNA expression of the 
clock genes in luteal cells employs the LGCs.  These are the cells that are developing 
into the granulosa-lutein cells of the CL.  These cells are obtained from the follicular 
fluid from follicles that have been surgically enucleated of their oocytes, under an 
assisted conception cycle.  The follicular fluid or aspirate therefore contains a mixture 
of cells, from a mixture of follicles, from a single individual woman.  These follicles 
are large and have been exposed to a high dose of hCG that was administered to 
mimic the pre-ovulatory LH surge.  The follicular fluid was obtained 35 hours after 
the pseudo-LH surge from three or more large follicles, which were generated under a 
programme of hormonal treatment using fertility drugs that stimulate the maturation 
of several follicles, rather than the usual single dominant follicle, in the ovaries.  
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During oocyte retrieval, cell culture media is used to flush out the cells from the 
enucleated follicles.  It is from this aspirate, that the LGCs are extracted.  As these 
cells are not required for the in vitro fertilisation (IVF) process, they are usually 
discarded and therefore are relatively readily available. 
 
The use of this cell culture system as a model of the human CL has been validated by 
numerous other studies (Dickinson et al., 2008, Duncan et al., 2005b, Duncan et al., 
2005a, van den Driesche et al., 2008, Madhra et al., 2004, Myers et al., 2007a, Myers 
et al., 2007b, Myers et al., 2008).  Many of these studies have shown that these cells 
express genes that are characteristic and specific to human granulosa-lutein cells.  The 
LGCs have also been shown to synthesise and secrete progesterone, functioning 
steroidogenically like human granulosa-lutein cells (Ivell et al., 1999).  Moreover, and 
very importantly, these cells have been shown to persist in culture for approximately 
14 days, the same time period as that of the intact human luteal lifespan, before 
spontaneously degenerating and disappearing.  This suggests that whatever temporal 
regulation there is in the intact human CL that controls the timing of luteolysis and 
thus, the luteal lifespan is preserved largely intact, in the cultured LGCs.  
Furthermore, the lifespan of these cells can be extended and their demise forestalled 
by treatment with hCG, which mimics the effect of hCG in the intact human CL.  
Human chorionic gonadotrophin is a luteotrophic maternal recognition of pregnancy 
signal that is emitted by the conceptus and acts on the LH receptor, to ensure the 
continued survival and function of the CL during early gestation.  The hCG effect in 
the LGCs further replicates the in vivo situation of the intact human CL, by being 
required in increasing amounts for the continued maintenance of the LGCs as they 
age.  The intact human CL of pregnancy similarly requires and receives increasing 
amounts of hCG from the growing conceptus. 
 
The follicular aspirates are also a source of another cell type that resembles human 
luteal cells, as described in the previous chapter.  Human luteal fibroblast-like cells 
can be obtained from the cultures of LGCs, after the demise of the LGCs, which 
occurs after around 14 days (Duncan et al., 2005b, Myers et al., 2007a).  These luteal 
fibroblast-like cells, like the fibroblasts of the intact human CL, do not possess 
hCG/LH receptors.  They are therefore not directly affected by the exogenous hCG 
surge.  The enrichment of the LGC cultures for LGCs does not completely eliminate 
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the presence of a small number of these luteal fibroblast-like cells.  These cells are 
able to proliferate and do so in abundance after the demise of the LGCs, which occurs 
after ~14 days without hCG-rescue.  They are able to grow to confluence, producing a 
cell population that possesses cell-to-cell communication.  These cells are not 
terminally differentiated and can be maintained in primary cell culture.  They may 
therefore be used to represent another human luteal or luteal cell-like cell type, other 
than the LGCs, for the purpose of elucidating more about the potentially circadian 
expression of the clock genes in the human CL.  The fact that this other population of 
cells is fibroblast-like is also particularly useful, as fibroblasts have generally been 
shown to possess individual cell-based circadian clocks, which can be synchronised 
by a variety of zeitgebers, including serum shock in vitro (Balsalobre et al., 1998, 
Kaeffer and Pardini, 2005). 
 
Thus, the use of both these cell culture models promised to provide useful insight into 
the 24-hour expression of clock genes in the human CL, as it ages.  The working 
hypothesis is that the expression of the clock genes is linked to the temporal 
regulation of the luteal lifespan.  It is proposed that all of the clock genes may be 
expressed in the LGCs and luteal fibroblast-like cells, seeing that they are expressed 
in the granulosa-lutein cells and fibroblasts in the intact human CL.  It is further 
proposed that the expression of some if not all of these clock genes will be rhythmic 
across 24-hours and may change with the time spent in culture, representing the time 
elapsed in the progression of the luteal cycle.  The hCG-rescue of the LGCs may 
affect the clock gene expression of these cells.  The clock gene expression in the 
luteal fibroblast-like cells will also be altered, by serum shock, resulting in the 
emergence of more overtly rhythmic pattern of gene expression in their, collectively 
arrhythmic or dampening, circadian rhythms.  This will likely be due to better 










Thus, this chapter aims: 
 
3. to determine whether the clock genes: clk, bmal1, per1, per2 and cry1 are 
expressed in cultured human LGCs and luteal fibroblast-like cells; 
 
4. to assess whether the clock gene expression in the LGCs and luteal fibroblast-
like cells is rhythmic across 24-hours; 
 
5. to determine whether the 24-hour clock gene expression in the LGCs changes 
with time, between the first (D1) and eighth (D8) day of culture; 
 
6. to determine whether hCG treatment of the LGCs affects clock gene 
expression; 
 
7. to assess whether serum shock affects 24-hour clock gene expression in the 
luteal fibroblast-like cells. 
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5.2 MATERIALS AND METHODS 
5.2.1 ETHICAL APPROVAL 
The collection of ovarian and follicular cells from patients undergoing assisted 
conception at the EFREC was separately approved by the Reproductive Medicine 
Subcommittee followed by further approval by COREC.  Informed consent was 






With patient consent, follicular fluid was collected from women undergoing 
transvaginal oocyte retrieval for in vitro fertilisation after ovarian stimulation using a 
standard procedure.  Briefly, a long-protocol stimulated cycle was followed, using 
intranasal naferelin (Pharmacia Biotech, Milton Keynes, UK), a gonadotrophin-
releasing hormone analogue for down-regulation and daily purified gonadotrophins 
(Menopur, Ferring Pharmaceuticals, Langley, UK) for ovarian stimulation. When at 
least three follicles reached 18 mm diameter, 10 000 IU hCG was administered.  This 
large hCG dose mimicked the pre-ovulatory LH surge that triggers ovulation.  
Transvaginal oocyte collection was performed under sonographic guidance 35 hours 
later (Duncan et al., 2005b).  The follicular fluid that was flushed from the follicles 
was reserved and used as a source of LGCs and luteal fibroblast-like cells (Stamouli 
et al., 1996). 
 
The follicular fluid or aspirates that were obtained from three separate women were 
kept separate.  Each follicular aspirate was used for culturing a single set of LGCs for 
24-hour sampling.  Each set generated was a single n number.  These sets were 
referred to as individual samples (Figure  5.1).  There were three individual samples 
(n=3).  The follicular aspirates of two or three women were combined to culture a 
single set of LGCs.  This set of LGCs, comprising LGCs from multiple women, 
 148 
generated a single n number, and was referred to as a pooled sample (Figure  5.1).  
Three pooled samples were used (n=3).  Samples were pooled because demand for 
these cells was fierce, and there was not enough time to wait for follicular aspirates 
that contained sufficiently large quantities of LGCs to comprise a single individual 
sample.  Therefore, follicular aspirates with too few LGCs for a single sample were 
combined with other, similarly low LGC yielding, follicular aspirates, to produce a 
sample that was composed of a sufficient amount of LGCs.  The pooling of the 
follicular aspirates was only possible with follicular aspirates that were obtained on 
the same day.  Luteal fibroblast-like cells were all obtained from pooled follicular 


















Figure  5.1 Diagram showing the acquisition of individual and pooled LGC samples.  There are three samples; 
each composed of LGCs from a single individual woman, in this case, samples #1, #3 and #5.  There are three 
pooled samples, each sample composed of LGCs from several women, in this case, sample #2 is composed of 
cells from three individual women, sample #4 is composed of cells from two individual women and sample #6 is 
composed of cells from three individual women.  A diagram of the process of cell culture is also depicted, showing 
a pot of follicular aspirate, from which the LGCs are extracted, and then cultured in pre-coated cell culture plates, 
containing cell culture media. 
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5.2.3 LUTEINISED GRANULOSA CELL CULTURE 
LGCs were obtained from follicular aspirates after the removal of oocytes.  Individual 
follicles were not distinguished, and all follicular fluid from the same individual were 
pooled and centrifuged at 1500 rpm for 10 min.  The cells were resuspended in culture 
medium (Dulbecco’s Minimum Essential Medium/Ham’s F-12 mixture, Invitrogen 
Life Technologies, Inc., Gaithersburg, MD) supplemented with 2 mmol l-1 glutamine 
(Sigma, Dorset, UK), 6.25 mg l-1 insulin, 6.25 mg l-1 transferrin, 6.25 µg l-1 selenious 
acid (Roche, Welwyn Garden City, UK), 2.5 mg l-1 amphotericin, 50 mg l-1 penicillin 
and 60 mg l-1  streptomycin, layered over a 45% Percoll/culture medium mixture, and 
centrifuge at 1200 rpm for 30 min to pellet the blood cells.  LGCs, visible in the 
interface, were collected by pipette and washed three times in PBS.  The cells were 
resuspended in culture medium, and viable cells were counted using a trypan blue 
exclusion test (van den Driesche et al., 2008).  Where possible, the cells from 
individual patients were used for an entire experiment, (individuals data set, n =3) but 
failing that, cells from several patients were pooled to achieve a sufficient quantity of 
viable cells for an experiment, n=3 (pooled data set, n=3).  Each time course 
experiment comprised six sets of 350 000 cells, plated onto 2 wells of 15-mm round-
well plates precoated with BD Matrigel™ Basement Membrane Matrix Extracellular 
Matrix Proteins (Biotrace International, Brigend, UK).  The cells were cultured using 
0.5 ml culture medium at 37oC in 5% CO2 in air (Figure  5.1). 
 
Individual 66-mm round well plates containing 350 000 cells in 2 wells were sampled 
every 4 h for 24 h after 12 h of culture.  Remaining plates of cells were maintained 
with daily media changes, timed to coincide with the time of initial culture, as there 
were reports of media changes being sufficient for re-entraining circadian rhythms in 
cultured cells (Welsh et al., 2004).  The cells were then sampled on day 8 post-
culture.  Human chorionic gonadotrophin treatment involved the addition 1000 µg ml-
1 of recombinant hCG (Profasi, Serono Laboratories, Welwyn Garden City, UK) for 2 
h then replacement with the usual media.  The 2-h treatment was started at a time 2 
hours prior to the usual time for daily media change.  Untreated controls were given 
media changes at times of treatment addition and withdrawal. 
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The plates were removed from the incubator and the medium carefully pipetted off.  
The media was frozen until the progesterone concentrations were measured using 
RIAs, adapted from routine methods previously described (Gault et al., 2003).  RNA 
was then extracted from the cells, which were harvested every four hours on day 1 
















Figure  5.2 Timeline of the LGC culture.  The diagram indicates when the timing of cell culture, treatment with (+ 
hCG) and without (- hCG) and 4-hourly sampling over 24 hours on the first (D1) and eighth (D8) day of culture, 




5.2.4 LUTEAL FIBROBLAST CELL CULTURE 
The reproductive medicine subcommittee of the Lothian medical ethics committee 
approval included the culture of luteal fibroblast-like cells from the follicular aspirates 
collected during assisted conception.  The cells were derived as described previously 
and reported in the previous chapter (Duncan et al., 2005b, Myers et al., 2007a, 
Dickinson et al., 2008). 
 
For the 24-h time course experiments, the luteal fibroblast-like cells were cultured in 
66-mm round well plates (Fisher Scientific, Leicester, UK) and allowed to grow to 
confluence with daily media changes timed to the same time of day or to coincide 
with that of any concurrent LGC cultures (n=3).  Once the cells were confluent, they 
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were treated with 50% fœtal bovine serum for 2 h then the media replaced with 
serum-free media.  Untreated controls were given media changes consistent with the 
treatment volumes and times.  Individual plates were sampled every 4 h for 24 h.  The 
cells were harvested by removing the medium, which was discarded.  RNA was then 




5.2.5 TOTAL RNA EXTRACTION 
RNA was extracted using an RNeasy® Micro RNA extraction kit (Qiagen Ltd, West 
Sussex, UK) using the Total RNA Isolation from Animal Cells spin protocol with the 
on-column DNase treatment (Qiagen Ltd, West Sussex, UK).  There were less than 1 
x 105 cells in each sample.  Briefly, once the media had been removed from the cells, 
they were disrupted and lysed by the direct addition of 350 μl Buffer RLT containing 
1% β-mercaptoethanol to the plate.  The cells were scraped using sterile pipette tips 
and the cell lysate pipetted into a microfuge tube.  The lysate was vortexed to ensure 
it was well-mixed and that any clumps of cells would be disintegrated.  To 
homogenise the sample, the cell lysate was pipetted directly into a QIAshredder spin 
column (Qiagen Ltd, West Sussex, UK) which was placed in a 2 ml microfuge tube, 
then centrifuged for 2 min at maximum speed in a bench microcentrifuge.  The 
QIAshredder was removed and discarded, leaving the homogenised lysate in the 2 ml 
microfuge tube.   
 
One volume (usually 350 μl) of 70% ethanol was then added to the homogenised 
lysate and mixed well with pipetting.  This precipitates the RNA.  The sample, 
including any precipitate that had formed, was then carefully pipetted into an RNeasy 
MinElute Spin Column in a 2 ml collection tube.  The tube was then centrifuged for 
15 s at 8 000 x g.  The RNA was now bound to the silica-gel membrane in the RNeasy 
MinElute Column.  The flow-through was discarded. 
 
Buffer RW1 (350 μl) was then added to wash the RNeasy MinElute Spin Column.  
The tube was centrifuged for 15 s at 8 000 x g and the flow-through discarded.  The 
RNA was then treated with deoxyribonuclease (DNase) to remove any template DNA, 
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using a Qiagen RNase-free DNase set (Qiagen Ltd, West Sussex, UK).  Next, 10 μl 
DNase I stock solution (Qiagen Ltd, West Sussex, UK) was mixed gently with 70 μl 
of Buffer RDD and added directly onto the RNeasy MinElute silica-gel membrane.  
The DNase was left to work in the column for 15 min at room temperature.  The 
column was then washed by adding 350 μl of Buffer RW1 to the column and 
centrifuging for 15 s at 8 000 x g and the flow-through was discarded. 
 
The column was transferred into a new 2 ml collection tube.  Buffer RPE (500 μl) was 
then pipetted into the column and centrifuged for 15 s at 8 000 x g.  The flow-through 
was discarded.  The silica-gel membrane was then dried by the addition of 500 μl of 
80% ethanol to the column, which was then centrifuged for 2 min at 8 000 x g.  The 
flow-through and collection tube were discarded.  The column was then dried more 
thoroughly.  It was transferred to a new 2 ml collection tube.  The cap was left open 
and then the tube centrifuged at maximum speed for 5 min in a bench 
microcentrifuge.  The flow-through and collection tube were discarded. 
 
The RNA was then eluted.  The column was transferred to a 1.5 ml collection tube 
and 14 μl of RNase-free water was pipetted directly onto the centre of the silica-gel 
membrane.  The tube was closed and left to incubate on ice for 10 min.  The tube was 
then centrifuged for 1 min at maximum speed on the bench centrifuge.  This step was 
repeated with a second 10 μl volume of RNase-free water.  The RNA was then 
quantified on an Agilent 2100 Bioanalyzer (Agilent Technologies UK Ltd, 
Wokingham, Berkshire, UK).  RNase-free water was added to the RNA to achieve a 




5.2.6 RNA QUANTIFICATION 
RNA was quantified using an Agilent RNA 6000 Nano LabChip® kit (Agilent 
Technologies UK Ltd, Wokingham, Berkshire, UK) on an Agilent 2100 Bioanalyzer 
(Agilent Technologies UK Ltd, Wokingham, Berkshire, UK).  The Agilent assay 
works using capillary electrophoresis and so, not only quantifies the RNA, but 
simultaneously provides an assessment of the RNA purity.  The purity measurement 
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works in much the same way as using sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE).  The Bioanalyzer contains software that generates 
electropherograms of each sample and ladder as well as an RNA Integrity Number 
(RIN) that is a quantification estimate and calculates the ribosomal ratios of total 
RNA samples.  
 
Each RNA sample (1 μl) and an Agilent RNA 6000 Nano Marker ladder (1 μl) were 
denatured by heating at 70oC for 2 min before rapidly chilling on ice.  The RNA 
samples and ladder were loaded into an Agilent RNA 6000 Nano LabChip containing 
microfluidic gel freshly mixed with fluorescent dye.  The dye binds to nucleic acids 
and so allows the fluorescent detection of the RNA fragments, as well as any 
contaminating template DNA.  Each LabChip is made up of an interconnected set of 
micro-channels that are used to separate the nucleic acid fragments, based on their 




5.2.7 PREPARATION OF COMPLEMENTARY DNA BY 
REVERSE-TRANSCRIPTION 
The RNA was batch reverse transcribed using GeneAmp® RNA PCR Kit (Applied 
Biosystems, Warrington, UK) with random hexamers.  Total RNA (125 μg) was 
added to a reaction mix containing 1x RT Buffer, 5 mM magnesium chloride (MgCl2), 
1 mM dNTPs, 1.25 µM random hexamers, 1 U µl-1 recombinant RNasin® ribonuclease 
(RNase) inhibitor and 1 µl recombinant Moloney murine leukaemia virus (MuLV) 
reverse transcriptase in a final reaction volume of 20 µl.  The reverse transcriptions 
were performed in duplicate, with positive controls using human placental RNA.  
Negative controls comprising reactions performed without the addition of template 
RNA as well as using a 3-5 randomly selected test samples with a reaction mix 
lacking reverse transcriptase were included. 
 
The samples were incubated at room temperature for 10 min.  They were then heated 
to 42oC for 60 min in order to provide the optimum temperature for enzymatic action.  
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The reaction was then stopped and the enzyme denatured by incubating at 95oC for 10 






In order to quantify the expression levels of the clock genes, specific PCR primers 
designed to amplify the clock gene DNA was required. TaqMan® Gene Expression 
assays were used which provided commercially available primers and probes for 
human clock genes.  The TaqMan® system employing these primers and probes was 
preferred as it offered higher throughput than the LightCycler® system, as well as 
enabled the use of a heterologous endogenous control in a multiplex amplification 
reaction with the gene of interest.  These TaqMan® Gene Expression Assays used 




GENE ASSAY NUMBER FLUORESCENT DYE AMPLICON SIZE (bp) 
clock Hs00231857_m1 FAM 88 
bmal1 Hs00231048_m1 NED 61 
per1 Hs00231857_m1 FAM 88 
per2 Hs00256143_m1 FAM 121 
cry1 Hs00172734_m1 NED 84 
Table  5.1 List of the TaqMan® Gene Expression Assays used, including catalogue numbers, fluorescent dye label 
and amplicon size. 
 
 
The primers and probes were intron-spanning where possible to better ensure the 
amplification of only cDNA template rather than any contaminating genomic DNA.  
The probes were TaqMan® MGB™ probes.  These probes incorporate a 5’ reporter 
dye and a 3’ non-fluorescent quencher (NFQ). The NFQ produces a lower 
background signal, which increases the precision of the gene expression 
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quantification. The major groove binder (MGB) moiety works by stabilising the probe 
when it is hybridised by binding to the major groove of the DNA.  This increases the 
melting temperature (Tm) of the probe to improve the specificity of the unquenching 
of the fluorescent label by the endonuclease activity of the Taq polymerase. 
 
An internal control PCR reaction was required to run in duplex with the PCR 
amplification of the gene of interest.  Ribosomal 18S RNA was selected for the 
internal control.  It is used routinely and is abundant in cells.  It would therefore 
provide a reliably detectable level of gene expression.  It was also found not to be 
circadianly expressed in sheep, nor was it affected by photoperiod in sheep (Dupre et 
al., 2008).  The crossing threshold (CT) of the 18S reaction was also not predicted to 
be too distant from that of the clock genes in the ovine CL. The 18S primers and 
probe selected were the standard ones which are routinely used (Applied Biosystems, 
Warrington, UK).  They were fluorescently labelled with the VIC dye and are used in 
conjunction with an MGB probe. 
 
The primer and probe concentrations were then optimised.  The optimal 
concentrations for the primer pairs were determined using a range of concentrations.  
The primers were used in ratios of 1:1, 3:1, 6:1 and 18:1 reciprocally between the 
forward and reverse primers and the Tm was varied by ± 2
oC increments.  The primer 
pair concentrations were optimised using temperature gradients.  The probe 
concentrations were then optimised by titrating against the primer pairs at their 
optimised concentrations, to ensure that the probe does not limit the fluorescence in 
the PCR due to its more abundant template: ribosomal 18S cDNA.  The primers and 
probes were performed in singleplex PCRs initially then in duplex PCRs which 
included the internal control primers and probes.  The optimal conditions resulted in 





5.2.9 REAL-TIME QUANTITATIVE REVERSE TRANSCRIBED-
POLYMERASE CHAIN REACTION USING THE 
APPLIED BIOSYSTEMS TAQMAN® SYSTEM 
Once the primers were selected, they were used in real-time qRT-PCR to amplify up 
the clock gene DNA.  The qRT-PCR was performed, using a two-step RT-PCR 
protocol, in the Applied Biosystems TaqMan system, which was comprised of the 
TaqMan 3700HT instrument with reagents from the AmpliTaq Gold® Fast PCR 
Master Mix kit.  This system follows the standard principles behind real-time qRT-
PCR, as described previously.  It uses quenched fluorescent probes that hybridise 
between the forward and reverse primers and which become unquenched when 
cleaved by the nuclease activity of the polymerase during the PCR amplification 
process.  The amount of fluorescence detected is used to monitor the amount of 
template amplification.   
 
The duplex qRT-PCR reaction was made up of 1.5 μl cDNA, 1x AmpliTaq Gold® 
Fast PCR Master Mix, UP, 1x each of forward and reverse primers, 1x probe, 0.02 
μM each of forward and reverse 18S primers, 0.08 μM 18S probe to a final reaction 
volume of 10 μl.  The AmpliTaq Gold® Fast PCR Master Mix, UP is a solution 
containing hot start Taq polymerase, dNTPs, magnesium and buffer.  It is used in fast 
PCR reactions, which take approximately 40 min rather than the standard 2 h.  
Reactions were loaded into 96-well plates and the PCRs performed in a TaqMan 
3700HT instrument, using a fast protocol.  Complementary DNA from ovine adrenal 
gland was used as a positive control.  Negative controls included reactions omitting 
the template which was replaced by nuclease-free water.  PCR reactions were 
performed in triplicate with each of the duplicate cDNA. 
 
The CT values were then used to calculate the relative gene expression of each gene of 
interest, using the second derivative method with the adrenal gland positive control as 
the reference sample (Kubista et al., 2006). 
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5.3 RESULTS 
5.3.1 PROGESTERONE FROM LUTEINISED GRANULOSA 
CELLS 
The media extracted from the LGCs prior to RNA extraction were assayed using 
radiolabelled immuno-assays (RIA) to quantify the progesterone (P4) concentration.  
This provided an indication of the steroidogenic function of the cells, which, as 
expected, showed a decrease in P4 levels from D1 to D8 (Figure  5.3).  This meant that 
the LGCs had lost some of their steroidogenic function with time, as is the case in the 
intact human CL of the reproductive cycle.  The hCG treatment of the LGCs on D8 
shows the restoration of P4 secretion to levels akin to those on D1, and which are 
higher than those of the D8 LGCs without hCG treatment.  The P4 levels indicate that 
the LGCs are healthy, steroidogenically functional and hCG responsive. 
 
It is important to note that the changes reported in the P4 levels between the LGC 
populations between D1 and D8, with and without hCG, were not statistically 
significant.  This was disregarded though, because the failure to detect any statistical 
significance is due the relatively low levels of P4 that the LGCs are producing.  This is 
due to the absence of a substrate from which P4 can be synthesised.  Cholesterol, in 
the form of low-density lipoprotein (LDL), is often used to supplement the culture 
media of the LGCs in order to provide such a substrate for P4 synthesis.  Its addition 
to LGC cultures is well known to produce relatively high levels of P4, particularly 




































Figure  5.3 Histogram of progesterone levels.  This shows the progesterone concentrations in the media from LGC 
on days one (D1) and eight (D8) of culture, with (D8 hCG) and without hCG (D8).  The error bars refer to the 




5.3.2 24-HOUR CLOCK GENE EXPRESSION IN LUTEINISED 
GRANULOSA CELLS 
5.3.2.1 GENE EXPRESSION BETWEEN INDIVIDUAL AND 
POOLED SAMPLES 
There was an increased level of clk expression across 24-hours in five out of six of the 
samples (exception sample #6), which peaked at ZT 10 – 14 on D1 and at ZT 10 – 22 
on D8, but with marked variation both in the timing of the maximum and in the 
absolute level of expression (Figure  5.4).  Sample #4 was notable in having a much 
higher overall level of gene expression than any of the other samples.  Samples #5 and 
#6 were also notable in that they shared no clear peak that was consistent with any of 





Figure  5.4 The gene expression of clk in individual (#1, #3 and #5) and pooled (#2, #4 and #6) LGC samples, 
demonstrating the increased rhythmicity of the gene expression on D8 (orange) compared to that on D1 (green). 
 
 
The expression profiles of clk loosely segregate into three characteristic 24-hour gene 
expression patterns: 1) high expression, 2) rhythmic and 3) arrhythmic (Figure  5.4).  
The high expression profile was typified by the clk expression of sample #4, which 
revealed a maximum at ZT 10 on D1 and at ZT 14 on D8, with robust expression.  
The rhythmic clk gene expression profile was typified by sample #1 and sample #2.  
This was classified according to the clear evidence of peaks and troughs in the 24-
hour profiles that fitted relatively closely with a sigmoid curve.  The arrhythmic gene 
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expression profile was typified by sample #5 and sample #6 (with the ZT 2 data point 
excluded), with a relatively small change in the level of clk gene expression across 24 
hours. 
 
After this arbitrary classification, the 24-h expression of the other four clock genes 
were then examined in relation to the pattern of clk rhythmicity using the three 
categories: sample #4 – high expression (Figure  5.5), sample #1 – rhythmic (Figure 




5.3.2.2 HIGH EXPRESSION PROFILE 
Sample #4 expressed particularly high clk gene expression and the rhythmic 
expression on D1 and D8 were very robust.  The 24-hour expression of the other 
clock genes was also very robust in this sample (Figure  5.5).  The D8 24-hour profiles 
of gene expression corresponded more closely to sigmoid curves, with the peaks of all 
but cry1 occurring at higher levels of gene expression than on D1.  All the D8 peaks 
occurred at either ZT 10 or ZT 14 while all the D1 peaks occurred at ZT 10, except 
for per1 which peaked earlier at ZT 6.  There appeared to be a phase delay of ~4 
hours in the D8 expression of clk, per1 and per2, based on the time of peak gene 
expression (acrophase).  The acrophases did not shift between D1 and D8 of bmal1 
and cry1 gene expression, nor was there a marked increase in the level of gene 
expression between the acrophases on D1 and D8.  Contrary to expectation, there was 
no evidence of antiphasic timing in the 24-hour profiles of expression for the genes 
comprising the negative limb of the circadian clock mechanism (per1, per2 and cry1) 




Figure  5.5 This individual sample, sample #4, shows relatively high gene expression of clk, per1 and cry1, as 







5.3.2.3 RHYTHMIC PROFILE 
The rhythmic profile of gene expression was demonstrated by sample #1, where all of 
the graphs of the 24-hour profiles of clock gene expression relatively closely 
resembled a sigmoid curve (Figure  5.6).  All the D8 acrophases occurred at ZT 14, 
showing a ~4 hour phase delay of the D1 acrophases, except for per1, which was 
delayed by a further ~4 hours.  The level of gene expression was increased in general 
and also higher at the peaks of the D8 circadian expression of clk, bmal1 and cry1.  
This was not the case for the per genes, which appeared to have a decrease in the 
general level of clock gene expression on D8, as well as lower amounts of gene 
expression at its D8 acrophase.  The general level of the expression of the clock genes 
were largely in line with those of the other samples, except the expression of per2, 
which was quite high on D8 in this sample compared to per2 expression on D1 and 
D8 in all the other samples.  The acrophase of the D8 cry1 rhythm was also the 
highest of all the samples, taking into account the D1 and D8 acrophases.  Again, no 
antiphasic relationships were observed between the rhythmic expression of the genes 
belonging to the negative limb of the circadian clock mechanism and the genes 





Figure  5.6 This pooled sample, sample #1, shows relatively rhythmic gene expression of all the clock genes on 
both D1 (green) and D8 (orange). 
 
 
5.3.2.4 ARRHYTHMIC PROFILE 
The arrhythmic profile of gene expression is characterised by very low general levels 
of clock gene expression, typified by sample #5 (Figure  5.7).  The pattern of 24-hour 
gene expression of all of the clock genes on D1 and D8 did not closely resemble a 
sigmoid curve, and the peaks of expression throughout the 24-hour period were not as 
immediately obvious as they were in other samples, except sample #6, which also had 
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relatively low general levels of clock gene expression.  Bearing in mind the low levels 
of gene expression denoted by the y axes, there was a downward trend in gene 
expression from ZT 2 to ZT 22 across the 24-hour period on D1 and an upward trend 
between ZT 2 and ZT 22 on D8.  On D1, the lowest level of gene expression occurred 
at ZT 22 for all the clock genes, except per1 which had its lowest level of expression 
occurring earlier, at ZT 18.  The highest level of clock gene expression on D1 tended 
to occur at either ZT 2 or ZT 10.  On D8, the highest level of expression was observed 
with all the clock genes at ZT 22.  The lowest level of gene expression occurred at ZT 
6 in all of the clock genes, except per2 which occurred earlier at ZT 2.   As noted, in 
both the high expression and the rhythmic profiles was evident, there was again an 
increase in the general level of clock gene expression on D8 compared to that of D1, 





Figure  5.7 This pooled sample, sample #5, shows relatively arrhythmic gene expression of all the clock genes, 




5.3.2.5 THE per1 GENE EXPRESSION 
It was noticed that the expression profile of per1 differed from that of the other clock 
genes on D1, the acrophase occurring earlier than those of the other clock genes in 
both the high expression profile (sample #4) and the rhythmic profile (sample #1), and 
with its level of general gene expression decreasing from D1 to D8, reverse to the 
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trend that was observed with the other clock genes in the arrhythmic profile (sample 
#5).  The 24-hour expression profiles of per1 on D1 and D8 were therefore examined 
to see if they bucked the trend in all of the samples.  This did indeed turn out to be the 
case.  The general level of gene expression on D8 was found to be lower than that on 




Figure  5.8 24-hour per1 gene expression in the different LGC samples, on D1 (green) and D8 (orange). 
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5.3.2.6 CHANGES IN ACROPHASE 
Differences in the acrophase of the 24-hour profiles of the different clock genes were 
analysed in all of the samples, from D1, D8 and D8 with hCG treatment (Figure  5.9).  
The differences in the acrophases may represent phase shifts in the circadian rhythms 
of the clock genes in the LGCs.  All of the clock gene acrophases were phase delayed, 
occurring later on D8 than they did on D1.  This phase delay is likely to be bona fide 
as the standard errors of the mean, indicated by the error bars generally do not extend 
beyond the line that separates phase advances from phase delays (Figure  5.9).  This 
line is demarcated by the dotted line that lines up with zero on the y axis. 
 
Treatment with hCG on D8 phase advanced the acrophases and putative circadian 
rhythms of all of the clock genes (Figure  5.9).  This phase advance is again, likely to 
be bona fide, as the standard errors of the mean, indicated by the error bars, do not 
extend over the line between phase advance and phase delay.   
 
Whether the hCG treatment restored the timing of the D8 acrophases to that of D1 
was then assessed (Figure  5.9).  If the hCG treatment advanced the acrophases to the 
same degree as they were delayed from D1 to D8, no change should be observed 
between the acrophase timing on D8 hCG and D1.  This was generally the case.  
Although, not all the data points fell exactly on the zero-line that indicated no change, 
the standard errors of the mean all, except that of per1, fell across this line.  Therefore 
there is no net change in the timing of the acrophases of the circadian rhythms of clk, 
bmal1, per2 and cry1 between D8 hCG and D1.  The hCG treatment did effectively 
restore the timing of the acrophases of these genes to that of D1.  The per1 gene is the 





Figure  5.9 Changes in acrophase of 24-hour clock gene expression from LGCs between days one (D1) and eight 




5.3.2.7 CHANGES IN MEAN 24-HOUR GENE EXPRESSION 
LEVELS BETWEEN D1, D8 AND D8 hCG 
There appeared to be differences in the degree to which the levels of gene expression 
of the clock genes in the LGCs changed across the 24-h profiles, between D1 and D8.  
The mean levels of gene expression were calculated for all the 24-hour gene 
expression profiles of all of the clock genes, on D1 and D8, with and without hCG 
treatment.  These were then compared to see if any consistent changes could be 
detected between the means of the D1 and D8 circadian rhythms.  It is assumed that 
the greater the mean level of gene expression, the more robust the gene expression, 
and the more reliable the result.  The comparison of the mean values between D1 and 
D8 revealed that there was effectively no change in the general level of the bmal1, 
per1 and per2 gene expression (Figure  5.10).  This is demonstrated by the extension 
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of the standard errors of the mean beyond the boundary that demarcates the increase 
from the decrease in the general amount of gene expression.  This boundary can be 
seen in the graph as a dotted line, which lines up with zero on the y axis, indicating 
that there is zero or no change in the average level of gene expression.  The means of 
the clk and cry1 gene expression however increased after eight days in culture. 
 
The treatment of the LGCs with hCG on D8 increased the mean level of gene 
expression of all of the clock gene rhythms, excluding clk compared to D8 without 
hCG (as well as compared to D1) (Figure  5.10 and Figure  5.11).  The per2 gene was 
particularly affected by hCG treatment, although the large standard error of the mean 
indicated that there was a large variation in the extent of the increase.  The hCG-
induced increase of the level of the clock gene expression was sufficiently great that 
virtually all of the clock gene means were greater than those of D8 as well as those of 
D1.  The hCG therefore increased the general level of gene expression of the bmal1, 
per1 and per2 genes from those of D8, that had remained unchanged from those of 
D1, while increasing even further the level of the clk and bmal1 gene expression that 
had already increased after eight days spent in culture. 
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Figure  5.10 Changes in the average 24-hour level of clock gene expression in the LGCs between days one (D1) 






Figure  5.11 Histograms of the mean level of 24-hour gene expression of each of the clock genes on days one (D1) 
and eight (D1) of culture, with (D8 hCG) and without hCG (D8).  The horizontal bars represent differences that 




5.3.2.8 STATISTICAL ANALYSIS 
In order to further analyse the quantitative gene expression data, using statistics, an 
analysis of the variance (ANOVA) was conducted.  This involved the analysis of the 




One-way ANOVA assessed whether the amount of expression of one of the clock 
genes varied significantly across the 24-hour period, in all six samples, on either D1 
or D8, with or without hCG treatment.  No significant variances could be found in the 
24-hour gene expression profiles of any of the clock genes, during D1 or D8, with or 
without hCG treatment (Figure  5.12). 
 
Two-way ANOVA assessed whether the 24-hour gene expression variances of one of 
the clock genes varied significantly between D1 and D8, with or without hCG 
treatment.  The 24-hour variances of the clock gene expression profiles were not 




Figure  5.12 The data from the pooled and individual samples were placed into a single data set (n=6) and 
analysed statistically using one-way analysis of variance (1-way ANOVA) to ascertain whether the gene 
expression profile varied significantly across 24 hours, and using two-way analysis of variance (2-way ANOVA) to 
ascertain whether the 24-h profiles varied significantly between D1 (green), D8 (orange) and D8 hCG (red) for 
each clock gene.  The error bars refer to the standard error of the mean. 
 
 
Overall, there were no significant changes in 24-h clock gene expression of any of the 
measured clock genes, clk, bmal1, per1, per2 and cry1, after 1 day (D1) or 8 days 
(D8) of culture or with hCG treatment after 8 days (D8 hCG) of culture.  This is likely 
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to be due to the large standard errors of the mean, which indicate a relatively large 
variation in the levels of gene expression elicited by the different samples.  Despite 
this, trends could be observed.  The peak levels of gene expression across 24 hours 
tended to be delayed by eight days spent in culture, and this delay could be reversed 
by hCG treatment on the eighth day of culture.  The maximal differences between the 
peak and trough levels of clock gene expression across 24 hours on D1 and D8 were 
diminished by hCG treatment on D8.  The expression of the per1 gene tended to differ 




5.3.3 24-HOUR CLOCK GENE EXPRESSION IN LUTEAL 
FIBROBLAST-LIKE CELLS 
The clock genes: clk, bmal1, per1, per2 and cry1, were all expressed in the luteal 
fibroblast-like cells.  The 24-hour expression profiles varied greatly between samples; 
and a representative data set of one study is illustrated in Figure  5.13.  The circadian 
rhythmic expression was evident for all of the clock gene profiles.  Serum shock 
increased the amplitudes of the circadian expression of clk, bmal1, per2, cry1 and 
possibly per1.  The serum shock-induced increase in amplitude may indicate the 
successful resynchronisation of the cell-based circadian clocks with the luteal 
fibroblast-like cell populations.  The acrophases of clk, bmal1 and per2 coincided at 
ZT 14.  The serum shock did not alter the timing of these acrophases, nor did it appear 
to phase shift any of these circadian rhythms.  The acrophase of cry1 also occurred at 
ZT 14 without serum shock, but was phase advanced to ZT 10 by the serum shock.  
The acrophase of per1 occurred at ZT 22 after serum shock but the level of expression 
was very low compared to that of the other clock genes. 
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Figure  5.13 Graphs of clock gene expression, measured using fold change, in cultured luteal fibroblast-like cells 




All the five clock genes investigated: clk, bmal1, per1, per2 and cry1, were found to 
be expressed in the LGCs and the luteal fibroblast-like cells.  The 24-hour patterns in 
the level of mRNA expression of these genes were found to vary greatly between 
individual samples of the LGCs.  Although these 24-hour patterns were categorised 
into high expression, rhythmic or arrhythmic profiles, there was however, no 
significant change in the level of gene expression of any of the five clock genes, 
across 24 hours, on either D1 or D8, with or without hCG treatment.  The lack of 
statistical evidence supporting a change in the level of gene expression over the 24-
hour period however precludes the strict appellation of circadian gene expression to 
the clock gene expression profiles. 
 
It could be argued however that, even with the lack of statistical support, the gene 
expression that was observed in the LGCs is rhythmic.  This argument hinges on the 
consistent phase shifts of the putative acrophases in the 24-hour expression of all of 
the clock genes between D1 and D8 and between D8 with and D8 without hCG.  This 
>4 hour phase delay occurs consistently for all five clock genes over eight days 
between D1 and D8, and is compatible with the existence of an endogenous 
oscillation in the 24-hour expression of all of the clock genes.  Furthermore, this 
phase delay is reversed by hCG treatment, which phase advances the expression of all 
the clock genes, such that their putative acrophases are phase shifted by >4 hours.  
This hCG-mediated phase advance, in the opposite direction to the time-mediated 
phase delay, consistently appears to be of the same magnitude as the phase delay for 
each of the individual clock genes.  Thus, hCG reverses the effect of time on the 
phase, the actual timing, of the clock gene circadian rhythms. 
 
A constant oscillation time period, in effect, tau, can be calculated for these rhythms. 
Tau is often used in circadian physiology to describe a free-running period, the 
portion of time taken to complete one oscillation in the absence of entraining 
zeitgebers.  The average human tau is 24.2 hours (Czeisler and Gooley, 2007).  The 
tau in this case is not precisely free-running, but can still be calculated for the 
circadian oscillations, which are phase-responsive to hCG.  Tau is calculated here, 
 177 
based on the knowledge that the phase shifts by approximately five hours over the 
course of eight days, and presuming that the D1 oscillation was that of the entrained 
period and circadian, so 24 hours, rather than ultradian or infradian.  The tau 
therefore, of the LGC endogenous oscillation, is ~24.6 hours.  This indicates that 0.6 
hours, has been added every day, for eight days, to produce a >4 hour-delay in the 
timing of the clock gene expression in the LGCs.  It is notable that the period of the 
LGCs is, like the free-running tau of the human as a whole, slightly longer than the 
period of a geophysical day: 24 hours. 
 
The oscillations in the clock gene expression were however difficult to quantify in 
combination.  There was a relatively great range of expression profiles, in terms of 
timing of the acrophase, frequency and amplitude of the oscillations, as well as in 
terms of effect of time spent in culture and hCG treatment.  The extent to which the 
clock gene 24-hour expression profiles varied may be a real representation of the gene 
expression in the samples of cultured LGCs and luteal fibroblast-like cells.  This 
variability may arise from a population of cells, possessing cell-based clocks, which 
run autonomously of each other.  The autonomy of the endogenous clocks may be 
normally overrided by an entraining signal in the intact CL.  The requirement of 
extrinsic rather than intrinsic entrainment is a feature of peripheral clocks.  Looser 
coupling of the cellular circadian clocks is thought to confer greater flexibility, 
allowing these cell-based clocks to respond more rapidly and less noisily to temporal 
stimulus.  This enables the better integration and co-ordination of temporal 
information from and to the various other clocks and pacemakers around the body, in 
order to orchestrate their various temporally regulated processes into a harmonious 
and unified whole-body physiology. 
 
The human CL could therefore be a novel peripheral clock tissue.  Consider that each 
luteal cell in an intact CL contains a circadian clock, and that these clocks are able to 
run autonomously, and do so, in order to provide the constant synthesis and secretion 
of progesterone.  The gene of the StAR protein, which provides the rate-limiting step 
in steroid hormone production, has been reported to be rhythmically expressed, in a 
circadian fashion in poultry (Nakao et al., 2007).  StAR is involved in the transport of 
the steroid substrate, cholesterol, from the outer membrane of the mitochondria to the 
inner membrane of the mitochondria.  This is where cholesterol side chains are 
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cleaved to produce pregnenolone, which is an intermediate metabolite of the 
progesterone synthesis pathway.  The circadian expression of StAR has been 
proposed to be clock gene driven and is responsive to LH signalling.  This implies 
that there is a temporal component involved in the regulation of steroidogenesis.  
Time is often used to segregate biochemical processes that would be incompatible 
were they to occur simultaneously in the cell.  Therefore, it is possible that individual 
steroidogenic cells can synthesise P4 only at certain times, or only at a certain rate at 
certain times.  Undoubtedly, there is a wave-like pattern to the P4 concentrations that 
are secreted from the CL, which occurs as a result of pulsatile LH signalling to the 
CL.  However, this P4 secretion pattern is not pulsatile, nor is it circadian.  It would 
appear rather, that it is secreted relatively constantly.  The provision of a relatively 
constant concentration of P4 is probably crucial because a drop in P4 levels can result 
in increased uterine activity that can end gestation and cause the failure of the 
pregnancy (Mesiano, 2004).  P4 may even be involved in the regulation of the uterine 
endometrial clock genes, which are likely to be involved in the regulation of the 
proliferation, differentiation and function of the endometrium during pregnancy as 
well as during the non-conceptive menstrual cycle.  This is supported by evidence that 
P4 administration was able to synchronise the circadian rhythms of per2 in rodent 
uterine endometrial stromal cells in vivo (Hirata et al., 2008). 
 
It is hypothesised that clock genes function to regulate the rhythmic synthesis and 
secretion of P4 from individual luteal cells, such that the P4 output from the whole CL 
tissue is relatively constant.  It is probable that clock genes function to modulate the 
circadian expression and possibly also the post-translation modification of StAR, 
which in turn regulates the rhythmic synthesis of P4.  As there is no evidence of P4 
being stored in large amounts in the steroidogenic cells, it is likely that the P4 is thus, 
also rhythmically secreted by cells (Niswender et al., 2000).  The clock genes are 
therefore likely to also mediate the co-ordination of the rhythmic P4 secretion from 
individual cells, such that a relatively constant provision of P4 is produced by the CL 
tissue as a whole.  In order for there to be a constant provision of P4 from the CL, 
there must at any one time be a proportion of steroidogenic cells actively secreting P4.  
Thus, in order to ensure that the rhythmic cellular P4 output of the entire CL is kept 
relatively constant, in the face of pulsatile inputs such as LH, the individual 
steroidogenic cells must therefore time their putatively temporally regulated P4 
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synthesis and secretion, so that at any one time, there is a relatively constant 
proportion of the steroidogenic cell population secreting P4.  These necessarily 
discordant cellular clocks must therefore be co-ordinated to a certain degree, by 
extrinsic or intrinsic signals or perhaps a combination of both.   
 
A candidate signalling molecule that may co-ordinate the timing of the discordant 
luteal clocks is hCG, which has been reported to be released in a temporally regulated 
manner from placental tissue ex vivo (Barnea et al., 1992, Barnea and Kaplan, 1989).  
The putatively pulsatile hCG may act to resynchronise the luteal clocks, thereby 
facilitating the maintenance of co-ordinated temporal luteal steroidogenic function.  
However, the accepted wisdom is that hCG, unlike LH, is not pulsatily released.  It is 
however very possible that it interacts in another, as yet unknown, way with the luteal 
cell clocks, to mediate some temporal co-ordination.  It has been observed in the 
current study that hCG treatment of the LGCs on D8 at ZT 0 restores certain features 
to 24-hour clock gene expression, along with steroidogenic function.  The timing of 
the acrophases of all of the clock genes shifted from the first to the eighth day in 
culture.  The treatment of the LGCs on D8 with hCG however, returned the timing of 
these acrophases from the shifted D8 times to the previous D1 times.  It would appear 
therefore that the hCG treatment is effectively resetting the clock gene-driven timers 
in the LGCs.  The same could be true in the intact human CL of pregnancy.  The hCG 
treatment also affected the average 24-hour level of gene expression of the putative 
rhythms in the clock gene expression of all five genes.  The average amounts of gene 
expression were increased by the hCG treatment, which is consistent with the hCG 
synchronising the LGC clocks, so that they function more effectively and thus, 
collectively produce a higher level of gene expression. 
 
It is also notable that there was no real change in mean levels of bmal1, per1 and per2 
gene expression between D1 and D8.  D1 may mark the time during which the LGCs 
are maturing from, effectively, the early luteal phase to a time of full function.  D8 
may represent the time when the cells of an intact human CL start to decline, as they 
move from the mid-luteal to the late luteal phase.  The same level of clock gene 
expression on D1, which was sufficient for fully functional luteal P4 synthesis and 
secretion, may no longer be sufficient by D8 for the synthesis and secretion of P4 to 
the same concentrations.  The hCG treatment increased the level of gene expression in 
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all the clock genes, which corresponded to the resumption or maintenance of fully 
functional P4 synthesis and secretion to the same levels as those produced on D1.  It 
would therefore appear that the increased requirement for hCG that these LGCs 
exhibit over time may be related to the requirement for increasing levels of clock gene 
expression over time.  This may also explain the requirement for increasing amounts 
of hCG with time.  If a certain amount of hCG produced a corresponding amount of 
clock gene expression, then the need for increasing amounts of clock gene expression 
would require correspondingly increasing amounts of hCG.  In this way, the gradient 
of hCG concentrations needed to maintain the LGCs and the intact human CL may 
reflect the a gradient of increasing clock gene expression that is required by the LGCs 
and CL in vivo with time.   However, the LGC system may still be employed.  If these 
hypotheses were true, increasing levels of clock gene expression should be detected in 
the LGCs, the longer they are maintained in culture by sufficient, and therefore 
increasing amounts of hCG.  The increase in clock gene expression could also impact 
on the overall amount of P4 secretion, which has been observed to increase with time, 
in hCG-rescued LGCs that have been supplemented with LDL.  These cells have been 
observed to produce P4 concentrations greater than those of D1.  There may therefore 
exist a mechanism, where increasing P4 levels from the CL act to provide temporal 
information, in the form of a timer (accruing in time rather than oscillating in time), to 
the uterus to synchronise its endometrial clock gene expression, which then effects the 
provision of hCG in increasing amounts from the feto-placental unit to the CL, where 
the hCG resets the rhythmic expression of clock genes and where the temporal 
information from the hypothalamus can be integrated in the form of pulsatile LH.  In 
this way, the timing of the various temporally regulated processes of the reproductive 
tract can be co-ordinated and integrated with the timing in the rest of the body. 
 
There co-ordination of the putative discordant luteal clocks may also be intrinsically 
regulated by timing information emanating form the luteal cells themselves.  
Autocrine and paracrine interactions amongst luteal cells have already been shown to 
be crucial for luteal function (Duncan et al., 2009).  The response of the luteal 
fibroblast-like cells to serum shock indicates that these cells, which model luteal 
fibroblasts, are able to receive entraining signals and respond by increasing the 
amplitudes of their rhythmic clock gene expression.  The entrainment of cellular 
circadian clocks by serum shock can be reproduced in vitro by a variety of chemicals 
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and acute perturbations of the cell culture system (Schibler et al., 2003).  The luteal 
fibroblast-like cell response to serum shock is therefore unlikely to be restricted to 
serum shock, and is probably elicited in vivo by other signalling molecules.  This 
means that their clocks may be somewhat enslaved by the circadian outputs of the 
cells immediately around them.  If this were true of luteal fibroblasts in vivo, these 
cells may be well placed to integrate the temporal information emitted by 
neighbouring cells via paracrine signalling; cells such as other fibroblasts and 
steroidogenic cells.  Luteal fibroblasts are known to possess P4 receptors and P4 is 
known to be LH/hCG responsive (Maybin and Duncan, 2004, Duncan et al., 2005a).  
Furthermore, P4 is involved in paracrine signalling and has also been reported to 
entrain per2 expression in uterine endometrial stromal cells (Duncan et al., 2009, 
Hirata et al., 2008). 
 
The fibroblasts may also be able to emit temporally-entraining paracrine factors, 
which affect other fibroblasts and other cells of various luteal cell types.  It could be 
imagined therefore, that an auto-regulated system exists in the CL, co-ordinated by 
the variously timed cellular clocks, for the maintenance of loose temporal synchrony 
between cells.  The exceptional expression of per1 may also be involved in some way 
as it does not seem to be as robustly circadian or as responsive as the other clock 
genes, suggesting that it may have a stabilising influence on the luteal clocks, which 
might otherwise be too responsive.  The classic two-cell theory of œstradiol synthesis 
already establishes a precedent for the co-ordination of a crucial and complex 
biochemical process, using communication, which is essential, between two types of 
cell, within the CL (Johnson and Everitt, 2000).  It describes the process of œstrogen 
synthesis, which is performed jointly by the theca cells and granulosa cells of the 
ovarian follicle.  The theca-lutein and granulosa-lutein cells, derived from these same 
follicular cells, are thought to maintain this relationship, in addition to the 
independent granulosa-lutein cell steroidogenesis, which evolved when they acquired 
LH receptors.  This mechanism may also then be co-opted by the luteal cells for the 
establishment of communication networks between multiple cell types, which are 
used to provide temporal regulation of luteal function and lifespan. 
 
Although a link between circadian rhythmicity and steroidogenesis in the mammalian 
ovary has not yet been discovered, one has been revealed in the avian ovary (Nakao et 
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al., 2007).  The mature pre-ovulatory follicles of chickens develop synchronised clock 
gene rhythms in their granulosa cells, which regulate the rhythmic secretion of P4 and 
affect the timing of ovulation.  This circadian clockwork is not evident in the early 
ovarian follicle, indicating that it develops with the proliferation of the granulosa cells 
during follicular development, under gonadotrophin regulation.  Gonadotrophins may 
thus affect the expression of circadian clockwork.  The effect of hCG on the LGCs 
may therefore represent the first example of a similar link between circadian 
rhythmicity, steroidogenesis and gonadotrophins in the mammalian female 
reproductive system. 
 
Overall, the results of this chapter, though largely speculative, have been potentially 
very informative, though statistically robust corroboration would be preferred.  It may 
be that the variation proposed to arise from discordant cellular clocks arises from a 
functionally heterogeneous cell population, composed as they are of LGCs from 
different follicles at varying stages of maturity, which in some instances, have been 
obtained from more than one woman.  It could also be argued that the culturing of the 
LGCs abolishes the cell-to-cell communication channels that are clearly essential for 
the full function of the CL as a whole.  This argument could even be supported by the 
more robust circadian-like gene expression profiles observed in the confluent cultured 
luteal fibroblast-like cells.  It is possible that the increase in the level of clock gene 
expression and in the robustness of the putatively rhythmic gene expression in these 
cells, is due to the establishment of the cell-to-cell communication, which occurred as 
the cells were able to proliferate.  It is also notable that the there was no tissue-wide 
synchrony in the clock protein levels and cellular compartmentalisation observed in 
the intact CL in Chapter 2.  
 
One final point of interest was that there was also no antiphasic relationship in the 24-
hour clock gene expression profiles between the genes belonging to the negative limb 
and the positive limb of the circadian clock mechanism.  This may indicate that the 
time delay from the peak mRNA expression to the peak protein accumulation in the 
cytoplasm and nucleus varies for the different clock genes.  The regulation of the 
luteal clock may thus be largely post-translational.  This equivocal evidence coupled 
with the lack of statistical significance in the results of this chapter, means that it has 
not been possible to establish whether any of the five clock genes are expressed in a 
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circadian rhythm in the cells representing the human CL.  The findings of this chapter 
do however indicate that there is a likely interaction between the expression of the 
clock genes and luteal steroidogenic function, survival and lifespan, particularly with 
regards to the effect of gonadotrophin action.   
 
In summary, this chapter has demonstrated for the first time that: 
 
1. the clock genes: clk, bmal1, per1, per2 and chy1, are expressed in the human 
LGCs and luteal fibroblast-like cells; 
 
2. these genes appear to be rhythmically expressed across 24 hours; 
 
3. the clock gene expression in the LGCs appeared to be affected by time spent 
in culture and hCG treatment:  
 
a. with the timing of the acrophases of the apparently rhythmic clock 
gene expression becoming phase delayed after eight days in culture, 
and being phased advanced by hCG; 
 
b. with the mean amount of clock gene expression increasing in response 
to hCG treatment; 
 
4. the mean levels of rhythmic clock gene expression was increased by serum 
shock of the luteal fibroblast-like cells; 
 
5. the peaks in apparently rhythmic clock gene expression between the 
transcriptional activators (clk and bmal1) and transcriptional repressors (per1, 
per2 and cry1) were not  in antiphase in the LGCs. 
 
The question of whether the clock genes are circadian rhythmically expressed in 
the CL is still a crucial one which needs to be answered.  Therefore, another 
model was employed, one that samples intact corpora lutea, preserving the 
intercellular communication channels that may be crucial for luteal function and 
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for the transmission of temporal information in the regulation of the CL and its 
lifespan.  This is the focus of the next chapter. 
 
The question of whether the clock genes are circadian rhythmically expressed in the 
CL is still a crucial one that needs to be answered.  Therefore, another model was 
employed, one that samples intact corpora lutea, preserving the intercellular 
communication channels that may be crucial for luteal function and for the 
transmission of temporal information in the regulation of the CL and its lifespan.  
This is the focus of the next chapter. 
6 CLOCK GENE EXPRESSION IN THE 




It has not yet been possible to establish whether the clock genes in the CL are 
expressed in circadian rhythms and whether these rhythms segregate antiphasically, 
between the transcriptional activator genes: clk and bmal1 representing the positive 
limb of the circadian clock mechanism, and the transcriptional inactivator genes: 
per1, per2, cry1 and cry2 representing the negative limb of the circadian clock 
mechanism, which would indicate the presence of a circadian clock in this tissue.  As 
it was not possible to sample corpora lutea from women across a 24-hour time course, 
more readily available corpora lutea will be sampled from sheep. 
 
Sheep are a long-lived, diurnal mammalian species, which possess a seasonally 
regulated reproductive axis.  The Soay breed is particularly useful as it is relatively 
primitive and as such, still possesses much of the strict temporal regulation of 
reproduction that more commercial breeds have been outbred to lose.  The sheep 
species has been successfully used in many previous studies, modelling the 
reproductive axis and ovarian function (Spencer and Bazer, 2002, Campbell et al., 
2003). 
 
The sheep CL is generated in much the same way as it is in humans.  It is formed 
from the follicular cells after ovulation, which has occurred following a pre-ovulatory 
LH surge.  The follicular cells rapidly differentiate and proliferate and the tissue 
remodels to form a steroidogenically active CL, that secretes P4 (Niswender et al., 
2000).  The corpora lutea of sheep have a lifespan of approximately 14 ± 2 days.  This 
lifespan is regulated in a fundamentally different way from that of humans.  Humans 
employ a luteotrophic mechanism while sheep employs a luteolytic one, so pregnancy 
in humans is luteotrophic while in sheep, it is antiluteolytic.  The key signalling 
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molecule is hCG in humans and PGF2 in sheep.  Ovine P4 secretion inhibits uterine 
PGF2 release and with time, the endometrial tissue loses its sensitivity to P4 and so, 
PGF2 is increasingly secreted.  Thus, by virtue of its initial and continued secretion, 
P4 is considered the key regulator of luteal lifespan in sheep (Schams and Berisha, 
2004).   
 
It is not just the uterine endometrial cells that secrete PGF2; the CL itself secretes 
PGF2.  The effect of the luteal PGF2 however is unlike that derived from the 
endometrium.  The luteal PGF2 is luteotrophic during the early and mid-luteal 
phases.  Progesterone is again involved in regulating the PGF2 secretion, this time 
from the CL.  It has been observed that the inhibition of P4 has produced opposite 
effects on PGF2 release, depending on the luteal phase.  Antagonism of P4 during the 
EL phase results in a reduction of luteal PGF2 secretion.  Antagonism of P4 during 
the mid-luteal phase however results in an increase in luteal PGF2 secretion 
(Skarzynski et al., 2001).  This apparently bimodal effect of P4 on luteal PGF2 clearly 
relates to its role in the regulation of luteolysis.  This bimodal effect seems dependent 
on luteal phase.  It follows then that the regulation of luteolysis and thus, luteal 
lifespan by P4 is dependent on the luteal phase and ergo, timing.  It is also possible 
that the exogeneous control of luteal lifespan, via the uterine and endometrial PGF2, 
is regulated in a time-dependent manner.  In other words, there could be a clock 
working at the level of the ovine uterus, endometrium and/or CL, that regulates the 
timing of the luteal lifespan.  This is however less likely to be the case in humans, 
where the clock-control is more likely to be intrinsic to the CL alone.  Despite the 
potential, the timing mechanism itself is likely to be conserved. 
 
It must also be considered that the sheep is a seasonal animal which is only 
reproductively active during the winter months.  Therefore, the animals in this study 
were kept under short day conditions to maintain the ovarian cycle.  A well-known 
observation in sheep is the relay of photoperiodic information via the 24-hour 
melatonin rhythm.  The melatonin signal is decoded in the brain and PT of the 
pituitary gland to affect the reproductive axis (Malpaux et al., 1999, Hanon et al., 
2008).  In the PT, the melatonin is able to directly activate cry1 expression (Lincoln, 
2006).  Melatonin receptors have also been observed in luteal cells, though no clear 
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role for melatonin has been elucidated in the CL (Woo et al., 2001, Soares et al., 
2003).  This study therefore measured the melatonin concentration in the sheep, to 
investigate whether there was a temporal relationship between melatonin and clock 
gene expression in the CL. 
 
This chapter aims to:- 
 
1. characterise the expression of the clock genes: bmal1, per1, per2, cry1 and 
crye2 in the ovine CL across 24 hours and establish whether the phase 
relationships between the 24-hour gene expression profiles were consistent 
with a classical circadian clock; 
 
2. determine whether the expression of clock genes, bmal1, per1, per2, cry1 and 
cry2 would differ between early and late luteal phases, either in terms of:- 
 
 overall levels of gene expression  
 phase shifts and/or phase relationships of gene expression; 
 
3. investigate the relationship between luteal clock gene expression and 
melatonin secretion to see if cry1 activation was consistent with that of a 
melatonin-target tissue, such as the PT. 
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6.2 MATERIALS AND METHODS 
6.2.1 ANIMALS 
All animals were treated and experimental procedures performed in compliance with 
the UK Animals Scientific Procedures Act of 1986.  
 
Forty-five pubertal, yearling ewes of the Soay breed of feral sheep (16.54 ± 17.75 kg 
body weight), born in April and May were allowed to live and graze freely outdoors 
for the summer months.  They were then brought indoors in November and housed in 
a barn area.  They were then moved to light-controlled rooms at the start of 
December.  They were maintained under short days (LD 8:16), mimicking the winter 
photoperiod.  The time of daily lights-on (ZT 0) was constant at 0800 h (CT 8). They 
were fed a standardised diet of grass pellets: 500 g per animal (Vitagrass, Cumbria) 
daily, 1 h into the light phase (ZT 1). Hay and water were available ad libitum.  White 
fluorescent strip lights provided approximately 160 lux at the animals’ eye level 
during the light phase, whereas dim red light of less than approximately 5 lux was 
provided during the dark phase.  Temperature in the animal rooms was regulated with 
a variable airflow system and heating to maintain the ambient temperature between 10 
and 20°C.  Spontaneous locomotor activity was recorded every 10 min by using 
infrared sensors with a Mini Mitter VitalView recorder (Mini Mitter, Sunriver, OR) 
that plotted actograms. 
 
The reproductive cycles of the sheep were synchronised using exogeneous PGF2, 
which provides a mechanism of inducing luteal regression.  The use of PGF2 and 
progestogen for the synchronisation of ovine reproductive cycles is routinely 
practiced.  This study achieved synchronisation between animals using two cycles of 
PGF2 and progestogen treatment, with the sheep becoming synchronised with each 
other to within two days.  From mid-winter (January), the Soay ewes were injected 
intramuscularly with 0.4 ml of PGF2, three times with 14-day intervals, to induce and 
thus synchronise ovulation and œstrous cycles.  To further potentiate the synchronised 
entry into the breeding season, the ewes were primed with intravaginal P4 sponges for 
12 days prior to the first PGF2 injection.  The removal of the sponges just before 
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PGF2 administration causes a dramatic fall in P4 levels, which precipitate hormonal 
events that lead to the onset of œstrus within the following 36-48 h.  The ram effect 
was also employed, where a sexually active, vasectomised ram was introduced into 
the same housings as the ewes.  The ram effect consists of male pheromones, released 
from sebaceous and scent glands in the skin, inducing a rapid increase in the 
frequency of pulsatile luteinising hormone secretion, which in turn, promotes the 
entry into œstrous.  Blood P4 concentrations were measured using RIAs to confirm the 
synchronised, sexually active status of the ewes.  Melatonin RIAs were also 
performed, using blood samples collected at ZT 2 – 3 during the subjective day, to 
establish the circadian status of the ewes.  The RIAs were routinely performed using 





Ovulation occurs 72 h after the PGF2 treatment followed by the formation of the CL 
over the next 12 days.  Approximately half the sheep were killed on Day 3 of the 
luteal phase, called the early luteal (EL) phase.  The remainder were killed on Day 10 
of the luteal phase, called the late luteal (LL) phase.  The ewes were killed by 
pentobarbital injection into the jugular vein.  On both occasions, groups of four 
animals were sampled at four-hourly intervals, over 24 hours, starting at ZT 3.  
Immediately before killing, a blood sample was collected from the jugular vein with a 
syringe or Vacutainer® (BD, Oxford, UK).  This was heparinised and centrifuged 
immediately after collection, and used for the measurement of P4 and melatonin 
concentrations by RIA.  The sheep killed during the dark phase of the LD cycle were 
killed without the lights on.  An opaque black bag was placed over the head after 
death and remained in place until the brains were dissected from the skulls, to prevent 
any possible effect of light.  The animals were weighed before removal of the ovaries.  
Not all of the sheep possessed a CL, which resulted in a n number of two for one of 
the time points: ZT 23 during the EL phase.  The other n numbers during both EL and 
LL phases are also listed, in Table  6.1. 
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Zeitgeber time EL phase sample n numbers LL phase sample n numbers 
3 4 4 
7 3 4 
11 3 4 
15 4 4 
19 3 5 
23 2 5 
Table  6.1 The n numbers of CL sampled at each 24-h time point during the EL and LL phases.   
 
It is noted that the n of 2 can not provide a meaningful standard error of the mean, 
despite the presence of error bars for this time point in the graphical data presented in 
the Results section of this chapter.   
 
The resected ovaries containing a CL were cut in half, so that the CL was also halved.  
The ovary halves were snap frozen on dry ice and once frozen, stored at -80oC.  
RNase inhibitor solution was used on all surfaces and surgical instruments to help 
preserve the ovarian RNA.  Care was taken to clean surfaces and surgical instruments 
between samples in order to avoid cross-contamination.   
 
Pieces of adrenal gland and liver tissue were also randomly sampled from two sheep.  




6.2.3 TOTAL RNA EXTRACTION 
To measure clock gene expression, total RNA was purified from homogenised luteal 
tissues using an RNeasy® Micro RNA extraction kit (Qiagen Ltd, West Sussex, UK) 
using the Total RNA Isolation from Animal Tissues spin protocol with the on-column 
DNase treatment (Qiagen Ltd, West Sussex, UK).  A piece (5 mg) of each CL sample 
was thawed in 300 μl of Buffer RLT containing 1% β-mercaptoethanol, then 
disrupted and homogenised twice in an electronic Qiagen Tissue Lyser (Qiagen Ltd, 
West Sussex, UK), set at 10 000 revolutions per minute (rpm) for 3 min at room 
temperature.  RNase-free water (590 μl) was then added to the sample.  The 
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homogenate was pipetted into a sterile 2 ml microfuge tube.  Proteinase K (Qiagen 
Ltd, West Sussex, UK) (10 μl) was then added to the homogenate and mixed 
thoroughly by pipetting.  The homogenate was incubated with the enzyme for 10 min 
at 55oC.  The sample was then centrifuged at 8 000 x g at room temperature.  The 
supernatant was carefully pipetted into a sterile 2 ml microfuge tube and the pellet 
discarded.   
 
Thereafter, 100% ethanol (450 μl) was added to precipitate the RNA.  The sample 
(700 μl), including any precipitate that had formed, was then carefully pipetted into an 
RNeasy MinElute Spin Column in a 2 ml collection tube.  The tube was then 
centrifuged for 15 s at 8 000 x g.  The RNA was now bound to the silica-gel 
membrane in the RNeasy MinElute Column.  The flow-through was discarded. 
 
Buffer RW1 (350 μl) was then added to wash the RNeasy MinElute Spin Column.  
The tube was centrifuged for 15 s at 8 000 x g and the flow-through discarded.  The 
RNA was then treated with deoxyribonuclease (DNase) to remove any template DNA, 
using a Qiagen RNase-free DNase set (Qiagen Ltd, West Sussex, UK).  Next, 10 μl of 
DNase I stock solution (Qiagen Ltd, West Sussex, UK) was mixed gently with 70 μl 
of Buffer RDD, then added directly onto the RNeasy MinElute silica-gel membrane.  
The DNase was left to work in the column for 15 min at room temperature.  The 
column was then washed by adding 350 μl of Buffer RW1 to the column and 
centrifuging for 15 s at 8 000 x g.  The flow-through was discarded. 
 
The column was transferred into a new 2 ml collection tube.  Buffer RPE (500 μl) was 
then pipetted into the column and centrifuged for 15 s at 8 000 x g.  The flow-through 
was discarded.  The silica-gel membrane was then dried by the addition of 500 μl of 
80% ethanol to the column, which was then centrifuged for 2 min at 8 000 x g.  The 
flow-through and collection tube were discarded.  The column was then dried more 
thoroughly.  It was transferred to a new 2 ml collection tube.  The cap was left open 
and then the tube centrifuged at maximum speed for 5 min in a bench 
microcentrifuge.  The flow-through and collection tube were discarded. 
 
The RNA was then eluted.  The column was transferred to a 1.5 ml collection tube.  
RNase-free water (30 μl) was pipetted directly onto the centre of the silica-gel 
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membrane.  The tube was closed and left to incubate on ice for 10 min.  The tube was 
then centrifuged for 1 min at maximum speed on the bench centrifuge.  This step was 
repeated with a second 30 μl volume of RNase-free water.  The RNA was then 
quantified on an Agilent 2100 Bioanalyzer (Agilent Technologies UK Ltd, 
Wokingham, Berkshire, UK).  RNase-free water was added to the RNA to achieve a 




6.2.4 RNA QUANTIFICATION 
RNA extracted from the ovine corpora lutea was quantified using an Agilent RNA 
6000 Nano LabChip® kit (Agilent Technologies UK Ltd, Wokingham, Berkshire, 
UK) on an Agilent 2100 Bioanalyzer (Agilent Technologies UK Ltd, Wokingham, 
Berkshire, UK).   
Each RNA (1 μl) sample and an Agilent RNA 6000 Nano Marker ladder (1 μl) were 
denatured by heating at 70oC for 2 min before rapidly chilling on ice.  The RNA 
samples and ladder were loaded into an Agilent RNA 6000 Nano LabChip containing 
microfluidic gel freshly mixed with fluorescent dye.  The dye binds to nucleic acids 
and so allows the fluorescent detection of the RNA fragments, as well as any 
contaminating template DNA.  Each LabChip is made up of an interconnected set of 
micro-channels that are used to separate the nucleic acid fragments, based on their 




6.2.5 PREPARATION OF COMPLEMENTARY DNA BY 
REVERSE-TRANSCRIPTION 
To generate cDNA, the RNA was batch reverse transcribed using GeneAmp® RNA 
PCR Kit (Applied Biosystems, Warrington, UK) with random hexamers.  Total RNA 
(2 500 μg) was added to a reaction mix containing 1x RT Buffer, 5 mM MgCl2, 1 mM 
dNTPs, 1.25 µ M random hexamers, 1 U µl-1 recombinant RNasin® RNase inhibitor 
and 1 µl recombinant MuLV reverse transcriptase in a final reaction volume of 50 µl.  
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The reverse transcriptions were performed in duplicate, with positive controls using 
ovine adrenal gland and liver RNA.  Negative controls comprising reactions 
performed without the addition of template RNA as well as using 3-5 randomly 
selected test samples with a reaction mix lacking reverse transcriptase were included.  
The reactions were performed duplicate. 
 
The samples were incubated at room temperature for 10 min.  They were then heated 
to 42oC for 45 min in order to provide the optimum temperature for enzymatic action.  
The reaction was then stopped and the enzyme denatured by incubating at 95oC for 10 
min.  The resulting cDNA was stored short-term at 4oC or long-term at -80oC until 




6.2.6 PRIMER AND PROBE DESIGN 
The nucleotide sequences of the clock genes were obtained from the NCBI GenBank 
nucleotide database (http://www.ncbi.nlm.nih.gov/) and ENSEMBL database 
(http://www.ensembl.org/index.html.).  This database lists sequences by ascribing 
them Accession Numbers.  Primers were designed as standard using primer design 
software.  The software used was Primer Express™ (Applied Biosystems, 
Warrington, UK).  Primers were designed with various criteria in mind.  For one, the 
guanine-cytosine (GC) content of the sequences were not to exceed 30-80% as this 
would make the primers anneal too unspecifically to itself forming primer-dimers as 
well as binding unspecifically to the template cDNA.  Runs of four or more identical 
nucleotides, particularly guanine, were also avoided for the same reason.  The Tm and 
annealing temperatures were kept in the range of 58-60oC.  The number of guanines 
or cytosines or both were limited to two or less in the last five bases at the 3’ end of 
the primer sequences.  The forward and reverse primers were designed to anneal as 
closely to the probe on the template as possible without overlapping it. 
 
The probes used to quantify the clock gene expression were designed to be TaqMan® 
MGB™ probes.  These probes incorporate a 5’ reporter dye and a 3’ NFQ. The NFQ 
produces a lower background signal, which increases the precision of the gene 
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expression quantitation. The MGB moiety works by stabilising the probe when it is 
hybridised and thus raises its Tm so that it is less likely that the fluorescence is 
unquenched by anything but the endonuclease activity of the Taq polymerase. 
 
Primers and probes were then checked for specific binding by using the NCBI 
BLAST, available online at http://blast.ncbi.nlm.nih.gov/Blast.cgi.  This tool enables 
the identification of regions that are the same or similar between nucleotide 
sequences.  It does this by mining genome and other nucleotide databases which are 
published online, using a search-term sequence.  To minimise amplification of 
genomic DNA, the primers and probes were designed to span intron sequences where 
possible. The sizes of the PCR products were designed to be less than 250 bp to 
optimise the real-time quantification of the amplified DNA during RT-PCR. 
 
As many of the clock genes have different RNA transcripts, the primer sequences 
were compared to these transcript sequences.  This ensured that the PCR products 
would be of consistent size and that, as much as possible, the total transcript 
expression of each gene would be measured.  The primers were also checked to see if 
they were intron-spanning in all the transcripts.  Transcript sequence data was 
obtained as standard from the Ensembl database using the Ensembl Genome Browser, 
available online at http://www.ensembl.org/index.html. 
 
The ovine and bovine clock gene accession numbers and number of transcripts per 
gene are listed below (Table  6.2):- 
 
 
GENE ACCESSION NUMBER NUMBER OF TRANSCRIPTS 
oper1 AF044911 1 
oper2 AY253914 1 
ocry1 AY275673 1 
bcry2 ENSBTAG00000021223 1 
bbmal1 ENSBTAG00000013029 2 
bclk ENSBTAG00000001272 2 
ogapdh AF030943 1 
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Table  6.2 List of ovine and bovine clock gene accession numbers and number of transcripts per gene. 
 
 
Where there was more than one transcript, primers designed to amplify both 
transcripts simultaneously were designed.  An internal control PCR reaction was 
required to run in duplex with the PCR amplification of the gene of interest.  The 
housekeeping gene: glyceraldehyde-3-phosphate dehydrogenase (gapdh) was initially 
tested as an internal control.  It is used more routinely than ribosomal 18S in clock 
gene experiments of this nature.  The ovine gapdh had also been independently 
validated to be unchanged, either by circadian time or photoperiod (Kubista et al., 
2006).  The test of gapdh versus 18S showed that they were equally good.  It was 
decided that 18S would not be used although it had been used previously in the 
experiments with the luteinised granulosa cells to provide a reliably detectable level 
of gene expression.  The CT of the gapdh reaction was also not predicted to be too 
distant from that of the clock genes in the ovine corpus luteum. The gapdh primers 
and probe were commercially available as a TaqMan® Gene Expression Assay 
(Applied Biosystems, Warrington, UK).  They were fluorescently labelled with the 
VIC dye and are used in conjunction with an MGB probe.  
 
The primer and probe concentrations were then optimised.  The optimal 
concentrations for the primer pairs were determined using a range of concentrations.  
The primers were used in ratios of 1:1, 3:1, 6:1 and 18:1 reciprocally between the 
forward and reverse primers.  The Tm was also varied ± 2
oC.  The optimal probe 
concentrations were then optimised by titrating against the primer pairs at optimal 
concentration, to ensure that the probe does not limit the fluorescence in the PCR due 
to its more abundant template: gapdh cDNA.  The primers and probes were performed 
in singleplex PCRs initially then in duplex PCRs which included the internal control 
primers and probes.  The optimal conditions resulted in the lowest CT value without 
excess primer or probe.  These PCRs were performed with serial dilutions of cDNA 
template, producing standard curves that added further validation of the specificity of 





Figure  6.1 TaqMan® amplification plot of the oper1 real-time PCR product concentration detected using an 
unquenched flourescent FAM dye signal, from a PCR duplexed with og6pdh, which was performed in triplicate 
with serially diluted cDNA.  The red line demarcates the CT threshold.  The inset is the standard curve plotted 





Figure  6.2 TaqMan® amplification plot of the og6pdh real-time PCR product concentration detected using an 
unquenched flourescent VIC dye signal, from a PCR duplexed with oper1, which was performed in triplicate with 
serially diluted cDNA.  The red line demarcates the CT threshold.  The inset is the standard curve plotted using the 




Figure  6.3 Standard curve of the difference between the duplexed oper1 and og6pdh PCR CT values (CT) using 
serial dilutions of cDNA. 
 
 
The primer and probe sequences and PCR product sizes are listed below (Table  6.3):- 
 
 
GENE FORWARD PRIMER 5’-3’ REVERSE PRIMER 5’-3’ PROBE 5’-3’ SIZE
oper1 ccgtgtgccatggacatgt aaccaggacaccttctccgtg cacggagccggtgtcctggtt 93 bp 
oper2 agggcatcacctctgagttca ttgtggccgctgtgtcc cgtgaagaatgtggatatg 59 bp 
ocry1 ggtggagaaactgaagcacttaca aagaaaagcttgggtggcaa ttggaaaggcatttgg 64 bp 
bcry2 ccgagssctcgcatactctctat ctgaatgggcagaagccg cctggacaagatcat 62 bp 
bbmal1 ccctcacggaaggttagaataca aaatgcaagggaagctcacag caccaaggaagaataa 66 bp 
bclk ttaatgctagaggctcttgatggtt tgtgtctgagagtgtaacttcattgc ttttttagcaatcatgacagatg 88 bp 
ogapdh acgctcccatgtttgtgatg ctcaagattgtcagcaatgcct tgaaccacgagaagtat 71 bp 




The primers were synthesised by Applied Biosystems (Warrington, UK).  They were 
validated by performing duplex qRT-PCR with serial dilutions of adrenal and liver 
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RNA.  The ΔCT values were then plotted on the y axis against a logarithmic to the 
base 10 scale of the RNA concentration.  A line of best fit was then fitted to the 
values plotted.  An R2 value was then obtained from the equation describing the 
gradient of the best fit line.  The R2 values were less than 0.1, indicating that any 
gradient in the best fit line was not significant.  This meant that the CT values did not 
significantly differ between PCR reactions of the serially diluted template cDNA. 
 
All the PCR products were sequenced using ABI PRISM Big Dye Terminator 
Sequencing Kits (Applied Biosystems) to confirm that the sequence of the PCR-
amplified fragments matched that of the gene to which the primers were designed.  
However, the PCR products were too small in all cases, except for oper1, to be 
sequenced directly.  They therefore would have to be cloned into plasmids to produce 
longer plasmid-preparation DNA for sequencing.  Alternatively or additionally, 
several of the products contained restriction endonuclease cleavage sites, which once 
cleaved by endonuclease treatment, would produce products of known size that may 
be separated and sized using a 4% agarose gel electrophoresis.  It was decided that 
these not be done; that the specificity of the primer pair and MGB probe combination 
would suffice for confirming the specificity of the amplification reaction.  This was 
decided because the cloning would be time-consuming and time was restricted.  The 
endonuclease reaction would be less time-consuming but had a lower chance of 
success.  The PCR products were already very small and so cleaving them might 





6.2.7 REAL-TIME QUANTITATIVE REVERSE TRANSCRIBED 
POLYMERASE CHAIN REACTION USING THE APPLIED 
BIOSYSTEMS TAQMAN SYSTEM  
Real-time qRT-PCR was performed using, using a two-step RT-PCR protocol, in the 
Applied Biosystems TaqMan system, which was comprised of the TaqMan 
3700HT instrument with reagents from the AmpliTaq Gold® Fast PCR Master Mix 
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kit.  This system follows the standard principles behind real-time qRT-PCR, as 
described in the General Materials and Methods.  It uses quenched fluorescent probes 
that hybridise between the forward and reverse primers and which become 
unquenched when cleaved by the nuclease activity of the polymerase during the PCR 
amplification process.  The amount of fluorescence detected is used to monitor the 
amount of template amplification.   
 
The duplex qRT-PCR reaction was made up of 1.5 μl cDNA, 1x AmpliTaq Gold® 
Fast PCR Master Mix, UP, 1.125 μM each of forward and reverse custom primers, 
0.75 μM custom probe, 0.02 μM each of forward and reverse 18S primers, 0.08 μM 
18S probe to a final reaction volume of 25 μl.  The AmpliTaq Gold® Fast PCR 
Master Mix, UP is a solution containing hot start Taq polymerase, dNTPs, magnesium 
and buffer.  It is used in fast PCR reactions, which take approximately 40 min rather 
than the standard 2 h.  Reactions were loaded into 96-well plates and the PCRs 
performed in a TaqMan 3700HT instrument, using a fast protocol.  Complementary 
DNA from ovine adrenal gland and liver were used as positive controls.  Negative 
controls included reactions omitting the template which was replaced by nuclease-free 
water.  PCR reactions were performed in triplicate with duplicate cDNA. 
 
The CT values were then used to calculate the relative gene expression of each gene of 
interest, using the second derivative method with the adrenal gland positive control as 
the reference sample (Andersson et al., 2005, Lincoln et al., 2002). 
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6.3 RESULTS 
6.3.1 24-HOUR PROGESTERONE CONCENTRATIONS IN THE 
EARLY AND LATE LUTEAL PHASES 
The blood P4 levels were significantly increased from the EL to the LL phase (Figure 




Figure  6.4 24-hour profiles of blood progesterone concentrations during the early and the late luteal phases.  The 
EL concentrations were compared with the LL concentrations using Student’s t-test.  The error bars refer to the 
standard error of the mean. 
 
 
This appropriate characterisation of the luteal phases was further supported by the 
macroscopic appearance of the corpora lutea when sampled.  The corpora lutea 
contained both granulosa-lutein cells, better referred to as large lutein cells (LLC) in 
sheep and theca-lutein cells, better referred to as small lutein cells (SLC) in sheep, 
which were derived from the follicle, and in the sheep, were not organised in layers as 





6.3.2 24-HOUR CLOCK GENE EXPRESSION IN OVINE 
CORPUS LUTEUM 
The expression of all five clock genes: per1, per2, cry1, cry2 and bmal1 were 
revealed in the ovine CL (Figure  6.5). 
 
During the EL phase, the expression of bmal1, per1, cry1 and cry2 did not vary 
significantly over the course of 24 hours and were therefore, not circadian.  The P 
values were all greater than 0.1 (P>0.1): bmal1 P=0.616, per1 P=0.610, cry1 P=0.150 
and cry2 P=0.156.  The expression of per2 however, was robustly rhythmic, peaking 
at ZT 11 with its nadir ZT 3 (ANOVA P=0.037). 
 
During the LL phase, the expression of bmal1 (P=0.014), per1 (P=0.013), cry1 
(P=0.007) and cry2 (P=0.004) were discovered to be circadian.  The one-way 
ANOVA indicated that the amount of gene expression, of each of these genes, varied 
significantly across the 24 hours.  Conversely, the previously circadian expression of 
per2 was now no longer circadian.  One-way ANOVA of the 24-hour gene expression 
profile in the LL phase yielded a P value of 0.177, which was more than the 0.05 
significance threshold (P>0.05).  The circadian rhythm of bmal1 was seen to peak at 
ZT 19, in conjunction with the acrophases of cry1 and cry2.  The expression of per1 
peaked 16 hours earlier, at ZT 3.  The peak amount of per2 gene expression also 
occurred at ZT 3.  The nadirs of these rhythms converged less than the acrophases did 
between the clock genes, with bmal1 and cry2 at their lowest at ZT 7.  The nadir of 
the per1 rhythm was ZT 15, while that of cry1 was at ZT 3.  The phases of the 
circadian rhythms in the LL phase did not appear to be antiphasic between the 
transcriptional activator, bmal1 and the other, transcriptional inactivator, clock genes.  
The curve of the bmal1 circadian rhythm appeared to most closely resemble that of 
per1, while the two cry genes, appeared to be relatively similar.  They were certainly 
more similar to each other than they were with either of the other two rhythmic genes. 
 
The general level of gene expression of each clock gene was comparable between the 
EL and LL phases.  The EL per2 and cry1, along with the late luteal cry1 profiles 
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demonstrated the highest levels of gene expression.  These were all in the range of 
1500-fold higher than the baseline, which was considerably greater than that of the 
other 24-hour profiles.  The late luteal per2 expression profile, though not circadian, 
was also relatively high, at an approximate 500-fold change, while the remaining 




Figure  6.5 Graphs showing the amounts of gene expression of bmal1, per1, per2, cry1 and cry2 in the ovine CL, 
across 24-h, during the early (EL) and the late (LL) luteal phases.  The gene expression was quantified using real-
time qRT-PCR, measured in fold change and normalised to ogapdh.  The data were statistically analysed for 24-
hour variance using 1-way ANOVA assuming normal distribution and the P values indicated next to the 
corresponding graphs.  The shaded area demarcates the night time dark phase.  The error bars refer to the 




The 24-hour clock gene expression profiles were then compared between the EL and 
the LL phases, to see whether there was a significant difference between the circadian 
gene expression of the clock genes between the two luteal phases (Figure  6.6).  Two-
way ANOVA was used to statistically compare the two sets of gene expression 
profiles.  Although the expression of bmal1 became circadian in the LL phase, it was 
not sufficiently divergent from the 24-hour profile of the EL phase, which did not 
vary significantly across the 24 hours (P=0.209).  The emergence of the per1 
circadian rhythm in the LL phase though, was significant, although it only just fell 
below the 0.05 significance threshold (P=0.0497).  The loss of the circadian rhythm in 
per2 expression from the EL to the LL phase was also significant, and highly so at 
P=0.001.  The EL and LL phase 24-hour profiles of cry1 gene expression were 
strikingly similar, and sure enough, proved to not be significantly different (P=0.593).  
The cry2 gene expression profiles however, were significantly different between the 





Figure  6.6 Graphs 
showing the amounts 
of gene expression of 
bmal1, per1, per2, cry1 
and cry2 in the ovine 
CL, across 24-h, during 
the early (EL) and the 
late (LL) luteal phases.  
The gene expression 
was quantified using 
real-time qRT-PCR, 
measured in fold 
change and normalised 
to ogapdh.  The 24-
hour clock gene 
expression profiles 
were analysed for 
change between the 
EL and LL phases 
using 2-way ANOVA.  
The shaded area 
demarcates the night 
time dark phase.  The 
error bars refer to the 
standard error of the 
mean.  n=3-5.   
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6.3.3 24-HOUR MELATONIN CONCENTRATIONS IN THE 
EARLY AND LATE LUTEAL PHASES 
The blood melatonin concentrations were significantly higher at night (ZT 8 - ZT 
24/0) than during the day (ZT 24/0 - ZT 8) in both the EL (Student’s t-test P = 
0.0071) and the LL (Student’s t-test P = 0.0015) phases (Figure  6.7).  There was no 




Figure  6.7 24-hour profiles of blood melatonin concentrations during the early and the late luteal phases.  The 
daytime and the night time concentrations were compared using Student’s t-test. The shaded area demarcates the 
night time dark phase.  The error bars refer to the standard error of the mean. 
 
 
The 24-hour blood melatonin levels were then compared to the corresponding 24-hour 
clock gene expression levels in the EL and LL phases.  A correlation was observed 
between the melatonin and cry1 24-hour profiles, in EL and LL (Figure  6.8).  The 
peak melatonin concentration in the EL phase coincided with EL peak in cry1 gene 
expression, at ZT 19.  This was also the case in the LL phase, with the coincident 
peaks occurring also at ZT 19.  The timing of the nadirs in the melatonin 
concentrations and the level of cry1 gene expression were also roughly coincident, in 
both the luteal phases.  The LL nadirs of the melatonin levels and cry1 expression 
were at ZT 3, where they were coincident. 
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Figure  6.8 24-hour profiles of blood melatonin concentrations are shown as histograms.  Corresponding 24-hour 
profiles of cry1 gene expression in the ovine CL, during the early (EL) and the late (LL) luteal phases, are shown 
as line graphs.  The shaded area demarcates the night time dark phase.  The error bars refer to the standard error 
of the mean. 
 
 
Previous studies have measured 24-hour clock gene expression rhythms in the SCN 
and PT in the Soay sheep (Lincoln et al., 2002).  These provided two data sets with 
which the luteal data sets could be compared.  This comparison was only performed 




The correlation, observed in the current study, between the melatonin concentrations 
and the cry1 gene expression levels, have already been observed in other studies.  The 
correlation was initially noticed in the ovine PT and shown to be causally linked, by 
treatments with melatonin (Johnston et al., 2006).  This correlation, which is evident 
in the late luteal CL and the PT of the sheep, is not seen in the ovine SCN.  The 
circadian gene expression profiles of the other clock genes in the CL were also 
different to those in the PT and in the SCN (Figure  6.9).  The circadian expression of 
one of the genes that comprises to the positive limb of the circadian clock mechanism: 
bmal1 is expressed in antiphase with two of the genes comprising to the negative limb 
of the circadian clock mechanism: per1 and cry1 in the SCN.  This antiphasic 
relationship is maintained in the PT, between bmal1 and per1.  The expression of cry1 
in the PT is no longer antiphasic to that of bmal1.  It is now seen to peak at the same 
time as the blood melatonin concentration peak.  The antiphasic relationships between 
the genes of the positive and negative limbs of the circadian clock are not maintained 
at all in the late luteal CL.  In fact, by comparing the late luteal circadian expression 
profiles of the positive limb gene, bmal1 versus negative limb genes, per1, per2, cry1 
and cry2, it is possible to see that the 24-hour expression profiles of the same limb 





Figure  6.9 The comparison of melatonin and clock gene expression between the late luteal CL (CL LL), the PT 
and the SCN.  The 24-hour bmal1, per1 and cry1 gene expression data and blood melatonin concentrations have 
been converted into percentages of the maximum gene expression level (% Max), such that the acrophase of 
each circadian profile is 100 %.  These data have been converted for the purpose of normalising them for 
comparison.  These are depicted by the line graphs.  Corresponding blood melatonin concentrations from the 
same data sets are shown as histograms.  The error bars refer to the standard error of the mean. 
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6.4 DISCUSSION 
The 24-hour profiling of the clock gene expression in the ovine CL was determined.  
This procedure, where multiple individuals are used to constitute a single sampling 
time point in the 24-hour time course, has been previously used in numerous studies, 
to successfully define the circadian expression of clock genes in the ovine SCN and 
PT (Sladek et al., 2007, Johnston et al., 2006, Lincoln et al., 2005, Johnston et al., 
2004, Lincoln et al., 2002, Dupre et al., 2008).  The increased blood P4 levels from the 
EL to the LL phase indicated that the corpora lutea were producing lower amounts of 
P4 in EL than LL phases, as expected for the progression of the corpora lutea through 
the ovarian cycle.  The increased night time blood melatonin levels indicated that the 
sheep were expressing normal rhythmic melatonin production.  
 
The first aim was to establish whether the expression of the five selected clock genes: 
bmal1, period1, period2, cryptochrome1 and cryptochrome2 changed across 24 h, 
with a pattern reminiscent of a cell-based, endogenous circadian clock.  The results, 
notably for the LL phase, revealed significantly rhythmic expression of all the clock 
genes with the exception of per2, which was rhythmic in EL.    The phase 
relationships of the 24-hour profiles, which were only circadian for both the genes of 
the negative limb of the circadian clock mechanism and the genes of the positive limb 
of the circadian clock mechanism in the LL phase, were not consistent with those of a 
classical cell-based, endogenous circadian clock. 
 
The gene bmal1, belonging to the positive limb of the circadian clock feedback loop 
was circadianly expressed in the CL during the LL phase.  Its expression was 
relatively high in the late night, between ZT 19 – 23.  This contrasts with the situation 
in the ovine SCN, where bmal1 is maximal in the middle of the dark phase, and in the 
PT, where it is maximal during the early night (Figure  6.9).  This information, taken 
together, is consistent with the view that peripheral tissues have different circadian 
timing to that of pacemaker tissues, and are regulated independently and differentially 
by neural and endocrine signals (Nakamura et al., 2005, Carr et al., 2003, Peirson et 
al., 2006, Hirota and Fukada, 2004).  In the CL, the bmal1 had a very similar timing 
to that for cry2 which normally constitutes the negative limb of circadian clock 
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feedback loop.  In addition, the 24-hour profile of per1 and cry1 showed increases 
during the night or early morning, to peak at either ZT 19 or ZT 3 respectively.  There 
was no evidence of an inverse relationship between bmal1 and the other (negative 
limb) clock genes, in contrast to the pattern previously reported in the ovine SCN and 
PT.  Thus, the results are inconsistent with the idea that the classical circadian clock 
which drives bmal1 expression and feedback, unless the feedback time relationships 
at the level of the circadian clock proteins are very different from that normally 
associated with a circadian clock.  The results are more indicative of a situation where 
the clock genes are being driven by some additional, potentially extrinsic, factor. 
 
There was very clear evidence that the 24-hour profiles of the clock gene expression 
differed between the EL and the LL phases.  They differed in terms of circadian 
variation between the two luteal states, but not in the absolute level of gene 
expressions.  The analysis revealed that the profiles for all the clock genes except 
bmal1 were different between the EL and the LL phases.  These data suggest that the 
cells of the CL are progressing during development of the CL and that per2 behaves 
in a distinct fashion from the other clock genes.  The 24-hour expression of per2 
transforms from arrhythmic to rhythmic as the luteal cycle progresses from the EL 
phase to the LL phase, whereas the reverse occurs for the other clock genes examined.  
It may be that this apparent acquisition of circadian rhythmicity in the clock genes bar 
per2 is involved in the timing of luteolysis and therefore luteal lifespan.  The loss of 
the EL phase per2 circadian rhythmicity may also be part of the regulation of the 
luteal development and lifespan. 
 
Clock genes have been observed acquiring de novo overt circadian rhythmicity in 
gene expression.  Studies looking at clock gene expression during the ontogenesis of 
the rat liver showed the evolution of rhythmic clock gene expression from prenatal to 
postnatal stages (Sakamoto et al., 2002).  Sladek et al. found that all the clock genes 
they examined, per1, per2, cry1, clock, bmal1 and rev-erbα were expressed 
throughout their observation period from embryonic day 20 (E20), postnatal day 30 
(P30).  The rodent clock gene expression was measured from E20, through postnatal 
day 2 (P2), 10 (P10), 20 (P20), to adulthood on P30.  In general, all the canonical 
clock genes (not including rev-erbα) took till P30 to establish overtly circadian 
rhythms, with high amplitude, of gene expression.  The gene: cry1 was rhythmic with 
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a low amplitude at E20 but then was not rhythmic at subsequent developmental stages 
until P30.  The gene: bmal1 was rhythmic with a low amplitude at P2 but again, was 
no longer rhythmic by P10.  The rhythm was however re-established with greater 
amplitude by P20 and persisted with high amplitude till P30.  The gene: per1 became 
rhythmic with high amplitude by P10 and remained so through to P30.  The gene: 
per2 became overtly rhythmic at P20 through to P30.  The gene: cry1 and clock were 
the last to become overtly rhythmic, at P30.  The gene: rev-erbα expressed overt 
circadian rhythms throughout, from E20 to P30.  The authors resist much comment on 
the early, low amplitude rhythms of cry1 and bma1l, implying that these rhythms 
were somewhat not equivocal, because of their low amplitude and the later emergence 
of overt, high amplitude rhythms.  The authors concluded that only rev-erbα was 
rhythmically expressed throughout the entire observation period, while the other clock 
genes took more time to gradually attain their overtly rhythmic status. 
 
This apparently gradual acquisition of overtly rhythmic clock gene expression may 
also occur in the ovine CL, with ovine luteal development recapitulating the ontogeny 
of the rodent liver (Sakamoto et al., 2002).  The large amount of cell division and 
differentiation occurring in luteogenesis may be like that occurring in the formation of 
other organs during embryogenesis.   The only exception here would be per2, which 
showed high amplitude variation during the EL phase but not the LL phase.  The 
variation is overt and can not be dismissed as equivocal due to its amplitude.  
Furthermore, per2 was found in the rat heart to have a circadian rhythm during early 
ontogenesis, that then disappeared but later re-emerged (Sladek et al., 2007). 
Both cry1 and bmal1 also started circadianly rhythmic gene expression that then 
stopped and then re-started again, during the ontogenesis of the rat liver (Sakamoto et 
al., 2002).  The cry1 expression was circadian on E20 but was no longer detectable by 
P2, just three days later.  The cry1 rhythm re-emerged by P30 though it was 
undetectable ten days earlier.  The bmal1 rhythm was seen on P2 but then disappeared 
until around P20.  The phases of these early rhythms that disappeared were phase 
delayed compared to the adult rhythm phases.  There is no discussion of the phase 
relationships between the clock genes forming the negative and positive limbs of the 
circadian clock.  It does appear however that by P30, there was a classical clockwork 
phase relationship between these genes.  Even at P20, the genes expression phase 
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relationship between the period genes appeared to be somewhat in antiphase to clk 
and bmal1. 
 
It was also observed in the ontogeny of the rat heart that per2 took the longest out of 
all the clock genes to establish an overtly rhythmic 24-hour gene expression profile 
(Sakamoto et al., 2002).  The phasing of the rhythmic per2 expression also appeared 
to shift from postnatal day 20 to postnatal day 30, which was not the case for the 
rhythmic expression of cry1, bmal1 and clk (Sladek et al., 2007).  These data suggest 
that per2 may differ in some way to the other clock genes, as it does in the EL and LL 
phase CL.  The early establishment then loss of circadian cry1 and bmal1 in the rat 
liver during development also indicates that the loss of rhythmicity with time, like that 
of the per2 expression in the EL and LL phase CL, may be meaningful.   It may be a 
feature of developing peripheral clocks as this phenomenon has yet to be reported in 
the development of circadian clock gene expression in the SCN.  The SCN also 
gradually develops circadian rhythmicity in its clock gene expression but it does so 
more rapidly than the peripheral clocks so far examined (Seron-Ferre et al., 2007).  It 
established circadian rhythmicity long before the heart or liver does. It also 
establishes this rhythmicity with phases that are the same early on in development as 
they are later in the adult.  This is not the case in peripheral tissues.  Tissue specific 
differences in programming of the development of the molecular oscillations have 
been suggested (Tamura et al., 2008). 
 
With the developing liver, it was also suggested that the clock genes were not initially 
strongly subject to the SCN signal.  Rather, it was proposed that the circadian rhythms 
were food entrained.  This was possible, though the constant rhythmicity of the rev-
erbα gene from E20 through to adulthood would seem to belie that.  It does however 
provide a possible cause for the different phases in circadian gene expression between 
early postnatal life and adulthood.  One might speculate that the clock gene 
expression during development of peripheral tissues is subject to zeitgebers other than 
the SCN.  If this were true, it may not only be the timing of meal times which can 
shift the phases of an emerging peripheral circadian clock.  It is likely that the 
hormonal milieu could impact on the phasing of the peripheral circadian clocks of 
endocrine tissues such as the CL. 
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The mystery of how rhythmic gene expression is generated in the expression of the 
clock genes, in the apparent absence of a classical autoregulated, transcription-
translation positive feedback loop may well be solved by addressing the possibility of 
post-translation modification of the clock proteins.  The phases of circadian gene 
expression between the clock genes did not indicate the presence of a circadian clock 
but the observation that PER2 protein is able to oscillate in a circadian fashion in the 
absence of circadian per2 expression indicates that post-translational modification 
may be able to produce circadian clockwork (Albrecht et al., 2007).  This, coupled 
with the observation of the apparently unique localisation of the PER2 protein in the 
cytoplasm of the granulosa-lutein cells in the intact human CL, suggest that there may 
well be post-translational mechanisms operating in the provision of temporal 
regulation by the clock genes and their cognate proteins in the CL.   
 
The third aim of this study was to assess whether the CL may be a melatonin-target 
tissue, with regard to its clock gene expression.  This hypothesis was based on 
evidence that melatonin activates P4 production in primates and regulates clock gene 
expression in melatonin-target tissues, such as the ovine PT (Woo et al., 2001, Jilg et 
al., 2005, Johnston et al., 2006).  In the primate, melatonin affects steroid production, 
such as progesterone release.  The CL expresses melatonin receptors and responds to 
melatonin (Albrecht et al., 2007).  Additional evidence shows that the ovine PT, 
which expresses MT1 receptors, responds to melatonin by activating its clock gene 
expression and using this to regulate its circadian clock.  Melatonin activates cry1 
through a stimulatory mechanism at night and activates per1 during the day through 
the removal of the inhibition of gene expression i.e. a ‘de-repression’ mechanism 
(Lincoln, 2006).  The prediction of this hypothesis is that similar types of timing-
control may occur in the CL as it does in the PT of the sheep. 
 
In the ovine CL, cry1 expression was maximal during the dark phase, when the 
melatonin concentrations were high, which may be consistent with a stimulatory role 
of melatonin on cry1 expression.  In both the EL and LL phases, cry1 was maximal 
later in the night, at ZT 19, and this correlated with the time when blood melatonin 
concentrations were also at a maximum.  In the ovine PT, a similar scenario occurs: 
with maximum levels of melatonin occurring at the same time as the cry1 expression 
maximum, at ZT 15, in the early part of the night.  Combined together, these results 
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are consistent with the view that melatonin may activate cry1 in the ovine CL and be a 
significant regulator of clock gene expression.  Moreover, for per1, in contrast to 
cry1, gene expression is elevated during the late night and was maximal in the 
morning, in the late luteal CL.  The pattern was quite similar to that of the ovine PT 
and SCN.  This was also consistent with the view that melatonin regulates per1 
through a ‘de-repression’ mechanism.  Interestingly, the 24-hour profile of per1 
expression was very similar between the three ovine tissues, whereas this was not the 
case with cry1 expression, suggesting that there is a specific relationship between 
melatonin and cry1 expression. 
 
Overall, the current study provides circumstantial evidence that daily clock gene 
expression in the ovine CL is potentially driven by melatonin rather than being merely 
an intrinsic clockwork mechanism and as such, the CL may be regarded as a 
melatonin-target tissue.  In this respect, it is interesting that sheep are reproductively 
active under short winter photoperiods and thus, long-durational melatonin is likely to 
be permissive of full CL function.  It could therefore be predicted that an ovine CL 
formed under long photoperiods, would not be able to function normally.  A specific 
phase-relationship between per1 and cry1 expression may be required in the ovine 
CL, as proposed for the functional control of the ovine PT, for full P4 secretion.  A 
reproductively active short-day animal would by contrast appear different under long-
day conditions and would not have fully functioning CL (Lincoln, 2006).   
 
This study demonstrates, for the first time, that the five studied clock genes were all 
expressed across 24 h in the ovine CL, with a clearly defined rhythmicity, most robust 
for the clock genes in LL but with a paradoxical difference for per2, which was 
rhythmic in EL and not in LL.  The lack of an inverse relationship between the 
rhythmic expression of bmal1 and the other clock genes: per and cry is inconsistent 
with a classical endogenous clock.  The results better supports a model in which clock 
gene expression changes during maturation of the tissue, regulated by extrinsic 
hormone factors, but still providing temporal control of the luteal lifespan. 
 




1. the clock genes: bmal1, per1, per2, cry1 and cry2 are expressed in the ovine 
CL; 
 
2. these genes are expressed throughout the luteal lifespan; 
 
3. bmal1, per1, cry1 and cry2 are expressed in circadian rhythms during the LL 
phase but not during the EL phase; 
 
4. per2 is expressed in a circadian rhythm during the EL phase but not during the 
late luteal phase; 
 
5. the phase relationships between these rhythmic gene expression profiles are 
not consistent with that of a classical circadian clock. 
 
As endogenous clocks can be generated by clock protein oscillations in the absence of 
rhythmic mRNA expression, it is important that the clock protein expression in the 
CL is examined, across 24 hours, in order to establish more conclusively whether 
circadian clocks operate in the CL and in the regulation of its lifespan. 
 





The establishment of whether an endogenous, clock gene-driven circadian clock 
exists in the cells of the CL remains equivocal.  Although circadian rhythms in clock 
gene expression were observed in the ovine CL, the phase relationships between them 
were not consistent with those of a classical circadian clock.  There have however 
been reports of circadian clock work existing only at the level of the clock proteins 
(Axmann et al., 2007, Dong and Golden, 2008, Johnson, 2007).  It is therefore 
essential that these proteins be better examined in the CL, to ascertain whether any 
circadian fluctuation can be identified in their quantity of cellular 
compartmentalisation, across a minimum period of 24 hours. 
 
In order to do this, the corpora lutea sampled in the previous chapter from Soay sheep, 
across 24 hours, from the EL phase and the LL phase, will be examined.  Each of 
these corpora lutea were divided at the time of sampling into two bilateral halves.  
One half was stored for mRNA extraction and gene expression analysis and the other 
half was immediately immersion fixed for IHC.  As such, it was crucial that 
antibodies were found that would be able to visualise the clock proteins in the sheep.  
Furthermore, these would need to be sufficiently specific that they could be used in 
immunoflourescent histochemistry, co-localised to luteal cell type markers.  This 
would be absolutely necessary as the cellular organisation of the ovine CL is much 
more random than that of the human CL.  There are no layers of LLCs and SLCs; 
rather, these cells are freely mixed with each other in the mass of the ovine CL, along 
with fibroblasts and cells of other luteal cell types. 
 
The gene expression analysis of the ovine corpora lutea, in the previous chapter, 
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established that circadian mRNA expression was evident, mostly in the LL phase.  
There was a high-amplitude circadian rhythm in per2 expression during the EL phase 
which was then no longer detectable in the LL phase.  The PER2 protein was 
observed in Chapter 1 as unusual in its cytoplasmic localisation, in the human 
granulosa-lutein cells, appearing to aggregate into foci that radiated around the 
nucleus, closely apposed to what appears to be the basement membrane.  This 
suggests that there may be more than transcriptional regulation involved in the role of 
this clock gene, in potentially regulating temporal processes, in the CL. 
 
The importance of protein-protein interaction in the functioning of the circadian clock 
has already been long established.  The clock proteins, PER and CRY are known to 
both hetero- and homo-dimerise, in order to produce the necessary time lags required 
for the provision of a 24-hour period.  The dimerisation of these proteins to each other 
is thought to prevent them from being ubiquitinylated and so, stop them degrading via 
the ubiquitin-proteosome protein-degradation pathway.  The accumulation of these 
proteins is timed so that the dimers occur coincidently, only at specific intervals, thus 
constituting an internal coincidence timer, which has been proposed to be the 
mechanism by which the photoperiodic melatonin signal is decoded in the PT 
(Lincoln, 2006).  This is highlighted by a study of the rodent PT, where the clock 
proteins could only be quantified in the nucleus and the rhythmic change did not 
reflect the mRNA rhythm.  Peak PER1 protein levels occurred three hours later than 
the per1 mRNA maxima and CRY1 protein occurred 14 hours later than the cry1 
mRNA maxima, and the timing of both protein maxima were found to be coincident 
(Jilg et al., 2005).  These proteins clearly localised to the nucleus for a specific 
function, at timed intervals.  These proteins and the timing of their interaction with 
each other and with DNA, when they function as transcriptional activators or 
repressors, are therefore essentially the components of the circadian system that give 
rise to the provision of the specific 24-hour period, that is circadian. 
 
The visualisation of these proteins would also perhaps allow the characterisation of 
these interactions, which have previously not been clearly revealed.  Although real-
time imaging exists of the clock proteins function in living cells, these cells exist 
either in vitro or ex vivo.  It has not yet been characterised in cells of an intact 
mammalian tissue, sampled across 24 hours, and most certainly not in the CL in vivo. 
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Initial attempts to visualise the clock proteins using the commercial antibodies that 
were successful in Chapter 2 met with mixed success.  The BMAL1 antibody worked 
successfully, but it was the only one of the whole battery of antibodies that did.  As 
such, it was decided that specific antibodies would be raised against the ovine clock 
proteins: PER1 and CRY1, as these constituted the negative limb of the circadian 
clock; BMAL1 representing the positive limb of the clock having already been 
visualised. 
 
It was not however, possible to complete the systematic visualisation of the clock 
proteins in the ovine CL across 24 hours, due to time constraints.  As such, this 
chapter will focus largely on successfully raising sheep-specific antibodies against 
clock genes, and testing them in ovine tissues, aiming ultimately at successfully 
visualising the clock proteins in the ovine CL. 
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Therefore, this chapter aims: 
 
1. to identify ovine amino acid sequences for CRY1 and PER1 and assess 
sequence homology for protein specificity; 
 
2. to identify putative epitopes in the selected ovine amino acid sequences, using 
epitope-mapping software; 
 
3. to assess the likelihood of projection from the protein tertiary structure and 
plasma membrane of the putative epitopes amino acid sequence using 
hydrophobicity plot analysis; 
 
4. to raise antibodies in pre-screened rabbits, using both commercial and in-
house methods and testing the titre of the antibodies; 
 
5. to establish a positive control using immunohistochemistry to test the ovine 
CRY1 and PER1 antibodies in ovine brain tissues known to robustly express 
circadian clock genes; 
 
6. to investigate CRY1 and PER1 in the ovine CL using IHC with the ovine-
specific antibodies. 
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7.2 MATERIALS AND METHODS 
There is an element of Results in this Materials and Methods section, due to the 
arrangement of the aims of this chapter.  The results derived in the process of raising 
the antibody, though addressing the direct aims listed in for this chapter, will be 
included in the Materials and Methods.  The use of the anti-clock protein antibodies in 
the ovine CL will be described in the Results section.  The results contained within 
both the Materials and Methods and the Results sections will then be discussed 




7.2.1 PRODUCING OVINE PER1 AND CRY1 ANTIBODIES  
Antibodies were produced specifically against ovine PER1 and ovine CRY1 peptides. 
 
 
7.2.1.1 IMMUNOGEN DERIVATION 
7.2.1.1.1 PEPTIDE-ANTIGENS 
Arguably the most important aspect in the production of antibodies is the design of 
the peptide-antigen.  A peptide-antigen is a small segment, approximately 15-18 
amino acids long, of the protein sequence of interest.  Peptide-antigens are used for 
immunisation of animals that then produce antibodies against the protein of interest.  
These antibodies can then be purified, titred and checked for activity against antigenic 
control peptides.  Suitably active antibodies can then be assessed for use in 
immunochemistry.  These antibodies are by nature, polyclonal, as a spectrum of 
antibodies is generated in response to the various epitopes in the immunogen 




7.2.1.1.1.1 OVINE CLOCK PROTEIN SEQUENCES 
The published protein sequences for ovine PER1 and ovine CRY1 were obtained from 
the NCBI GenBank DNA databases, with the respective accession numbers: 
AAC03000 and AAQ62559 (Figure  7.1). 
 
 
irishtlydl dkiielnggq ppltykrfqt liskmeplei pvetitsevm ekcttplsdd  hdekygvpsl eelgfdtdgl psavwpgget 
ealtrlerhl erkawvanfe rprmnansll asptglspyl rfgclscrlf yfkltdlykk vkknssppls l
NCBI Protein Database Accession No: AAQ62559
CRY1 Ovis aries
spsppsssia ysllsassep dnpstsgcss eqsarartqk elmtalrelk lrlpperrgk grsgtlatlq yalacvkqvq anqefyqqws 
leegepcamd mstytleele hvtseytlrn qdtfsvavsf ltgr
NCBI Protein Database Accession No: AAC03000
PER1 Ovis aries
 
Figure  7.1 The amino acid sequences of the oCRY1 and oPER1 proteins. 
 
 
The sequences were then aligned with those of CRY1 homologs in other species, as 
well as with ovine CRY2, using ClustalW software that was available online 
(http://www.ebi.ac.uk/Tools/clustalw2/index.html) and viewed with Jalview software 
(http://www.jalview.org/) (Figure  7.3 and Figure  7.3). 
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CRY1 ALIGNMENTS IN JALVIEW USING CLUSTALW 
 
Figure  7.2 Diagrammatic representations of the homologous portions of oCRY1 amino acid sequence with other 
species and with the homologous ovine protein, oCRY2. 
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PER1 ALIGNMENTS IN JALVIEW USING CLUSTALW 
 
Figure  7.3 Diagrammatic representations of the homologous portions of oPER1 amino acid sequence with other 






7.2.1.1.1.2 EPITOPE PREDICTION 
The sequences were mined for putative epitope sequences using Epitope Locator 
epitope prediction software, available online (www.imtech.res.in).  The potential of 





mnansll as yl rfgclscrlf fkltdlykk vkknssppl
 dkiielnggq ppl meplei pvetitsevm ekcttplsdd  hdekygvpsl eelgfdtdgl psavwpgget 
ealtrlerhl erkawvanfe rpr ptglsp y s l
spsppsssia ysllsassep dnpstsgcss eqsarartqk elmtalre k grsgtla qefyqqws 
leegepcamd mstytleele hvtsey f ltgr
PER1 Ovis aries
Epitope Locator program
lk lrlpperrg tlq yalacvkqvq an
tlrn qdtfsvavs
Figure  7.4 The putative epitopes in the known sequences of oCRY1 and oPER1 have been selected based on 
known epitope sequence, and have been highlighted in orange. 
 
 
7.2.1.1.1.3 HYDROPATHY ANALYSIS OF PUTATIVE EPITOPES 
Kyte-Doolittle hydrophobicity plots were generated for the protein sequences to try 
and identify hydrophilic regions that would be likely to protrude, epitope-like, from 







rmnansll aspt yl rfgclscrlf yfkltdlykk vkknssp
 dkiielnggq pplt meplei pvetitsevm ekcttplsdd * hdekygvpsl eelgfdtdgl psavwpgget 
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**
 
spsppsssia ysllsassep dnpstsgcss eqsarartqk elmtalre
Kyte-Doolittle Hydropathy Plot
lk lrlpperrg lq yalacvkqvq a
tlrn * qdtfsva
k * grsgtlat nqefyqqws 




Figure  7.5 Kyte-Doolittle Hydropathy plots and amino acid sequences of oCRY1 and oPER1, with the most 





7.2.1.1.1.4 PEPTIDE-ANTIGEN SEQUENCE SELECTION 
The high-scoring hydrophilic, epitopic sequences were then used to screen the NCBI 
databases for the same putative epitopes on other, undesired, proteins, in order to 
avoid antigenic sequences likely to produce cross-reactive antibodies.  The databases 
were searched using BLAST software (National Institutes of Health).  This also 
provided information regarding homologs in other species and tissue distribution.  
Two potential peptide-antigen sequences, per clock protein, were proposed and a final 
selection made, following advice, both, from in-house: Dr Kevin Morgan, Professors 
Rodney Kelly and Philippa Saunders and from the sequence spotter at Affiniti 
Research Products Ltd, Biomol International LP, Paul Sheppard (Figure  7.6). 
 
 
irishtlydl tykrfqt lisk dkiielnggq ppl meplei pvetitsevm ekcttplsdd * hdekygvpsl eelgfdtdgl psavwpgget 




rmnansll aspt yl rfgclscrlf yfkltdlykk vkknssppl
Epitope Locator program
spsppsssia ysllsassep dnpstsgcss eqsarartqk elmtalrelk lrlpperrgk * grsgtlat q 





Figure  7.6 Amino acid sequences of oCRY1 and oPER1 with the final antigen-peptide sequence selection 




7.2.1.1.1.5 IMMUNOGEN CONSTRUCTION 
To increase the immunogenic potential of the sequences, they are conjugated to 
keyhole limpet haemocyanin (KLH).  KLH is a carrier protein, much larger than the 
oligopeptide sequences selected, and capable of solely, stimulating an immune 
response.  The KLH is conjugated to the oligopeptide by a cysteine amino acid (C).  
As both of the selected sequences derive from the N-terminal of their respective 
proteins, the C is attached to the potentially less-antigenic C-terminal end of the 
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oligopeptide.  It is supposed that the N-terminals are more likely to protrude, as they 
would in their in vivo conformation, while the more C-terminal oligopeptide parts 






Sequence selected from database published online
Sequence checked by in-house and Affiniti Research sequence spotters
Sequence submitted to Affiniti Research and peptides synthesised
KLH-conjugated peptides used to immunise pre-screened rabbits at Diagnostics Scotland & in-house









Figure  7.7 Sequence of events in the selection of the antigen-peptide sequence, with diagrams depicting the 




The resulting immunogens (Figure  7.7), composed of oligopeptides coupled with 
carrier proteins, using a standard cross-linker: m-maleimidobenzoyl-N-
hydroxysuccinimide ester (MBS), were then synthesised by the Peptide & Protein 
Research Services of Affiniti Research Products Ltd, Biomol International LP.  
Unconjugated oligopeptides were also synthesised for use when testing the reactivity 
of the antibodies. 
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7.2.1.2 ANIMAL IMMUNISATION  
Rabbits were used as the hosts for immunisation.  Their treatment and the 
experimental procedures performed using them were in compliance with the UK 
Animals Scientific Procedures Act of 1986 and with the regulatory board license 
awarded to Professor Alan McNeilly (project license number: PPL60/3232 19B, A12) 
for the production of polyclonal antibodies using rabbits. 
 
Before immunisation with the immunogens, four rabbits from Diagnostic Scotland 
and three rabbits that were obtained for immunisation in-house were screened for any 
pre-existing cross-reactivity to clock gene peptides, using enzyme-linked 
immunosorbent assays (ELISAs).  The pre-immune sera were substituted for primary 
antibodies, used in IHC with ovine and murine hypothalamic and PT sections.  
Primary antibodies raised against VIP (DiaSorin Ltd, Wokingham, UK) and GSU 
were also used as positive controls in hypothalamic and PT sections respectively.  The 
IHC protocol that was followed was the one incorporating thick 50 μm sections in 
free-floating conditions. The sections were treated both, with and without, antigen 
retrieval using pronase.  The sera were tested over a range of dilutions: from 1:10 to 
1:1 000.  They and the positive control primary antibodies were incubated overnight 
at 4oC.  Both, SARB or GARB, secondary antibodies were used at a 1:500 dilution.   
 
Two of the four rabbits from Diagnostic Scotland failed the test and were excluded 
from any further use.  The remaining 2 rabbits from Diagnostic Scotland were 
inoculated with the CRY1 immunogen.  All 3 rabbits obtained for immunisation in-
house passed the pre-immunity test and were inoculated with the PER1 immunogen.   
 
Each rabbit received approximately 2 mg peptide with 0.3 ml warm MPL + TDM + 
CWS Adjuvant (Sigma, Dorset, UK) dissolved in 0.7 ml PBS.  The MPL + TDM + 
CWS Adjuvant is comprised of 0.5 mg monophosphoryl lipid A from Salmonella 
minnesota (MPL), 0.5 mg trehalose dicorynomycolate (TDM) and 0.5 mg cell wall 
skeleton from a tubercule bacillus (CWS) in 2% oil-Tween® 80-water.  The CWS 
provides additional immunopotentiating activity.  The rabbits were injected at 
multiple sites: 200 l intramuscularly per hind leg, 100 l subcutaneously in the neck 
and the remaining 300 l subcutaneously in a further 6 sites.  Re-inoculation was then 
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repeated approximately every 4 weeks.  The rabbits receiving the PER1 immunogen 
were re-inoculated twice and the rabbits receiving CRY1 immunogen were re-
inoculated four times.  A 50 ml blood donation was taken after each re-inoculation, a 
week later, from each rabbit.  The blood was left to clot: standing overnight at 4oC.  
The straw-coloured serum was then decanted into sterile universal containers and the 
clot discarded.  The sera were stored at 4oC in the interim while they were initially 
tested for immunoreactivity and until they were cleared of serum proteins and their 
concentration.  The final blood donation was obtained by exsanguinating the rabbits 
and thus provided the largest volume of blood and antibodies (Figure  7.8).  As the 
antibodies produced are polyclonal, it was prudent to obtain antibodies from the 
rabbits before their exposure to the immunogen became chronic as this has been 
previously known to adversely affect the clonal population of the antibodies. 
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Selected CRY1 sequence
Inoculate rabbits
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7.2.1.3 ANTIBODY PURIFICATION 
The sera, prior to clearance of serum proteins, were tested with ELISAs.  They were 
tested in a range of dilutions: from neat to 1:100 000, for reactivity against the 
unconjugated PER1 and CRY1 control peptide-antigens.  The pre-immune sera were 
used as negative controls. 
 
7.2.1.3.1 ENZYME-LINKED IMMUNOSORBENT ASSAY 
The sera, prior to clearance of serum proteins, were tested with enzyme-linked 
immunosorbent assays (ELISAs).  They were tested in a range of dilutions: from neat 
to 1:100 000, for reactivity against the unconjugated PER1 and CRY1 control 
peptide-antigens.  The pre-immune sera, which had already been screened using 
ELISAs (at 1:10, 1:20, 1:50, 1:100, 1:200, 1:500 and 1:1 000 dilutions, with SARB 
diluted 1:50 and visualised using DAB), were used as negative controls.   
 
Briefly: the lyophilised control peptides were reconstituted in distilled water to a 0.5 
mg/l concentration, maintained at pH 7.  Peptide solution (100 l) at a 0.5 mg/l 
concentration was used to coat each well of a Reacti-BindTM maleic anhydride 
activated polystyrene 96-well plate.  Half the wells were coated with PER1 and the 
other half with CRY1.  The plate was incubated on a microplate shaker for 1 h at 
room temperature.  The maleic anhydride on the plate reacts and bonds with the 
largely basic PER1 and largely acidic CRY1 peptides.  The wells were washed 3 x 
200 l of SuperBlock Blocking Buffer then rinsed a further 3 x 300 l PBS.  The 
peptide or ligand was thus immobilised on the plates, which were used immediately 
for ELISAs. 
 
The test sera, containing antibodies, were diluted 1:100, 1:1 000 and 1:10 000 in wash 
buffer consisting of 0.1% BSA and 0.05% Tween 20 detergent in PBS.  This primary 
or capture antibody (100 l) was added to each well, in duplicate, and the plate 
incubated for 1 h at room temperature.  This allowed the antibodies in the sera to bind 
to the peptide-antigen.  Excess antibody was then rinsed off three times with 200 l of 
wash buffer.  HRP-labelled goat anti-rabbit immunoglobulin G (IgG) secondary or 
detection antibody (Amersham Biosciences, Buckinghamshire, UK) (100 l) 
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dissolved 1:50 in wash buffer was added to each well and the plate incubated for 1 h 
at room temperature.  The secondary antibody specifically binds to the primary 
antibody.  Excess antibody was again rinsed off three times with 200 l wash buffer.  
The amount of secondary antibody bound to the primary antibody-peptide-antigen 
matrix was then measured using a colorimetric substrate. 
 
Colorimetric substrate solution (100 l) was added to each well and the colour left to 
develop for 30 min.  The reaction was stopped, by adding 50 l of stop solution.  The 
absorbance of the wells at 450 nm was measured using spectrophotometry.  The 
greater the colorimetric reaction, the darker and more light-absorbent the liquid in the 
ELISA plate.  A successful antibody reaction is demonstrated by a colorimetric 
reaction that is graduated, corresponding to the serial dilutions of the sera.  The 
ELISA was performed in duplicate as a control. 
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Figure  7.9 A schematic diagram of an ELISA plate with colorimetric detection of the oCRY1 antibodies from three 
rabbits: R1, R2 and R3 and the oPER1 antibodies from two rabbits: R4 and R5 binding to the unconjugated 
positive control peptide oCRY1 and oPER1 respectively, with corresponding absorbance values at 450 nm of the 






7.2.1.3.2 CAPRYLIC ACID AND AMMONIUM SULFATE 
IMMUNOGLOBULIN G PURIFICATION 
This protocol was adapted from standard published ones.  The sera, from the 
exsanguination (final bleed) of each rabbit, were purified.  The sera were each diluted 
with 2 volumes of 60 mM acetate buffer, comprised of 0.15% sodium acetate and 0.3% 
acetic acid in distilled water, pH 4.5 (titrated with 1 M Tris).  Caprylic acid (25 l) 
(Sigma, Dorset, UK) was added per ml of diluted sera.  The acid was added slowly, 
drop-wise, using a syringe and 20-gauge needle, into constantly agitated sera.  In 
mildly acidic conditions, the addition of short-chain fatty acids, such as caprylic acid, 
to serum will precipitate most serum proteins with the exception of the IgG.    The 
sera were left stirring for 30 min at room temperature after the addition of caprylic 
acid, to allow the non-IgG serum proteins and albumin to completely precipitate out 
of solution.  The solution was then centrifuged for 15 min at 3 000 g at 4oC.  The 
supernatant was carefully decanted and filtered to remove any residual precipitate.  
The pellet was discarded and the supernatant dialysed for 2 days against PBS at 4oC.  
The resulting dialysed solution, containing IgG, was then quantified, using a Bio-Rad 
Protein Assay (Bio-Rad Laboratories (UK) Ltd, Hertfordshire, UK).  The purified sera 




7.2.1.4 TESTING ANTIBODIES WITH 
IMMUNOHISTOCHEMISTRY 
The antibodies were tested using free-floating 50 μm-section and conventional 5 μm-
section IHC protocols on ovine hypothalamus and PT sections.  The hypothalamic 
sections contained the SCN, PeVN, PVN and SON. The antibodies were also control 
tested for specificity.  Where there were some pre-immune sera left after the ELISAs, 
this was used as a negative control.  Conventional IHC was performed using 
overnight pre-incubation of the primary antibody with 10 x antibody concentration of 
the unconjugated peptide-antigen.  This 10-fold excess of antigen bound specifically 
to the antibodies, flooding their antigen epitope-recognition sites, thus inactivating the 




7.2.1.4.1 DERIVING POSITIVE CONTROLS 
7.2.1.4.1.1 IMMUNOHISTOCHEMISTRY 
The immunohistochemistry protocol was adapted from existing protocols practiced 
in-house.  The technique employed 5 μm thin tissue sections. Antibodies were first 
used against SCN neuronal marker peptides, as they were reported to be more 
abundant than clock proteins.  The marker peptide was VASOPRESSIN (VP).  
Antibodies against the clock protein, BMAL1 would also be used. 
 
7.2.1.4.1.1.1 TISSUE SAMPLING 
Normal healthy sheep scheduled for culling were used to provide tissue to test the 
antibodies, using IHC.  The sheep were killed using pentobarbital injection, and their 
heads decapitated.  The decapitated heads were perfused through both carotid arteries 
with 1 L PBS, then 1 L 4% NBF.  The partially fixed brain was then resected with the 
PT attached.  It was extracted with as much of the attached pituitary gland that could 
be prised out of the sella turcica.  A hypothalamopitutiary block containing the SCN, 
PT and possibly some pituitary gland was resected (Figure  7.10).  It was post-fixed by 





Figure  7.10 A: Photograph of ovine brain, sagitally sectioned along the midline.  B: Schematic diagram of ovine 
brain, in sagital midline section.  The rectangle indicates the hypothalamopituitary section that was resected during 




The block was coronally re-blocked, along the coronal plane, into two smaller blocks: 
one containing the SCN and one containing the PT.  The tissue was then saturated and 
embedded in paraffin wax.  The wax-embedded blocks were sectioned at a relatively 
standard thickness of 5 μm on a Leica Jung RM 2035 microtome (Leica 
Microsystems, Milton Keynes, UK) mounted on Menzel-Gläser Superfrost Plus 
slides (BDH via VWR International Ltd, Leicester, UK) and then left to dry and 






7.2.1.4.1.1.3 IMMUNOHISTOCHEMISTRY WITH THIN MOUNTED SECTIONS 
The sections were dewaxed in 100% xylene and rehydrated in a series of graduated 
alcohols then water.  They were then antigen retrieved by pressure cooking in 0.01 M 
citrate buffer (pH 6).  They were cooked for 5 min at full pressure then left to stand 
for 20 min and finally cooled under running tap water.  Any endogenous peroxidase 
activity in the tissues was blocked by washing the sections in 3% (v/v) H2O2 in 40% 
methanol for 30 min at room temperature.  The sections were then washed three times 
for 5 min in PBS.  Any nonspecific antibody-binding sites were blocked by incubating 
sections in blocking serum composed of NGS (Autogen Bioclear UK Ltd, Wiltshire, 
UK) diluted 1:4 in PBS containing 5% BSA (Sigma, Dorset, UK).  The sections were 
then incubated in humidity chambers overnight at 4oC with the primary antibody 
diluted in blocking serum.  The primary antibodies against SCN marker peptides: VP 
and VIP (DiaSorin Ltd, Wokingham, UK) were used at various dilutions: VP at 
1:1000 and VIP at 1:100,  
Table  7.1).  The primary antibodies against ovine clock proteins were used neat and 
the BMAL1 antibody (Autogen Bioclear UK Ltd, Wiltshire, UK) was used at a 1:20 
dilution ( 
Table  7.1).  Control sections were incubated with blocking serum to confirm the 









Rabbit anti-sheep PER1 IgG - neat SARB 
Rabbit anti-sheep CRY1 IgG - neat SARB 
Rabbit anti-Drosophila BMAL1 IgG BMALD11-A 1:20 GARB 
Rabbit anti-VP antisera 20069 1:1000 SARB 
Rabbit anti-porcine VIP antisera 20077 1:100 GARB 
 
Table  7.1 Caprylic-acid purified polyclonal ovine clock gene primary antibodies and affinity purified commercial 
primary antibodies used in this study: vasopressin (VP) and vaso-intestinal peptide (VIP), indicating the species 
the antibody was raised in and against, the antibody catalogue number where appropriate, the dilution used and 






Excess primary antibody was washed off in three 10-min PBS washes.  The sections 
were then incubated with the appropriate secondary antibody, either swine anti-rabbit 
biotinylated (SARB) (Dako, Cambridge, UK) or goat anti-rabbit biotinylated (GARB) 
(Vector Labs, California, USA), diluted 1:500 in blocking serum, for 1 h at room 
temperature.  Unbound antibody was washed off in three, 10-min, PBS washes.  
ABC-HRP (Dako, Cambridge, UK), diluted in 0.05 M Tris-HCl (pH 7.4) according to 
the manufacturer’s instructions, was added to the sections.  They were incubated at 
room temperature for 30 min then the excess ABC-HRP was washed off in three, 5-
min, PBS washes.  The ABC-HRP was then detected using the peroxidase substrate, 
DAB (Dako, Cambridge, UK).  When the brown DAB staining was optimal (neither 
too weak nor too strong), as detected under a Zeiss ICS KF2 light microscope (Carl 
Zeiss Ltd, Welwyn Garden City, Hertfordshire, UK), the peroxide reaction was 
stopped.  It was stopped by immersing the sections in distilled water.  The DAB stain 
was effectively of the immunoreactive-protein.  The negative control should generally 
be devoid of any brown DAB staining. 
 
The sections were then counterstained with a blue nuclear stain: Harris’ haematoxylin 
(BDH via VWR International Ltd, Leicester, UK).  The sections were then dehydrated 
in graduated alcohols and xylene.  They were then mounted (Cover Glass; VWR 
International Ltd, Leicester, UK) with Pertex mounting medium (Cell Path, 
Hertfordshire, UK).  The cellular localisation of the immunoreactive-protein was 
examined and any staining photographed, using a Provis AX70 microscope (Olympus 
Optical, London, UK) fitted with a Canon DS6031 digital camera (Canon Europe, 
Amsterdam, The Netherlands). 
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7.2.1.4.1.1.4 IMMUNOHISTOCHEMISTRY RESULTS 
7.2.1.4.1.1.4.1 CRY1 
The polyclonal anti-oCRY1 antibodies raised were successfully used in positive 
control sections of hypothalamopituitary tissue (Figure  7.11).  The antibodies 
visualised the oCRY1 in the ovine median eminence (ME) and PT.  The neural ME 
staining was very different from that of the glandular-like PT.  The staining in the ME 
was much sparser, as would be expected for neural tissue (Figure  7.11 Panels A and 
B). Individual oCRY1-positive neurones can be seen (Figure  7.11 Panel C).  The PT 
staining was very dense and the oCRY1 appeared to localise specifically to cells, that 
were arranged in small clusters, that were then arranged in a striated pattern, virtually 
throughout the PT tissue (Figure  7.11 Panel D).  The negative control omitting the 




Figure  7.11 Photomicrographs showing ovine CRY1 
staining (brown) in ovine hypothalamopituitary 
sections containing the third ventricle (3V), median 
eminence (ME) and PT.  The arrowheads point to 
positively stained cells.  CRY1 staining in the ME 
and PT are shown in the hypothalamopituitary 
section at low power in A and high power in B.  C 
shows CRY1 in ME neurones and D shows CRY1 in 
the ME and PT.  E is the negative control omitting 
primary antibody.  The scale bars represent 100 m 
except in A, where it represents 1000 m. 
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The anti-oCRY1 antibodies also successfully localised the clock protein to the SCN 
and periventricular nucleus (PeVN) (Figure  7.12).  The staining of the PeVN neurones 
can clearly been seen along with the smaller SCN neurones (Figure  7.12 Panel A).  
These can be seen more clearly at higher magnification, where the CRY1 protein 
appears to be mostly cytoplasmic in the SCN neurones (Figure  7.12 Panel B) as well 
as in the PeVN neurones (Figure  7.12 Panel C).  The negative control omitting 
primary antibody is shown in Panel D.  VP staining has been used to provide some 
idea of the anatomy and the location of the SCN (Figure  7.12 Panel E), which has 
been highlighted using the colour-replacement tool in Adobe Photoshop CS2 (Figure 







Figure  7.12 Photomicrographs showing ovine 
hypothalamic sections containing the third ventricle 
(3V), optic chiasm (OC), periventricular nucleus 
(PeVN) and SCN with ovine CRY1 staining (brown) 
in A, B and C, and VP staining(brown) in E and F, 
with a nuclear counterstain (blue).  The staining of 
oCRY1 in neurones on the PeVN and SCN is shown 
at low power in A, and in higher power in the SCN 
neurones in B, and at higher power in PeVN 
neurones in C.  The VP staining in the SCN has 
been highlighted (indigo) using the colour 
replacement function of the Photoshop CS2 image-
processing software.  The arrowheads point to 
neuronal staining.  D is the negative control omitting 
primary antibody.  The scale bars represent 100 m.   
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7.2.1.4.1.1.4.2 PER1 
The anti-oPER1 polyclonal antibodies produced very specific stain, in a small 
proportion of the cells in the hypothalamopituitary tissue (Figure  7.13).  Cells that 
appear the same morphologically, differ in their oPER1 localisation.  The stain 
appears to always be nuclear.  The negative control omitting antibody was clear, so 
the staining observed is specific to the primary antibody.  The staining patterns in the 
pars distalis of the pituitary gland appear more widely distributed than the staining in 
the PT (Figure  7.13 Panel A and B), ME (Figure  7.13 Panel A) and paraventricular 
nucleus (PVN) (Figure  7.13 Panels E and F).  The cells that stain particularly densely 
appear to be corticotrophs, due to their sparse location on the edge of the main 
clusters of pituitary (lactotroph) cells (Figure  7.13 Panels C and D).  The negative 
controls omitting primary antibody in the PT and neural tissue of the 







Figure  7.13 Photomicrographs showing ovine hypothalamopituitary sections containing the third ventricle (3V), 
PVN, PT and pars distalis (PD) with ovine PER1 staining (brown) with nuclear counterstain (blue).  The 
arrowheads point to positively stained cells.  G and H are negative controls omitting primary antibody.  The scale 
bars represent 100 mm except in A, C and E, where it represents 1000 mm.  G and H are negative controls 






7.3.1.1 CLOCK PROTEINS IN THE OVINE CORPUS LUTEUM 
IHC was then performed on ovine sections that were obtained from corpora lutea that 
were sampled on Day 30 of the ovine ovarian cycle.  These sections were obtained 
from an existing tissue bank of paraffin-embedded NBF-fixed normal ovine corpora 
lutea.  These sections were used for initial optimisation of the IHC protocol.  The 
ovine clock proteins: CRY1, PER1 and BMAL1 were all observed in the ovine 
corpora lutea (Figure  7.14).  CRY1 localised mainly to the cytoplasm, without strong 
nuclear staining, in the LLCs and SLCs.  The fibroblasts and vascular endothelial 
cells however, did not generally show CRY1 localisation.  The oPER1 protein was 
also present in the cytoplasm of the LLCs, but with the nucleus also often strongly 
stained.  The SLCs demonstrated considerably less cytoplasmic staining and virtually 
no nuclear staining.  Fibroblasts and vascular endothelial cells showed only faint 
oPER1 staining.  BMAL1 was also observed in the sheep CL, using commercial 
antibodies.  It was present in all cell types, predominantly in the LLCs, where staining 
was both nuclear and cytoplasmic.  SLCs were also positively stained but less notably 




Figure  7.14 Photomicrographs showing ovine corpus luteum sections, containing an admixture of luteal cell types 
including LLCs, SLCs, fibroblasts and vascular endothelial cells, with staining (brown) for A: ovine CRY1, B: ovine 
PER1 and C: BMAL1.  D is the negative control omitting primary antibody.  The arrowheads point to putative: 
LLCs (orange), SLCs (green), fibroblasts (blue) and vascular endothelial cells (red).  The scale bars represent 100 






The general aim of this chapter was to raise antibodies against ovine CRY1 (oCRY1) 
and ovine PER1 (oPER1), with the purpose of using them to localise expression of the 
clock genes in the sheep CL.  This was addressed by attempting to identify the 
specific ovine amino acid sequence of each of the two clock proteins, assessing the 
predicted tertiary structure using epitope mapping and hydropathy plotting to identify 
sites most likely to be antigenic, and that could then be used, in an immunisation 
protocol, to raise antibodies in rabbits, in sufficient quantities to be of practical value.  
To this aim, we used a commercial company (Diagnostic Scotland) to produce 
oCRY1 antibodies, while electing to raised the oPER1 antibodies in-house. 
 
At the time of the study, only partial amino acid sequence was available for oCRY1 
and oPER1.  The alignment of these sequences with homolog sequences from other 
species (pig: sus scrofa, human: homo sapiens, rat: rattus norvegicus) as well as ovine 
CRY2 sequence, revealed a clear degree of homology.  This is consistent with the 
concept that clock genes are highly conserved and that their function in generating a 
circadian clock evolved at an early stage of evolution.  The degree of conservation in 
the ovine amino acid sequence meant that such sequence may not be recognised as 
antigenic in an immunisation protocol, as it may too closely resemble the native clock 
protein in the animal used for immunisation.  It was important therefore, that time was 
spent optimising the design of the peptide-antigen, in order that it would be optimally 
antigenic. 
 
To do this, potential epitopic sequences were identified in the ovine amino acid 
sequence, using epitope prediction and hydropathy analysis.  The epitope-mapping 
recognised putative immunogenic amino acid sequences based on known epitopic 
sequences found in other proteins.  The hydropathic characterisation was designed to 
identify the parts of the sequence which would most likely project from the native 
protein and therefore be recognised by the antibody when expressed in the tissue.  The 
characterisation was made based on the hydrophilic or hydrophobic nature of each 
individual amino acid, which determine by the polarity of their side chains.  As a 
result, a 16-amino acid sequence was selected to represent oCRY1 and a 16-amino 
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acid sequence was selected oPER1 for immunisation.  The sequences had an 
additional amino acid: cysteine to allow coupling to the KLH and also to allow 
linkage to the ELISA plates.  The KLH protein is added as it is highly immunogenic 
and increases the antigenic potential of the peptide when conjugated.  The 
immunisation process involved the use of an adjuvant in a series of immunisations, 
used to initially inoculate then boost the production of antibodies in the rabbits. 
 
The immunisation procedures were successful at raising antibodies to the oCRY1 and 
oPER1.  This was assessed initially using an ELISA system, where the unconjugated 
peptide was used as a positive control ligand, to coat the wells of the ELISA plates.  
The immunised sera, at a range of dilutions, were applied to the plates and the 
presence of the antibody that subsequently bound to the plates was assessed using a 
secondary antibody in a colour-changing reaction.  This revealed a clear dilution 
profile, indicating successful specific binding of the antibody to the positive control 
peptide, which allowed the selection of the sera from bleeds with the maximum titre.  
This highest titre antisera were collected from the immunised rabbits, collected from 
the exsanguinating Bleed 5 for oCRY1 and the exsanguinating Bleed 3 for oPER1.  
Aliquots of antisera were also purified using caprylic acid precipitation to remove the 
serum proteins, which left a resulting IgG antibody-rich solution.  The neat and 
purified antisera were then stored in aliquots at -20oC for future studies. 
 
The antibodies were tested in IHC studies using ovine tissues that are known to 
express the clock genes; tissues that include the SCN, adjacent brain nuclei and the 
pituitary gland.  The results for the oCRY1 antibodies revealed clearly defined 
immunoreactive cells.  The oCRY1 studies were much more informative than the 
oPER1 antibodies.  The oCRY1-positive cells were evident in the SCN; up to around 
50 % of the cells were stained.  This contrasts to the situation using commercial 
antibodies, raised against mouse CRY1, which failed to reveal CRY1-positive cells in 
the ovine SCN.  The ovine antibodies also revealed clearly defined cells strongly 
staining in the PeVN and ME, where the immunostaining was evidently principally in 
the cytoplasm, but with some in the nuclei.  Furthermore, in the PT, the staining was 
most strong, where the majority of cells were positive and the positive cells were 
formed into follicular bundles and stranded clusters, while in the PD, positive staining 
was seen with a pattern distinct from that of the PT. 
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The immunoreactivity was regarded as specific because there was no staining in the 
sections when the primary antibody was omitted.  The pre-immune sera ELISAs were 
also devoid of any immunoreactivity.  Also the staining was selective for different 
cells and showed a tissue-specific staining pattern.  Results are consistent with the 
wide distribution of clock gene expression seen by looking at cry1 mRNA in ovine 
brain using in situ hybridisation (Lincoln et al., 2002, Lincoln et al., 2003).  They are 
also consistent with the view that circadian clocks are expressed in a range of 
different neurones in the basal hypothalamus and in the specific secretory cells of the 
pituitary gland.  In particular, the very strong staining for oCRY1 in the PT fits with 
the idea that the PT is a melatonin-target tissue and that melatonin activates cry1 
expression in the PT to relay the effects of photoperiod on seasonal biology, through a 
circadian- or rather clock gene-based mechanism (Lincoln, 2006). 
 
In contrast, the oPER1 antibodies failed to reveal immunoreactive cells in the SCN 
and produced very selective staining in other tissues.  In the PT, relatively few cells 
(less than 10 %) were immuno-positive, and these did not reveal the basic follicular 
structure of the PT, indicating that they were distinct from the PT cells characterised 
by the oCRY1 antibodies.  In the PD, there were clearly defined oPER1 
immunoreactive cells, with strongly staining cytoplasm, that had a distribution that 
was again, very different from that of the oCRY1-positive cells.  These oPER1-
positive cells were tentatively identified as corticotrophs, due to their sparse location 
on the edge of the main clusters of pituitary (lactotroph) cells. 
 
Overall, there was no consistency in the IHC patterns for the two clock proteins, 
which is contrary to the expectation that they would be co-localised in all cells 
expressing a circadian clock.  The best explanation for the observed results is that the 
oPER1 antibodies recognised a specific epitope of the PER1 protein, that is expressed 
by a minority of cells and/or at a specific phase of synthesis and turnover in the 
circadian cycle.  This fits with the observation that immunoreactivity for oPER1 was 
localised to the nucleus in the PT as well as the PVN, in a small proportion of cells, 
whereas the oCRY1 immunoreactivity was cytoplasmic in a wider range of cells than 
these two tissues.  The more heterogeneous oPER1 staining patterns and sparser 
distribution of some of the staining suggests that the oCRY1 staining patterns are 
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more likely to reveal the true distribution of cells expressing the circadian clock than 
those of oPER1.  The selection of the amino acid sequence used to raise the antibodies 
to PER1, based on putative epitope characteristics and hydropathy plots, may have 
generated highly specific antibodies, that are not useful in the general characterisation 
of oPER1 expression but may be specifically useful in characterising the cyclic 
changes in PER1 protein during the 24-h cycle.  This will require further study in 
order to characterise the PER1 protein in order to confirm the specific PER1 protein 
(conformation) recognised.  Also, there was evidence that the antibodies raised in 
different rabbits gave different patterns of distribution, although never the same as 
those for oCRY1. 
 
The special focus of this thesis is on the role of clock genes in the CL.  The ovine 
antibodies were used in preliminary studies to look at clock gene expression in the 
ovine CL.  These studies revealed CRY1 and possibly PER1 immunoreactive cells.  
Notably, the large, LLCs showed staining for both oCRY1 and oPER1, as well as 
BMAL1.  The staining was consistently cytoplasmic for all three clock proteins, with 
more clearly discernible nuclear staining of oPER1 and BMAL1 than of oCRY1.  The 
greater nuclear localisation of BMAL1 than of CRY1 is consistent with the operation 
of a circadian clock where BMAL1 is the positive limb and CRY1 the negative limb 
of an oscillatory negative feedback loop.  It is possible that while the nuclear 
localisation of PER1 occurs, CRY1 is left predominantly cytoplasmic.  This has been 
observed for PER1 which heterodimerises with TIMELESS (TIM), a clock gene 
found in Drosophila, but then translocates into the nucleus in an undimerised form, as 
does TIM (Liu et al., 2007).  It is also not inconsistent with the presence of a cell-
based clock where the necessary time lags required are provided by protein behaviour.  
The staining of the cells was however, generally heterogeneous, which is comparable 
to that seen in the human CL.  The largely random arrangement of the cell types in the 
ovine CL compared to the layered structure of the human CL meant that the cell types 
could only be identified using their homology.  This was easier in the late luteal phase 
when the CL types were better differentiated than in the early luteal phase.  A more 
definitive method of identifying the ovine cell types that the clock proteins localise to 
would require immunoflourescent co-localisation.  The steroidogenic cells would be 
identified using 3HSD, and the LLCs distinguished from the SLCs by morphology, 
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as ovine LLCs do not produce œstrogen and therefore do not contain aromatase.  The 
fibroblasts would similarly be identified using cell morphology.  The staining that was 
observed is considered to be specific as the negative control omitting the primary 
antibody was entirely clear of staining. 
 
Unlike the situation with the neural and pituitary tissues, where expression of the 
oCRY1 and oPER1 immunoreactivity was very different for the two clock proteins, 
the patterns in the ovine CL were essentially the same or very similar.  This may be 
accounted for by the proteins assuming different native conformations in the different 
tissues.  These different conformations may indicate that the roles of these proteins 
are varied between the tissues, in which clock functions may be tissue-specific.  The 
IHC was performed on brain and luteal sections as a preliminary study and so, 
multiple brains and corpora lutea, sampled across 24 hours were not used. 
 
In conclusion, the ovine clock genes: oCRY1 and oPER1 as well as BMAl1 localised 
to all cell types in the ovine CL, though they were most consistent in the LLCs; which 
was very similar to that of the human granulosa-lutein cells. 
 
 
In summary, this chapter has:- 
 
1. successfully raised antibodies specifically against oCRY1 and oPER1; 
 
2. detected oCRY1 in the ovine SCN, PeVN, ME, PT and CL; 
 
3. detected oPER1 in the ovine PVN, PT, PD and CL; 
 
4. detected BMAL1 in the ovine CL 
 
8 GENERAL DISCUSSION 
 
 
Reproduction is a timely process, requiring the temporal co-ordination and convergence 
of many critical events (Boden and Kennaway, 2006, Kennaway, 2005, de la Iglesia and 
Schwartz, 2006, Goldman, 1999).  Several female reproductive structures are known to 
express clock genes, including the ovary, oviduct, oocyte, ovarian follicle, uterus and 
CL.  The function of the clock genes in these structures is not yet known, but has been 
speculated to involve the regulation of reproduction and fertility.  The expression of the 
canonical clock genes: arntl (bmal1), clk, per1, per2 and cry1 have been reported in the 
rat ovary, where arntl and per2 were rhythmically expressed, in antiphase, suggesting 
that a functional circadian clock resides in the ovary (Karman and Tischkau, 2006).  The 
expression of per1 and per2 has been observed throughout the œstrous cycle and has 
been localised using in situ hybridisation to the pre-antral, antral and pre-ovulatory 
follicles and interstitial glandular tissue (Fahrenkrug et al., 2006).  The rhythmic 
expression of arntl and per2 was also affected by LH (Karman and Tischkau, 2006).  
This suggests that clock genes function, potentially as endogenous clocks, throughout 
the maturation of the follicle. 
 
The oviduct also expresses bmal1 and per2 rhythmically.  The expression of the other 
canonical clock genes: clk, per1, cry1 and cry2 were also seen (Kennaway et al., 2003).  
It was proposed that the clock genes function to protect the developing embryo in the 
oviduct, for example, via the rhythmic expression of plasminogen activator inhibitor-1 
(PAI-1) which can protect the early embryo from proteases and/or matrix remodelling 
before implantation in the uterus (Kennaway et al., 2003).  The rhythmic expression of 
the clock and clock-controlled genes may provide a periodic environment to which the 
developing embryo exposed.  The embryo spends somewhere between one to two weeks 
in this periodic oviductal environment, depending on the species, a time span of several 
 258 
circadian periods, before implantation.  This periodicity is likely to be necessary for the 
timed development of the embryo which also expresses its own intrinsic clock genes and 
for the timed passage through the oviduct, where the circadian clock provides a highly 
regulated control of the time before entry into the uterus.  The uterus also expresses 
clock genes rhythmically, although their exact function remains unclear (Boden and 
Kennaway, 2006).  P4 production by the developing CL is known to act on the uterus to 
prime the development of the endometrium.  It is probable that the clock gene 
expression in the uterus governs the circadian window of implantation, when the 
developing blastocyst is able to successfully implant; some five to ten days after 
ovulation.  The importance of the circadian clock during gestation is indicated by the 
occurrence of increased fœtal resorption and full-term pregnancy failure in clock gene 
mutant mice (Miller et al., 2004). 
 
Following ovulation, the cells of the dominant follicle that were exposed to the LH surge 
develop in a CL by the process of luteogenesis.  The clock genes expressed in the 
ovarian follicle, particularly in the granulosa cells, appear to continue being expressed in 
the CL, particularly in the ovarian granulosa cell-derived granulosa-lutein cells (He et 
al., 2007a).  During luteogenesis, the luteal cells proliferate and hypertrophy, recruit 
blood vessels, differentiate and rapidly develop into a large endocrine organ.  The CL 
produces P4 in progressively increasing quantities from the early through to the late 
luteal phase.  P4 is essential for implantation through the activation of endometrial 
development in the uterus and for feeding back on to the brain to stop gonadotrophin 
secretion and to block further ovulation.  It thus determines the length of the œstrous or 
menstrual cycle.  If pregnancy does not occur, the CL is destroyed by a luteolytic 
mechanism, which is regulated in a variety of ways in different mammals.  This results 
in the withdrawal of P4, with consequent effects on the uterus, including menstruation in 
women, as well as the removal of inhibition effects in the brain, that then triggers the 
onset of the next reproductive cycle.  The lifespan of the CL, particularly in humans, is 
relatively stringently controlled, and is likely to feature clock gene regulation.  Certainly, 
the clock genes: bmal1, clk, per1, per2, cry1 and cry2 were observed, in the studies 
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contained in this thesis, to be expressed in the human and the ovine CL throughout the 
luteal cycle.  The clock proteins localised to all the cell types discernible in the human 
CL, and preliminary studies indicate that this is also true in the ovine CL.  Although, at 
the start of these studies, no clock genes had been discovered in the CL, there are now 
other independent reports which corroborate the findings of clock gene transcription and 
translation in the mammalian CL (Boden and Kennaway, 2006, Fahrenkrug et al., 2006). 
 
It is becoming increasingly evident that clock genes serve an important function in the 
regulation of reproduction.  The characterisation of clock gene mutant phenotypes has 
revealed specific incidence of subfertility and impaired reproductive function (Boden 
and Kennaway, 2006, Kennaway et al., 2005).  It has even been reported that colonies of 
bmal1 null mutant mice should be maintained as heterozygotes as colonies of 
homozygotes have severe fertility impairment (Boden and Kennaway, 2006).  It is 
already known that the pre-ovulatory LH surge is controlled by the circadian clock, 
gated to the night time in mammals including humans, by the SCN (Kennaway, 2005).  
Many other hormones involved in the reproductive axis are also known to be regulated 
by the circadian clock (Kennaway, 2005).  What is not known, is the function of the 
clock genes and the circadian system in the regulation of reproduction as a whole, and 
particularly at the level of the gonads and reproductive tract, in the HPG axis.  The 
female reproductive tract houses not only clock gene expression but many timely events, 
suggesting that the local expression of clock genes may be involved in regulating these 
events.  Examples of these events, such as follicular development and ovulation, along 
with the reproductive tissues that house them, which express clock genes are 
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Figure  8.1 Timeline of temporally regulated tissues and events in reproduction. 
 
 
The overall regulation of these processes is likely to occur at various levels of 
hierarchical organisation, both locally within the tissue and more systemically, 
controlled by the brain.  The various levels at which clock genes and temporal processes 
may regulate the reproductive axis are illustrated in Figure  8.2.  These processes are 
inter-related and feed back on each other to produce intercalated feedback loops.  These 
looped processes occur in various tissues, which are also likely to possess endogenous 
clocks.  Certainly, the hypothalamus, which governs many reproductive processes, 
contains the SCN – the master pacemaker of the circadian system, a nucleus composed 
mainly of cells with endogenous clocks.  The reproductive tract too is likely to be 
composed of peripheral tissues clocks, which will also fall under the control of the SCN.  
The hypothalamus then is at the top of both the circadian and reproductive 
organisational hierarchies and as such, very likely enables the integration of these two 
systems spatially, in order to provide temporal co-ordination of both systems, with each 
other and with geophysical time.  The function of clock genes in the hypothalamus 
however does not preclude a local function for the clock genes in the reproductive tract 
itself.  It is likely that clock genes in the reproductive tract are of importance in the co-
ordination of reproductive tract functions.  This is best illustrated in the domestic 
chicken, where the pre-ovulatory follicles express clock gene rhythms that are linked to 
the regulation of steroidogenic synthesis and release, and these rhythms feed back to the 
 261 
hypothalamus to govern the timing of gonadotrophin secretion and ovulation.  
Therefore, the SCN co-ordinates the reproductive axis with respect to the time of day, 
while the ovary co-ordinates the reproductive axis with respect to the maturation of the 
ovarian follicles, and combined together, these two systems ensure the optimal timing of 
the reproductive cycle. 
 
This proposed two-system mechanism is illustrated in Figure  8.2.  The circadian clock 
gene-expressing SCN pacemaker governs the pulsatile release of GnRH from the 
hypothalamus, which in turn effects the pulsatile release of LH and FSH from the 
pituitary gland, which also circadianly expresses clock genes.  These gonadotrophins 
stimulate the maturation of the ovarian follicle, which is able to synthesis œstrogens 
from its clock gene-expressing steroidogenic granulosa cells.  Œstrogens feed back to 
the hypothalamus, including the SCN, which is œstrogen-responsive - possessing both 
alpha (ER) and beta (ER) œstrogen receptors, to direct the pre-ovulatory surge in LH 
release (Kruijver and Swaab, 2002, Vida et al., 2008, Shinohara et al., 2001).  Ovulation, 
gated to the night time, releases the cumulus-oocyte complex, which expresses clock 
genes, from the pre-ovulatory follicle into the oviduct, which also expresses clock genes.  
The leftover follicular cells rapidly remodel into a clock gene-expressing CL, which also 
expresses StAR in a circadian fashion, and produces P4.  P4 affects the clock gene 
expressing uterine endometrial cells, in preparation for implantation of the successfully 
fertilised embryo, as well as affecting the oviduct and embryo itself.  It is able to feed 
back to the hypothalamus, where the SCN can respond via its P4 receptors (PR) 
(Kruijver and Swaab, 2002, Shinohara et al., 2001).  The embryo, which travels from the 
oviduct to implant as the feto-placental unit in the uterine endometrium, secretes hCG, 
which acts as a luteotrophic maternal recognition of pregnancy signal, that was found in 
the studies contained in this thesis to affect clock gene expression in the CL.  The P4 
signalling back to the embryo as well as the hypothalamus and SCN – which possesses 
P4 receptors, therefore closes two feedback loops.  The CL, like the ovarian follicle, is 
also able to synthesise œstrogen, which may also signal back to the hypothalamus and 
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The SCN also controls the nycthemeral secretion of melatonin, which acts as a measure 
of the photoperiod and which may thus impose another level of temporal regulation on 
the reproductive axis.  This is likely to be how the circadian and reproductive systems 
are co-ordinated with seasonal geophysical time in seasonally reproductive species.  
Disruption of melatonin signals have been shown to affect the timing of implantation, 
demonstrating that melatonin does interact with the reproductive axis periods (Miller et 
al., 2004, Berria et al., 1988, Barbacka-Surowiak et al., 2003).  Melatonin is also 
proposed to affect the CL, based on the reports of granulosa-lutein cells possessing both 
MT1 and MT2 melatonin receptors and on the observations of the studies reported in this 
thesis (Tamura et al., 2008). 
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In the ovine PT, which is a classical melatonin-target tissue, photoperiodism affects 
seasonal physiology through the phase control of clock gene: cry1 and per1 expression.  
With cry1 expression linked to dusk and per1 expression linked to dawn, the per-cry 
expression interval varies with the duration of the night and thus, it is proposed that with 
photoperiod, the relative coincidence between gene expression of the two genes is 
thought to determine the PER-CRY dimerisation and transcriptional control of 
downstream clock-controlled genes.  The expression of these two clock genes therefore 
function as an internal coincidence timer (Lincoln et al., 2002).  The expression of cry1 
in the ovine CL during the LL phase appears to be melatonin-inducible, much like it is in 
the ovine PT.  In the mature ovine CL, all the clock genes: bmal1, per1, cry1 and cry2, 
bar per2, were rhythmically expressed.  However, the phase relationship between the 
peaks of expression of the positive limb gene: bmal1 and the negative limb genes: per1, 
cry1 and cry2 of the circadian clock were not as expected for the classical endogenous 
circadian clock, epitomised by the clocks in the SCN.  Moreover, per2 was rhythmic in 
EL and not rhythmic in the mature late luteal CL.   
 
This raises the question of whether there is true intrinsic circadian clockwork in these 
luteal cells.  The phase relationships of clock gene expression from intact CL are not 
consistent with that of a classical circadian clock, but rhythmic clock gene expression 
was nevertheless, observed.  These rhythms could be generated by rhythmic protein 
interaction, which is regulated via post-translational mechanisms, such as 
phosphorylation.  Phosphorylation of the clock proteins already occurs in both the 
central and the peripheral clocks, where they are integral to the determination of the 
period of the clock.  This is demonstrated clearly by the tau mutation in hamsters, which 
produces a shorter than 24 hour phenotype as a result of a mutation in the CK1 gene, 
which encodes a kinase that phosphorylates clock proteins.  Thus, the post-
transcriptional and post-translational control of clock proteins may be a critical feature 
determining the clockwork.  The question of whether there is true intrinsic circadian 
clockwork in luteal cells cannot therefore be answered until the temporal profile of the 
clock proteins have been characterised.  These may well exist as it is already known that 
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post-translational mechanisms act to modulate the function of crucial proteins such as 
StAR, which is essential for the main function of the CL: steroidogenesis.  The 
requirement for post-translational mechanisms for the provision of temporal clock gene 
function indicates that extrinsic factors may be required to drive the clock gene 
expression. 
 
Melatonin may be such an extrinsic factor.  Its secretion at night may regulate rhythmic 
clock gene transcription in the CL as does in the PT.  This is possible since MT1 and 
MT2 melatonin receptors are expressed in the CL and melatonin is known to affect P4 
secretion from the CL (Woo et al., 2001).  In the PT, where the role of melatonin in the 
control of clock gene transcription has been best studied, an increase in melatonin 
concentration at night activates cry1 transcription, while the decrease in melatonin levels 
at dawn activates per1 transcription; and this control provides phase control of these two 
gene rhythms.  In the late luteal ovine CL, peak cry1 expression occurred in the night 
time, consistent with the possibility of melatonin-induced activation, while per1 
expression peaked in the early morning, consistent with the possibility that it is regulated 
by melatonin withdrawal.  This extrinsic regulation of cry1 and per1 by melatonin may 
be the mechanism by which luteal clock gene rhythms are functionally and seasonally 
co-ordinated.  The involvement of extrinsic control from hormones, such as melatonin, 
is most probable since it provides a mechanism whereby the rhythmic function of the CL 
is linked to the peripheral physiology and ultimately linked to the day-night cycle.  It is 
clear in humans that LH and hCG have a physiologically trophic effect on the CL.  It 
was observed here that the acrophases and mean levels of putatively rhythmic clock 
gene expression were affected by time spent in culture and hCG-treatment, in the LGCs.  
The effect of hCG on rhythmic arntl and bmal1 expression in the rat ovary has also now 
been reported (Karman and Tischkau, 2006).  It is also likely that other multiple 
extrinsic factors impact on the clock gene driven temporal regulation of the CL. 
 
If a melatonin-inducible clock gene expression mechanism operates in the CL as in the 
PT, this could affect clock gene driven outputs.  In the current studies of the ovine CL, 
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the sheep were housed under short photoperiod because this is stimulatory to the 
reproductive axis, through the activation of gonadotrophin secretion via the melatonin-
dependent system.  However, we did not study the CL in animals exposed to long 
photoperiods, to measure clock gene expression in the CL.  This could be achieved by 
holding the sheep under prolonged long photoperiod, which results in the development 
of photoperiodic refractoriness and the development of the reproductive axis.  The 
current prediction is that, if the CL behaves like the PT, the development of the CL 
might be disrupted under long photoperiod and this might be reflected by decreased 
progesterone secretion.  Thus, photoperiod may act through both the central control of 
gonadotrophin secretion in a classical fashion and also through a negative effect on the 
target tissues, such as the ovary. 
 
The effect of melatonin on the induction of cry1 in the CL may be specific to species 
whose reproductive axes are seasonally regulated, like the sheep and the hamster.  
Whether the same mechanism of melatonin-induced cry1 activation is found in the 
human CL (and human PT) remains to be seen.  There is evidence though that human 
fertility, certainly in males, is responsive to seasonal changes (Goldman, 1999, 
Kennaway, 2005).  The expression of the clock genes in the testis, like that of the late 
luteal ovine CL, also appears to be unlike that of a classical circadian clock.  Rather the 
clock gene expression appears to be involved in the regulation of spermatogenesis.  The 
expression of the clock genes in both male and female gonads appear to recapitulate that 
which is involved in the regulation of embryonic development (Seron-Ferre et al., 2007, 
Sakamoto et al., 2002, Sladek et al., 2007).  In this role, the clock genes do not appear to 
be functioning like a classical circadian clock, as they do during the development of the 
embryo as a whole.  There is evidence that clock gene expression during luteogenesis 
recapitulates clock gene expression in the ontogenesis of organs such as the heart and 
the liver (Seron-Ferre et al., 2007, Sakamoto et al., 2002, Sladek et al., 2007). 
 
The per2 gene is of special interest and may be involved in the extra-circadian role of 
clock genes during ontogeny and development.  It has already been shown to be unique 
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in several ways. Tissue-specific expression patterns and responses to stimuli such as 
food entrainment have been observed particularly in per2 (Feillet et al., 2006).  This 
particular clock gene was unusual in the ovine CL that it was expressed rhythmically 
during the early luteal phase but not during the late luteal phase, in direct contrast to the 
expression profile of the other clock genes measured.  This was consistent with the 
observation that per2 appears to function and respond in ways that are divergent from 
those of the other clock genes (Albrecht et al., 2007).  It is a negative regulator of 
VEGF, which plays a major angiogenic role in the CL.  VEGF is highly expressed 
during EL when it is essential for the development of rich capillary networks, after 
which, it continues to function to maintain and stabilise blood vessels, thus enhancing 
luteal function.  VEGF withdrawal is also involved in the controlled regression of the 
microvascular tree during luteolysis (Fraser and Wulff, 2003, Kaczmarek et al., 2005).  
The rapid neovascularisation of the CL during luteogenesis in some ways recapitulate 
those seen in tumorigenisis.  A role for per2 has often been observed in the suppression, 
development, progression and treatment of cancer.  Its expression is decreased along 
with that of per1 and cry2 in epithelial ovarian cancer (Tokunaga et al., 2008).  Mutant 
per2 mice have increased incidence of cancer and show abnormal expression of the 
oncogenes: cyclin D and c-myc.  These genes are involved in controlling the 
proliferation of cells.  The timing of cell division is in fact gated by the circadian clock, 
both within and among cells (Matsuo et al., 2003).  Much evidence now supports the 
role of per2 as a tumour suppressor gene, involved in regulating cell division as well as 
DNA repair, another factor which is involved in tumorigenesis (Albrecht et al., 2007).  
Another observation that was particular to per2 was of its protein distribution in the 
human granulosa-lutein cells of the intact CL, which were observed to aggregate in 
discrete foci arranged around the edge of the cells, as if apposed to the cellular basement 
membrane.  The PER2 protein has been found to oscillate circadianly in absence of 
rhythmic per2 transcription.  This is likely to be due to post-translational modifications 
such as phosphorylation, which has been reported to impact significantly on the amount 
of time that the protein is localised in the cytoplasm, either due to progress along the 
ubiquitin-proteosome degradation pathway or translocation into the nucleus (Albrecht et 
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al., 2007).  The PER2 protein may also interact with progesterone receptors, perhaps 
modulating the autocrine progesterone signalling in the CL.  PER2 possesses motifs that 
are similar to those of hormone co-activators and corepressors, such as the steroid 
hormone receptor co-activator-1 (SRC-1), which is known to interact with different 
nuclear receptors, including the progesterone and œstrogen receptors (Albrecht et al., 
2007).  It is therefore possible that PER2 may be able to act with nuclear receptors such 
as those of progesterone, though no interaction between PER2 and a nuclear receptor has 
yet been reported (Albrecht et al., 2007).  PER2 may function as a scaffold protein, 
binding more than one protein partner in order to bring them into close proximity with 
each other to work as a complex to induce a specific cellular response. 
 
The window during which the clock genes function in an extra-circadian role in 
luteogenesis may be small, as the rapid development of a fully functional tissues ensures 
the most efficient use of time during the finite luteal lifetime.  Similarly, the window for 
luteolysis may also be small, meaning that the observation of clock gene function during 
this time must be specifically targeted to the very late luteal phase when the CL is 
actively initiating and undergoing luteolysis.  Clock genes may well then be observed 
altering their different patterns of expression and/or protein localisation in the luteal 
cells, and have certainly already been shown to activate apoptotic pathway genes in 
other cells undergoing cell death (Gery et al., 2005, Chen-Goodspeed and Lee, 2007). 
 
The role of clock genes in the timing of luteolysis is particularly pertinent in humans, 
where the CL has a relatively fixed lifespan, which is presumably determined by the 
onset of luteolysis.  It was not possible however to determine whether the clock genes 
were rhythmically expressed over 24 hours in the intact human CL due to the inability to 
sample human corpora lutea over a 24-hour period.  It was also difficult to determine in 
vitro whether clock gene expression was rhythmic in LGCs.  The clock gene expression 
that was observed in the cells was highly variable over a 24-hour time course.  This was 
unaltered between samples from cells after one day in culture and eight days in culture.  
Nor was hCG observed to have a statistically significant effect on rhythmicity.  The 
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results of these LGC studies may not however be a true representation of clock gene 
expression in the intact CL.  It is proposed that the dispersion of the LGCs in the 
culturing process disrupts the cell-to-cell communication which is required for the 
temporal synchrony of the cells, such that an overt rhythmic expression cannot be seen 
in the clock genes.  It is likely that cell-to-cell communication between the luteal cells 
occurs.  This is further supported by the evidence of more overtly rhythmic clock gene 
expression that was observed in the luteal fibroblast-like cells after serum shock.  These 
cells, having grown to confluence, were able to preserve their channels of cell-to-cell 
communication, and thus synchronise their clock gene expression rhythms in order to 
evince detectable circadian rhythms (Balsalobre et al., 1998).  The clock gene expression 
in the luteal fibroblast-like cells also suggests that these cells may be involved in the 
temporal regulation of the CL, perhaps in conjunction with the steroidogenic cells.  The 
cell-to-cell communication channels in the intact CL may therefore exist both between 
cells of the same cell type and cells of different luteal cell types.  The entrainment of the 
luteal fibroblast-like cells by serum shock indicates that these cells can be entrained and 
as such, are susceptible to extrinsic signals.  These signals may originate from outside 
the ovary, for example hCG signalling to the steroidogenic cells, or from inside the 
ovary, where paracrine and autocrine signalling has already been demonstrated to be 
fundamental to the normal steroidogenic function of the CL (Johnson and Everitt, 2000, 
Duncan et al., 2009).  The concept of cell-to-cell communication in the CL is not novel.  
Luteal œstradiol synthesis is known to involve the theca-lutein and granulosa-lutein cell 
types working together, using paracrine cell-to-cell signalling.  Luteolysis also appears 
to involve paracrine signalling between the steroidogenic cells and the fibroblasts using 
activin (Myers et al., 2007a).  The use of intercellular communication has also been 
shown to be crucial for the temporal function of cells in the SCN (Liu et al., 2007).  The 
main features of this proposed cellular communication in the co-ordination of clock gene 
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Figure  8.3 A schematic of the fully functional CL demonstrating the putative cell-to-cell communication pathways that 
mediate temporal regulation of  luteal function and lifespan, including circadian gene expression, outlined by the 






It is likely that the mechanisms controlling the luteal lifespan are different between 
sheep and humans.  Sheep employ largely extrinsic control whereby PGF2 production 
by the uterus provides the dominant control, while humans appear to be more dependent 
on intrinsic timing, which is likely to involve clock gene regulation.  While the sheep 
utilises PGF2 as its principal luteolytic signal, it is still possible that an intrinsic control 
mechanism exists.  The regression of the CL could be induced artificially by PGF2, 
which might alter the clock gene expression and dissociate the extrinsic and intrinsic 
regulation of the CL.  Thus, it may be possible to develop a model where the uterine 
source of PGF2 is removed and the subsequent fate of the CL is studied in a system 
where the intrinsic and extrinsic clocks have been dissociated.  The intrinsic role of 
clock genes in the timing of the lifespan of the CL might be revealed, devoid of any 
other signalling from elsewhere in the reproductive axis. 
 
The view of clock genes and clocks have been revised in several ways and there is now a 
better understanding of the different kinds of clocks working in cells and tissues, which 
interact with each other in a hierarchical organisation of homeostatic control, and which 
together provide the basis of co-ordinated time-keeping within an organism and in 
synchrony with geophysical time.  
 
In summary, the main findings of this thesis were that clock genes are expressed in the 
human and ovine CL; that this expression is manifest at mRNA and protein level in all 
discernible cell types within the CL and that the pattern of expression differs between 
the early luteal phase compared to later luteal phases, in both sheep and humans.  The 
circadian expression of the clock genes was established in the late luteal phase CL in 
sheep and could not be confidently ascertained in humans due to practical restrictions, 
although there was a trend towards circadian gene expression in the LGCs.  With the 
exception of per2, the circadian pattern of clock gene expression emerged in the late 
luteal phase CL when the early luteal phase CL did not demonstrate circadian clock gene 
expression.  This emergence later in the lifespan of the CL was akin to that observed in 
embryonic development, where the clock genes are initially non-rhythmic but then 
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acquire circadian rhythmicity with age.  In this case, the clock genes have been proposed 
to perform a non-classical circadian timing role in the timing of embryonic development.  
The per2 gene was also found to be special, in its pattern of rhythmic gene expression 
across the luteal lifespan (initially rhythmic, then becoming arrhythmic) and in its 
protein localisation in the granulosa-lutein cells (aggregating in cytoplasmic foci).  The 
exceptional behaviour of per2 is consistent with a growing body of evidence supporting 
its role as a unique clock gene in many respects, able to maintain circadian protein levels 
in the absence of circadian gene expression, integrating peripheral clock inputs and 
outputs and acting as a tumour suppressor gene (Feillet et al., 2006, Albrecht et al., 
2007).  The CL was also found to be a potential target of melatonin regulation, based on 
its possession of melatonin MT1 receptors and the timing of circadian cry1 gene 
expression in the late luteal phase.  The expression of cry1 is known to be directly 
melatonin-induced in the PT and may be similarly activated, downstream of a melatonin 
signal, in the CL.  This supports the evolving view of a hierarchical organisation of the 
central and peripheral clocks, which are integrated in order to establish information 
feedback loops that maintain circadian homeostasis, and which can regulate seasonal 
physiology. 
 
The better elucidation of the role of timing and temporal regulation of the female 
reproductive axis is particularly important as more and more women choose to have 
children later in life, with a corresponding increase in the financial investment in 
assisted reproductive technologies.  The timing of the administration of fertility drugs 
and of surgical techniques may be revealed as important factors conducive to successful 
assisted reproduction.  It is likely, for example, that the surgical implantation of the 
fertilised oocyte could be optimised to occur at a circadian time when the uterus and the 
endometrium are most prepared for successful implantation.  The CL may also pose a 
useful paradigm for the study of clock gene expression in peripheral tissues where the 
expression of the clock genes may be multifunctional and may include non-classical 
circadian clock functions.  It could also provide examples of how else clock gene-driven 
clockwork mechanisms can function.  Reproduction, which is fundamental to life, may 
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represent a unique paradigm for unveiling primitive and highly conserved mechanisms, 
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